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Previous research has identified that HIV-positive drug users had poorer 
adherence to HIV medications compared to other HIV populations. However, 
there is a lack of understanding of their experiences of taking HIV 
medications in Taiwan. Therefore, I propose to develop a conceptual model 
to understand HIV-positive drug users’ adherence to HIV medication using a 
qualitative research method. Findings from this study show that the 
integration of HIV-positive identity into sense of self can play an important 
role in self-acceptance and emotion stability. The values individuals place on 
HIV medications is the core and driver of their medication-taking behaviour 
change. Individuals’ conscious engagement in medication taking can 
facilitate their adherence behaviour maintenance. To conclude, I believe this 
Identity-Values-Conscious Actions Model can provide a useful guideline for 
nurses to develop adherence assessment and associated interventions for 













Background: HIV-positive drug users’ poor adherence to Highly Active 
Antiretroviral Therapy (HAART) is a serious global health issue. Erratic use of 
HAART can result in incomplete viral suppression, increased Human 
Immunodeficiency Virus (HIV) transmission, development of drug resistance, 
and limitation of treatment options (Lima et al., 2008, Meresse et al., 2014, 
Sethi et al., 2003). In clinical practice, nurses play a key role in assessing 
and supporting HIV-positive drug users’ health conditions and adherence to 
medication regimens during their treatment process. In that sense, it is 
pivotal to understand HIV-positive drug users’ experiences of taking HAART 
in Taiwan. 
Aim: The aims of this research are to explore HIV-positive drug users’ 
experiences of taking HAART in Taiwan, and further develop a conceptual 
model synthesised from the study findings and existing theories that can 
enhance understanding their experiences. 
Method: A qualitative study drawing from Constructivist grounded theory 
approach was conducted to achieve the aims. A sample of 22 HIV-positive 
drug users was recruited in Northern and Southern Taiwan between 
September 2015 and July 2016. Semi-structured in-depth interviews were 
conducted to explore participants’ experiences of taking HAART. Data were 
analysed by using Charmaz’s (2014) initial and focused coding principles. 
The integration and formation of a conceptual model began with focused 
coding and proceeded through the subsequent analytic process. 
Findings: Three major concepts emerged in the analysis: 1) HIV-positive 
identity as part of self-identity, 2) Values attached to HAART, and 3) 
Conscious Actions. The three concepts were integrated into a conceptual 
model, Identity-Values-Conscious Actions Model. This proposed model 
suggests that individuals’ integration of HIV into self-identity can lay a solid 
foundation for self-acceptance and emotion stability. Having this integrated 
identity, the values individuals place on HAART play a central role in driving 
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their HAART-taking. While the values individuals place on HAART can trigger 
behavioural changes, data revealed that implementation of conscious actions 
is an important element for behaviour maintenance.  
Conclusion: The following conclusions can be drawn from this study. Firstly, 
the model developed from the study findings can extend our knowledge and 
understanding of the mechanism underlying HIV-positive drug users’ 
HAART-taking behaviour in the Taiwanese context, and can act as a new 
reference point to contribute to the development of adherence assessments 
and associated nursing interventions. Secondly, the findings of this study can 
draw policymakers’ attention to HIV-positive drug users’ voice, and suggest 
to influence policies that can lead to a more inclusive society. Finally, building 
on the findings from this research and previous studies, further work needs to 
be done to assess whether this model can be applied to help understand 
HIV-positive drug users’ experiences of taking HAART in different social and 
cultural contexts.   
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CHAPTER ONE: INTRODUCTION 
1.1. Introduction 
Acquired Immune Deficiency Syndrome (AIDS)/Human Immunodeficiency 
Virus (HIV) was first identified in 1981 (Sharp and Hahn, 2011, Vella et al., 
2012). Thirty years after its identification, at least 60 million people had been 
infected and more than 25 million deaths were caused by the disease (Sharp 
and Hahn, 2011). Following the significant impact of AIDS-related deaths, 
huge efforts started in an attempt to control the virus (Sharp and Hahn, 
2011). In 1996, Highly Active Antiretroviral Therapy (HAART) was introduced, 
which has been changing the landscape of HIV, from a lethal disease to a 
chronic and manageable health condition (Hogg et al., 2008, Vella et al., 
2012, World Health Organisation, WHO, 2014a). Since the advent of HAART, 
the number of people living with HIV has dropped from 60 million in 2011 to 
36.7 million in 2017 (Joint United Nations Programme on HIV/AIDS, UNAIDS, 
2017). 
However, it was evident and widely recognised that more than 95% of 
prescribed HAART medications should be taken in order to achieve complete 
viral suppression (Paterson et al., 2000, Ortego et al., 2011, WHO, 2013). 
Suboptimal adherence could lead to the emergence of drug resistance and 
limited treatment options (Sethi et al., 2003, Lima et al., 2008, Meresse et al., 
2014). As such, it highlights the importance of adherence to HAART among 
people with HIV. Among the general HIV population, HIV-positive drug users 
have been reported globally and in Taiwan to be less likely to access HIV 
care and adhere to treatment regimens (Ware et al., 2005, Wang et al., 2008, 
Yang et al., 2008a, Ortego et al., 2011, Wasti et al., 2012, World Health 
Organisation, World Health Organisation, WHO, 2013, Hansana et al., 2013, 
Chakrapani et al., 2014). In addition, the development of Tuberculosis (TB) is 
particularly common among HIV-positive drug users as a result of suboptimal 




is becoming extremely difficult to ignore the existence of HIV-positive drug 
users’ suboptimal adherence to HIV care (Ware et al., 2005, Wang et al., 
2008, Yang et al., 2008a, Ortego et al., 2011, Wasti et al., 2012).  
Despite the importance of regularly taking HAART, there remains a paucity of 
evidence on HIV-positive drug users’ experiences of taking HAART globally 
and specifically in Taiwan. The research to date has tended to focus on 
measuring the rates of drug users’ adherence to HAART rather than gaining 
insight into the mechanism underlying their HAART-taking behaviour. 
Additionally, no qualitative research has been conducted in relation to this 
research topic in Taiwan and East Asia at large. This formed the basis of the 
research inquiry for this thesis.  
Since September 2015, the United Nations (UN) has promoted 17 
Sustainable Development Goals (SDGs) plan of action in an attempt to end 
poverty, protect the planet and ensure prosperity for all (United Nations, UNs, 
2015). The understandings of drug users’ experiences of taking HAART in 
this qualitative study in Taiwan can help to fulfil the UNs’ SDGs by allowing 
HIV-positive drug users’ voice to be heard, appropriately shaping the delivery 
of HIV nursing care, and informing policymakers to create an inclusive and 
just environment for this vulnerable population in the Taiwanese context. 
The purposes of this chapter are to introduce 1) my motivation of undertaking 
this research in Taiwan in conjunction with the research aims and questions, 
2) how this study can facilitate fulfilling the UNs’ strategic policy of SDGs, 3) 
key terminology used in this study, and 4) the outline of this thesis. 
1.2. My motivation for this research 
My motivation to conduct this study with HIV-positive drug users is based on 
my previous clinical work experience in Taiwan. Over the period between 
2009 and 2010, I worked in an infectious diseases unit as a registered nurse. 
While there, I had taken care of patients with HIV, tuberculosis, hepatitis, 




the hospital as an HIV unit where patients with HIV would be admitted for 
undertaking treatments. The reason for this was that there were several HIV 
specialists based in our unit to provide specialised HIV care. While working 
there, I noticed that many patients with HIV appeared to stigmatise 
themselves. For example, upon admission, we would need to ask if patients 
would like to inform their family or friends of their HIV status. The majority of 
them preferred to not disclose their HIV status due to their feeling of shame 
regarding carrying HIV. There were also some patients who appeared to be 
rejected by their families due to their engagement in illicit drug use and other 
illegal activities. As such, it was fairly common to see that patients were 
hospitalised without the involvement of the patient’s family. Without the 
acquisition of support from significant others, patients tended to be more 
isolated and less actively talked to people.  
At the time of working as a nurse in Taiwan, I noticed that HIV-positive 
patients’ psychological well-being was less likely to be taken care of by 
nurses. Our heavy workloads did not allow us to have time to sit down with 
patients and deeply understand their situations and concerns. For instance, 
one of my patients, who was HIV positive and had lymphoma, appeared to 
be distressed. Even though he had support from his family, he appeared to 
feel down and refused to take medications. I had tried to talk to him, however 
he shut himself down and did not want to talk. None of the nurses, other 
health professionals, and his family would be able to persuade him to take 
medications. I could feel that he seemed to be lost and felt hopeless. I 
wondered whether  the patients’ background and stories could shape their 
self perception, health decisions, and subsequent actions. However, it 
seemed that we did not make many efforts to deeply understand him and 
explore the stories behind his non-adherence to a prescribed regimen. 
Instead, I heard one or two of my colleagues blaming him for not taking care 
of himself and being irresponsible for his own health.      
While working in the infectious diseases unit, patients who were HIV-positive 




hepatitis, or other infectious diseases). In particular, patients with HIV and 
tuberculosis needed to take several pills (more than 5 pills/per time). During 
patients’ hospitalisation, we would administer medications and supervise 
their medication taking. Nonetheless, I found that a number of patients did 
not regularly take medications at home. Such a discovery was learnt through 
my communication with patients upon their admission. Asking patients about 
whether they had unused medications was part of our nursing assessment 
upon their admission. Many patients would hand over bags of their unused 
medications to us, and then we would administer and finish those 
medications first before ordering new medications. It was part of our routine, 
however we did not deeply understand the reasons why they did not strictly 
follow a prescribed regimen. In our shift reports, we rarely paid much 
attention to it. Instead, we complained patients did not adhere to medication 
regimens and wasted medical resources. Reflecting on these experiences, 
this has brought me to the inquiry as to why some HIV-positive patients 
would not regularly take antiretroviral medications and what the underlying 
issues were that contributed to such acts.  
Having gone through the literature review on the topic of HIV-positive 
patients’ adherence to HAART in my first year of PhD studies, HIV-positive 
drug users were reported to have lower adherence rates compared to the 
general HIV population. However, there is a paucity of research that sheds 
light on HIV-positive drug users’ experiences of taking HAART internationally. 
In addition, issues relating to adherence to HAART have been predominantly 
approached from a quantitative perspective. In the relevant qualitative 
studies, HIV-positive patients’ experiences of taking HAART tended to be 
interpreted without in-depth understandings of the underlying issues. Existing 
theories discussed in the Chapter 3 were inadequately utilised so as to 
explain HIV-positive drug users’ HAART-taking behaviour and its process. 
Concerned about the lack of theoretical underpinning of HIV-positive drug 
users’ HAART-taking behaviour in the current evidence base, there is a need 




study findings to gain a clear understanding of HIV-positive drug users’ 
experiences of taking HAART.  
1.3. Research aims and questions 
This study set out to explore HIV-positive drug users’ experiences of taking 
HAART, and develop a conceptual model that can unpack the complexity of 
their HAART-taking acts.  
Drawing from a constructivist grounded theory approach, the research 
questions that I sought to answer for this study were: 
Main research question: 
What are the experiences of taking HAART among HIV-positive drug users? 
Four underpinning sub-questions: 
1. What meanings do HIV-positive drug users attribute to their experiences of 
taking HAART? 
2. What is the process of their HAART-taking behaviour?  
3. How are meanings of HIV-positive drug users’ experiences relating to 
HAART taking constructed through its process? 
4. What contributes to the stability and change of HIV-positive drug users’ 
HAART-taking behaviour? Under what conditions? 
1.4. Sustainable development goals and the rights of 
HIV-positive individuals 
In 2015, 17 SDGs and a plan of action were introduced by the UNs in an 
attempt to meet the present needs for all without compromising the ability of 
future generations (UN, 2015). For sustainable development goals to be 
achieved, the emphasis is placed on harmonising three core elements — 




United Nations Office on Drugs and Crime, UNODC, 2016). These elements 
are interconnected and all are key to the well-being of individuals and 
societies (UN, 2015, UNODC, 2016).    
Among the 17 SDGs, SDG 3, 5, 10, and 16 are very closely linked to this 
study (UNODC, 2016). SDG 3’s aim is to ensure healthy lives and promote 
well-being for all of all ages. HIV and illicit drug use can pose an impact on 
the health of HIV-positive drug users at individual and public health levels 
(Yang et al., 2008a, Gonzalo et al., 2009, Montaner et al., 2010, UNAIDS, 
2016, and UNODC, 2016). Interventions in relation to prevention, treatment, 
rehabilitation, and social integration all play an important role in addressing 
issues relating to illicit drug use and HIV, and reducing their negative health 
impact on society (UN, 2015, UNODC, 2016). This study provides an in-
depth understanding of HIV-positive drug users’ experiences of HAART-
taking, which in turn can inform nurses of developing tailored interventions to 
meet drug users’ needs and optimise their health outcomes. According to 
SDG 5 and SDG 10— gender equality and reducing inequalities within and 
among countries— UNODC (2016) advocates equal access to HIV care for 
people who use drugs and promote services that are gender responsive. In 
an attempt to achieve these goals, this study provided the opportunity to give 
HIV-positive drug users’ voices in Taiwan through interviewing. Findings from 
this study suggest that the creation of a just environment can enhance HIV-
positive drug users’ willingness to access care and without fears. In line with 
SDG 5 and 10, SDG 16 is to provide peaceful, just and inclusive societies. 
Findings from this study support a strong recommendation of the elimination 
of discrimination and stigmatisation towards people living with HIV and 
people who use drugs.  
By and large, ensuring the achievement of SDGs and HIV-positive drug 
users’ optimal adherence to HAART, this study provides several implications 
for the creation of an inclusive and just environment, and for the development 




1.5. Terminology- compliance, adherence and 
concordance 
There are three terms commonly used to describe medication-taking: 
compliance, adherence, and concordance (National Coordinating Centre for 
NHS Service Delivery and Organisation, NCCSDO, 2005, Cramer et al., 
2008, WHO, 2013).  
Compliance is defined as “the extent to which a patient’s act in accordance 
with the prescribed interval and a dose of dosing regimen (Cramer et al., 
2008, p.46).” The usage of this term has declined recently as it implied lack 
of patient involvement (NCCSDO, 2005). 
Adherence refers to “the extent to which patients’ behaviours matches 
agreed recommendations from the prescriber (NCCSDO, 2005, p.12)” This 
term is adopted more by many as an alternative to compliance, because 
‘adherence’ involves patient’s agreement to doctor’s recommendations 
(NCCSDO, 2005, WHO 2013).  
Concordance is a more recent term and is more commonly used in the 
United Kingdom (UK). Concordance is defined as “an agreement reached 
after negotiation between a patient and a healthcare professional that 
respects the beliefs and wishes of the patient (NCCSDO, 2005, p.33).” This 
term incorporates physician and patient’s respective views to a wider 
concept, stretching from prescribing communication to supporting patient’s 
medication-taking (NCCSDO, 2005). 
Drawing on the definitions of the three common terms, adherence was used 
to describe patient’s medication-taking in this thesis for two reasons. Firstly, 
adherence takes into account patient’s agreement to medication regimens, 
whereas compliance does not involve patient’s agreement (NCCSDO, 2005, 
Cramer et al., 2008, WHO 2013). Secondly, as this research focuses on the 
adherence behaviour of an individual without the involvement of prescribers, 




1.6. Describing the terms—Drug, drug use, drug 
addiction, drug dependence  
People may use drugs for a variety of reasons. The word, drug, has two 
connotations. One is used in a positive way, explaining its crucial roles in 
medicine (Abadinsky, 2011). Another tends to be negative, reflecting self-
destruction and socially deleterious patterns of misuse (Abadinsky, 2011). In 
this research, the word, drug, refers to illegal drugs that can lead to 
psychoactive effects, such as heroin, amphetamine, ketamine and ecstasy. 
Drug use is a generic term for the use of illegal drugs. The term has 
implications for excessive, dangerous, or undesirable to individual and 
community (Abadinsky, 2011). For the purpose of this study, HIV-positive 
drug users do not only refer to intravenous drug users (IDUs) but people who 
take illegal drugs orally. Participants in this study were classified into two 
main groups — 1) HIV-positive IDUs who were infected with HIV through 
sharing needles or other injecting equipment, and 2) HIV-positive Men who 
have Sex with Men (MSM) who use drugs to facilitate sexual activities (called 
chemsex). 
Addiction is referred to as the presence of increased tolerance, withdrawal 
and loss of control, a compulsion to take drugs on a continuous basis, and a 
difficulty in refraining from a substance accompanied by negative affect 
experienced in its absence (Heather, 1998, National Institute on Drug Abuse, 
NIDA, 2016). Drug addiction does not develop overnight, whereas it is a 
progressive development, starting with experimental exposure and for some 
finally turning into addiction (Hsieh et al., 2017). The term, addiction, is not 
used in Diagnostic and Statistical Manual (DSM) of Mental Disorders, but 
approximately corresponds with the DSM definition of substance use 
disorder. Substance use disorder is defined by DSM as “the condition in 
which the use of one or more substances can lead to a clinically significant 
distress or impairment (National Alliance on Mental Illness, NAMI, 2014, p1).” 
In people with ‘drug addiction’ or ‘substance use disorder’, drug dependence 




adapts to regular exposure to a substance, leading to craving for the 
substance (NIDA, 2016). To effectively control heroin addiction, Opioid 
Substitution Therapy (OST), such as methadone, can be accessed free of 
charge by HIV-positive drug users in Taiwan (Ministry of Health and Welfare, 
MOWH, 2017).  
In short, the terms, drug, drug use, addiction and dependence, were defined 
here to drive harmonisation of term usage throughout this thesis and enable 
distinction between concepts.     
1.7. Structure of the thesis 
In this chapter, I have  
 introduced an overview of my motivation for conducting this research. 
 provided the importance of this study. 
 indicated what I set out to achieve in this study, and how. 
 defined the key terms that will be used throughout this thesis. 
The remaining chapters are organised as follows: 
Chapter 2 contextualises the study in the relevant literature. This includes an 
overview of historical, social and political contexts in Taiwan, HIV and illicit 
drug use global epidemiology and in Taiwan and global policies and health 
policies in Taiwan in relation to HIV and illicit drug use. In addition, I will also 
provide a brief discussion surrounding drug-taking and health behaviour, HIV 
prevention and treatment, By locating the research problem in the context, 
this chapter provides the foundation for this study. 
In Chapter 3, I explore, discuss, and critique the existing theories and models 
that have been applied to understand individuals’ self-identity, beliefs, and 
health behaviours. 
Chapter 4 provides a systematic and critical review of empirical studies 




literature review, gaps and inconsistencies were identified whereby the 
research questions for the thesis were generated. 
In Chapter 5, a detailed account is offered on methodology and methods. 
This includes a critical discussion around qualitative research, 
methodological and theoretical considerations, the elements of grounded 
theory approach adopted for this study. Moreover, I will also provide a 
discussion around the study process, such as ethical principles used in this 
study, recruitment and sampling, data collection, analysis process, ethical 
issues, and the criteria for ensuring the quality of this study.  
Chapter 6, 7 and 8 offer a detailed account of the findings and analytic 
discussions of the data along within existing relevant literature. In Chapter 6, 
the concept of ‘HIV-positive identity as part of self-identity’ emphasises 
participants’ experiences of being HIV positive, its emotional impact, and how 
the possession of the HIV-positive identity influenced their sense of self and 
HAART-taking behaviour. Chapter 7 focuses on how the values participants 
placed on HAART ignited/undermined their HAART-taking behaviour. The 
concept of values attached to HAART appeared to be the core concept 
amongst the three major concepts, and to act as a driver of HIV-positive drug 
users’ HAART-taking behaviour. Chapter 8 provides a detailed discussion of 
‘conscious actions’. The concept of implementing conscious actions 
appeared to be key to maintain HIV-positive drug users’ regular HAART use.  
Chapter 9 concludes the thesis by synthesising the three concepts into a 
conceptual model, Identity-Values-Conscious Actions Model, which facilitates 
understanding the dynamics of HIV-positive drug users’ HAART-taking 
behaviour. Furthermore, implications for nursing practice, policy and future 






CHAPTER TWO: BACKGROUND 
2.1. Introduction 
This research focuses on HIV-positive drug users’ experiences of taking 
HAART within the Taiwanese context. The importance of social context to 
understanding individuals’ behaviour has been increasingly recognised by 
behavioural researchers. Social context is defined by Burke et al. (2013) as 
“the socio-cultural forces that shape people’s experiences and that directly 
and indirectly affect health behaviour (p3)”. In most social psychological 
theories, social, political, historical, and cultural influences upon individual 
behaviour are put in the position of background variables where they are 
acknowledged to affect individual beliefs (Ajzen, 1991, Bandura, 1991 and 
2001, Berger and Luckmann, 1966, Carricaburu and Pierret, 1995, Emirbayer 
and Mische, 1998, Rosenstock, 1974a and b, Wallston et al., 1978). Notably, 
these forces are co-constituitive and formed in relation to and by each other, 
subsequently influencing an individual’s internal belief system in ways of 
which the individual may not be consciously aware of (Bandura, 1991 and 
2001, Berger and Luckmann, 1966, Emirbayer and Mische, 1998). These 
beliefs transcend individuals’ values and attitudes towards objects and 
situations, all of which can guide and/or determine behaviour (Ajzen and 
Fishbein, 1977, Blumer, 1986, Rokeach, 1973). 
Given the emphasis placed on the collective influence of social and individual 
factors on human behaviour, the following sections introduce the social, 
historical, cultural, and political context in Taiwan. By locating the research 




2.2. Philosophies and social values in the Taiwanese 
society 
Taiwan was first called ‘Ilha Formosa’ by Portuguese sailors, meaning 
‘Beautiful Island’, when they came to Taiwan in 1544 (Rubinstein, 2006). By 
1945, Taiwan had already been inhabited by the Chinese, Dutch, Spanish 
and Japanese for several centuries (Rubinstein, 2006, Clart and Jones, 
2003). Over that period of time, residents in Taiwan mostly came from China 
and led a life without standardised political control by Chinese, Spanish and 
Dutch until the Japanese government colonized Taiwan and established 
effective political control over Taiwan for 50 years (Roy, 2003). However, 
after Japan’s defeat in World War II, Taiwan was handed back to the 
Republic of China governed by Chiang’s Kuomintang (KMT) party 
(Rubinstein, 2006). A few years later, troops of the KMT party were defeated 
by Communist armies due to wartime corruption and military desertion. 
Chiang and the remaining KMT forces fled to Taiwan in 1949 (Roy, 2003). 
There he re-established the government and continued operating as the 
Republic of China (the official name of Taiwan). Since then, Taiwan and 
China have been recognized as two separate sovereign states.  
Berger and Luckmann (1966) in their book, “Social Construction of Reality”, 
described that by virtue of the accumulation of historical experiences, a social 
stock of knowledge can be constituted and transmitted from generation to 
generation. Drawing on this notion, Taiwan still keeps Chinese traditional 
values owing to the historical association with China. Although Confucianism 
is rooted in China, it remains intact as the core value in Taiwan and plays a 
central role in the Taiwanese education system. Theoretically, it entails four 
important principles— ‘Jen’ (benevolence), ‘Yi’ (righteousness), ‘Chung’ 
(loyalty), ‘Hsia’ (filial piety) (Chen, 2001).  
Under this philosophy, people should be kind and considerate to others 
(Jen), be morally upright (Yi), be loyal to significant others (Chung), and have 
respect for parents and seniors (Hsia). This familial-social hierarchy in 




(Huang and Wu, 1994). Such a social norm includes both dominance and 
caretaking but is practiced in a benevolent way that focuses on the 
obligations within social relations rather than the restrictions placed on 
subordinates (Lee et al., 2007). In that sense, the core concepts of this 
philosophy are the emphasis of ethics, harmonious social relations and social 
hierarchy in the Taiwanese culture (Lin and Ho, 2009). Such cultural values 
are similar to the meaning of Collectivism.  
Collectivism refers to the assumption that people feel the bond with social 
groups and have a mutual obligation (Oyserman et al., 2002). In Asian 
cultures, people are more concerned about behaving appropriately and 
adapting to different social situations (Markus and Kitayama, 1991). Such a 
collectivism-orientation with respect towards social commitment has become 
an important cultural norm shared by Taiwanese residents. In contrast with 
the collectivism-orientation in East Asian countries, it could be argued that 
individuals in Western contexts tend to focus on the primacy of the individual 
(individualism) (Oyserman et al., 2002, Markus and Kitayama, 1991, Lee et 
al., 2007).  
By and large, the philosophical and historical backgrounds in Taiwan can 
affect individuals’ ways of thinking and acting towards themselves and others 
(Berger and Luckmann, 1966). As the result of the normal social processes 
people unconsciously subscribe to and abide by, it can exert an effect on an 
inner sense of social difference among those who did not comply with social 
norms (Fine and Asch, 1988).  
2.3. Religions in Taiwan 
‘Religion’ is viewed as a high power structure comprised of beliefs, rules, 
rituals and practices, which can influence the way people lead their lives 
(Lukoff et al., 1995, Tuncay, 2007). In the Taiwanese society, religious beliefs 
and practices are usually polytheistic and syncretistic (Chang, 2010, Chang, 
2009). Folk beliefs are considered the major traditional religions in Taiwan, a 




and Taoism (Chang, 2009, Chang, 2010, Chang and Chang, 2006). Chang 
and Chang’s cross-sectional study of 1925 Taiwanese residents (2006) 
showed that 72.6% of them believed in Folk beliefs, Buddhism, and Taoism.  
Due to the polytheistic and syncretistic religious beliefs in the Taiwanese 
culture, a strict distinction among believers of Folk religions, Buddhism, and 
Taoism is dubious. Most people who believe in these religions pray to various 
gods, deities and ancient legendary heroes (Zhai, 2007, Chang, 2010). With 
these traditional religions, it is believed that one’s good action will be 
rewarded in current or future lives (Chang, 2009, Chen, 2001). Religious 
worship is performed for accumulating merits for the next reincarnation, and 
for getting blessings of good health and fortune in one's current life (Chang, 
2009). As opposed to these polytheistic and syncretistic religious beliefs, 
Christianity is monotheistic, and the proportion of Taiwanese Christians is 
much fewer, accounting for 7.2% (Chang and Chang, 2006, Tao, 2008).  In 
Christianity, people emphasise good deeds and hold the beliefs that they can 
have an eternal life after death (Tao, 2008). Drawing on the ideology of 
different religions, it can be argued that religions are based on ideologies 
which provide value frameworks that can guide believers in determining their 
attitude and behaviour of everyday life. 
2.4. The economy and health system in Taiwan 
Taiwan is a democratic country with an estimated population of 23 million 
located in East Asia (Ministry of the Interior, 2017). The economy of Taiwan 
has developed rapidly since the 1960s, and has been transitioned from 
agriculture to industrial production and information technology (Chang and 
Caudill, 2005, Chen, 2002). According to the International Monetary Fund 
(2015), Taiwan is classified as an advanced economy. National economy is 
linked to individual health by influencing health policy making and health 
services infrastructure (Osypuk et al, 2014). Due to the transition in economy, 
the Taiwanese government places a great emphasis on integration of 




Since 1995, Taiwan has implemented a compulsory National Health 
Insurance (NHI) programme, which provides universal coverage to all 
Taiwanese citizens (Lu and Hsiao, 2003, Wu et al., 2010). The health 
insurance system in Taiwan is run by the Taiwan Bureau of National Health 
Insurance (TBNHI), and financed through a mix of premiums (Department of 
Health, DOH, 2012). The percentage of premium paid by the insured varies 
from 0% for low-income and disadvantaged citizens to 100% for self-
employed citizens (DOH, 2012). In 2013, the Taiwan government and the 
insured/employers respectively paid 23.6% and 76.3% of the total premium 
(MOHW, 2013). The percentage of Gross Domestic Product (GDP) spent on 
health care is 6.2% in contrast to 17.1% in the United States of America 
(USA) and 9.1% in the UK (MOHW, 2017, WHO, 2014).  
The NHI programme provides a comprehensive package of services, 
including preventive services, inpatient care, outpatient services, dental care, 
prescription drugs, laboratory and diagnostic tests, Chinese medicine, HIV 
medical care, harm reduction for drug users, and day care for mentally ill 
individuals (Lu and Hsiao, 2003, Cheng, 2003). These services are free-of-
charge (Wen et al., 2008, Cheng, 2003). However, co-payments are required 
and paid by an insured person each time a medical service is accessed, 
which is approximately £2 in General Practitioner (GP) clinics and 
approximately £8-£10 at hospitals (Lu and Hsiao, 2003, Wu et al., 2010). For 
the poor, healthcare is fully subsidised by the government (Lu and Hsiao, 
2003).  
Under this scheme, citizens not only have equal financial access to 
comprehensive services but have free range to choose hospitals and 
physicians (Cheng, 2003). The complete freedom of choosing physicians has 
led to less likelihood of long waiting times for medical care. However, doctor 
shopping (visiting multiple doctors without professional referrals) and 
receiving duplicate medications had been a major concern before the 
adoption of new policies (Wen et al., 2008, Hsu et al., 2011). To ease such 




prescription platforms across the boundary of hospitals, clinics, and 
pharmacies (Hsu et al., 2011, MOHW, 2017). As a result, it provides alerts to 
physicians and pharmacists when a potential duplicate medication is 
detected at the time of prescribing (Hsu et al., 2011, MOHW, 2017). This is 
unlike the health system in the UK which adopts a referral system where GPs 
are gatekeepers referring patients to specialist treatment (Forrest et al., 
2002).  
The health insurance card, called NHI-IC card, was first launched in 1999 
(Liu et al., 2006). The NHI-IC card is used to record important physician 
orders, prescriptions, drug allergies, medical history, laboratory records, 
treatment history, vaccination records, and organ donation notes (Liu et al., 
2006). Individuals must bring their NHI-IC card while visiting a doctor, which 
serves as a health passport (Liu et al., 2006). Moreover, because of its 
electronic nature, the NHI-IC card can function as a communication tool, 
which allows citizens and health care providers to access medical records 
electronically and manage health more effectively (MOHW, 2017, Liu et al., 
2006, Lai et al., 2007). But the card cannot be read without going through 
strict authorization security process (Lai et al., 2007). The NHI-IC card 
databank centre in TBNHI serves to manage and maintain card database 
and a wide network of health services so that TBNHI can keep track of the 
insured’s consumption of medical resources (Liu et al., 2006).  
In addition, a current computerised surveillance system in Taiwan is also 
based on the IC card systems (Huang and Hou, 2007). When an emerging 
infectious disease occurs, the Taiwan Centre for Disease Control (CDC) can 
easily track suspected cases and monitor the diffusion of the infectious 
disease through the IC card system (e.g. HIV cases), and support better 




2.5. HIV and illicit drug use epidemiology 
2.5.1. Global HIV epidemiology and transmission modes 
In 2015, it was estimated that there were 36.7 million people living with HIV 
worldwide (UNAIDS, 2016). Table 1 provides the HIV prevalence rate by 
global region. HIV is mainly transmitted through sexual contact, mother-to-
baby transmission, or needle sharing (UNAIDS, 2016, WHO, 2017b). 
However, the main modes of transmission vary between countries (UNAIDS, 
2016). For example, African countries had the largest HIV population 
worldwide (25.83 million) (UNAIDS, 2016).  There, heterosexual contact and 
mother-to-child are the common routes of HIV transmission (UNAIDS, 2016). 
Asia had the second largest HIV burden after Africa with an estimate of 5.1 
million HIV-positive individuals (mainly through heterosexual contact) 
(UNAIDS, 2016). In Eastern Europe and Central Asia, IDUs were the 
predominant HIV population (51%) (UNODC, 2016).  In Western European 
and North American countries, homosexual contact appeared to be the main 
route of HIV transmission (UNAIDS, 2016, Centre for Disease Control, CDC, 
2017b). 
Table 1: HIV prevalence by region (UNAIDS, 2016, p2) 
Region Total No (%) Living with HIV 
Global Total 36.7 million (100%) 
Eastern and Southern Africa 19.4 million (53%) 
Western and Central Africa 6.1 million (17%) 
Asia and the Pacific 5.1 million (14%) 
Western and Central Europe 
and North America 
2.1 million (6%) 
Latin America 1.8 million (5%) 
The Caribbean 310,000 (<1%) 
Eastern Europe and Central 
Asia 
1.6 million (4%) 
The Middle East and North 





2.5.2. HIV epidemiology and transmission modes in Taiwan 
In Taiwan, the CDC (2017a) estimated that there were approximately 33,428 
people living with HIV. By September of 2017, HIV infection has been mainly 
attributed to MSM (61.94%), followed by IDUs (19.81%) and heterosexual 
contact (16.71%) (Figure 1). The HIV-positive male drug users were mainly 
MSM who engaged in chemsex, followed by IDUs. As can been seen from 
Figure 1, there was a significant increase in the HIV incidence among IDUs 
in 2005, which was attributed to sharing needles. Since the introduction of 
harm reduction programmes, the HIV incidence among IDUs has dropped, 
from 18.2% in 2005 to 0.3% in 2010 (CDC, 2017b). HIV-infected men 
constitute 94.36% of the total HIV population in Taiwan (CDC, 2017a and b). 
The ratio of HIV-positive males to females was 19:1 by the end of 2017 
(CDC, 2017a). In contrast, it was reported that there were only 917 HIV-
positive female drug users across Taiwan (CDC, 2017a). Drawing on the 
aforementioned data, it resonates with the distribution of the HIV-positive 
drug users sample in this study (Chapter 5). Of 22 HIV-positive drug-using 
participants, 12 are MSM, 7 were male IDUs, and 3 were female IDUs.  
 





2.5.3. Global illicit drug use epidemiology  
Globally, there are 247 million people using illicit drugs, and of those 29 
million people suffer from drug use disorders and 12 million people inject 
drugs (UNODC, 2016). Cannabis is the most commonly-used drug, with an 
estimate of 183 million people having used it (UNODC, 2016). Amphetamine 
is the second most commonly-used drugs. The use of opiates is less 
common, with an estimate of 33 million users worldwide (UNODC, 2016). 
Since illicit drug use is a criminal offence, there is a challenge of estimating 
illicit drug use epidemiology. In addition, there is a concern over the fact that 
many people who use drugs, either occasionally or regularly, tend to use 
more than one substance concurrently or subsequently (polydrug users). As 
such, the current epidemiology of illicit drug use cannot clearly capture the 
picture of its dynamics. (UNODC, 2016). However, such estimation can still 
provide an insight of its prevalence and trends.  
2.5.4. Illicit drug use epidemiology in Taiwan 
While cannabis, amphetamine and heroin are the top three most commonly 
used drugs worldwide, the trends of illicit drug use vary from country to 
country. According to the latest annual report of Taiwan Food and Drug 
Administration (TFDA, 2017), the most commonly used illicit drugs in Taiwan 
were heroin, methamphetamine, and ketamine. Though the estimated 
number of illicit drug users is not documented in the TFDA, data in relation to 
drug-related arrests from the study by Feng et al. (2016) are used to estimate 
the approximate number of illicit drug users in Taiwan. In 2014, an average of 
34,948 arrestees were illicit drug users. Since 2006, the number of illicit drug 
users in Taiwan has increased quickly from 39,886 to 44,460 in 2007, and 
then gradually decreased to 31,397 by the end of 2014 due to the 
introduction of harm reduction and a decreased number of heroin users 
(CDC, 2017b, Feng et al., 2016).  
In summary, the aforementioned epidemiological data imply that illicit drug 
use is still creating new and local HIV cases, and the ways that illicit drug use 




2.6. The impact of illicit drug use 
Drug users often experience severe health-related harms associated with 
problem drug use and overall poor health outcomes (UNODC, 2016). The 
risk factors for drug users’ negative health impact stem from their mode of 
administration of drugs and the effects of drugs. In particular, injecting drug 
use poses a greater risk of overdose and infections, such as blood-borne 
virus infections (HIV and hepatitis B and C) (Armstrong et al., 2006, Garfien 
et al., 1996, Platt et al., 2016). According to UNAIDS (2016), UNODC (2016) 
and WHO (2017b), IDUs were classified as a key at-risk population for HIV, 
with almost a third of new HIV infection outside sub-Saharan Africa occurring 
among IDUs.  
Aside from IDUs, the use of stimulants has been reported to influence 
individuals’ sexual behaviour, thereby increasing the likelihood of unprotected 
sexual practice and HIV transmission (Drumright et al., 2006). This pattern 
particularly raises concerns in the case of MSM (Drumright et al., 2006). In 
the same vein, Vu’s (2015) systematic review and meta-analysis indicated a 
strong relationship between higher HIV prevalence and higher-risk sexual 
behaviour among MSM who used amphetamine. This indicates that illicit 
drug use can increase individuals’ risk-taking behaviour and consequently 
negatively impact their health.  
In Global Burden of Disease, WHO’s (2000) estimates of global Disability-
Adjusted Life Years (DALYs) attributable to opioid, amphetamine, and 
cocaine use suggested that use of these drugs accounted for 0.9% of DALYs 
in 2004 (Degenhardt and Hall, 2012).  In particular, drug dependence was 
the largest cause of illicit drug use burden (68%), followed by HIV/AIDS 
infection (Degenhardt and Hall, 2012). Opioids, cocaine, amphetamine, and 
cannabis together accounted for almost 12 years lifelong lost due to drug-
related deaths and disability (UNODC, 2016). 
While the global burden of illicit drug use has been estimated, the estimates 
did not include socio-cultural effects that illicit drug users experience in 




al., 1990, Ahern et al., 2007, Young et al., 2005). The topic in relation to the 
impact of illicit drug use is under researched in the Taiwanese context. Thus, 
in the following, I will discuss the socio-cultural effects on drug use from 
international literature.  
IDUs in Miller's (2008) and Kerr's (2013) qualitative studies in USA and 
Canada reported that living in an environment where drug abusers were 
treated as drug offenders and criminals, they had to hide their drug use and 
sometimes to share needles with other peers due to financial constraints and 
heavy drug dependence. This can also be seen in the example of Edinburgh 
in the 1980s where heroin problem was dealt with as a law enforcement 
issue, subsequently forcing heroin users to share needles and increasing HIV 
incidence (Robertson and Richardson, 2007). Criminalisation has been 
reported to increase the price of illicit drugs, and in turn, the high price can 
lead drug users to engage in criminal activities or to trade sex to finance their 
illicit drug use (Rácz, 2005, Degenhardt and Hall, 2012, Kerr et al., 2013). 
With lack of support from society, illicit drug users can form their own drug 
user networks and cultures (Kerr et al., 2013). The collective impact of social 
marginalisation and peer influence puts dependent drug users in a 
paradoxical situation in which they cannot escape from drug addiction and 
criminalising activities (Hammersley et al., 1990). Together, these 
aforementioned international literature showed that the laws accompanied by 
penalties may drive people who have already been using illicit drugs 
underground and make it difficult for them to re-integrate into society 
(Lazzarini et al., 2002).  
To decrease the harms related to drug use, harm reduction programme, 
including needle exchange programme and methadone maintenance 
treatment, has been introduced (Yang et al., 2008b). The programme have 
been recognised globally and in Taiwan to play an important role in 
preventing and reducing drug users’ risk-taking behaviours, such as 




(Gibson et al., 2001, Rhodes and Sarang, 2012, Barrio et al., 2012, Yang et 
al., 2008b).  
2.7. Drug users’ health behaviour 
Extensive literature mainly focuses on illicit drug users’ risk behaviour, whilst 
relatively few studies have investigated drug users’ health behaviours. 
Individual health behaviour refers to “any activities undertaken for the 
purpose of preventing or detecting disease or for improving health and well-
being (Connor and Norman, 2005, p.2)”. Health has been defined by WHO 
as “a state of complete physical, mental and social well-being and is not 
merely the absence of disease or infirmity (Larson, 1996, p.181)” In line with 
WHO’s definition in Larson’s published article, there are a variety of factors 
that can account for individual differences in the inclination to undertake 
health behaviours, including physical, emotional, social, and structural factors 
(Connor and Norman, 2005).  
According to UNODC (2017), only 1 in 6 drug users is in treatment. Similarly, 
it has been reported globally that a low proportion of HIV-positive drug users 
are on HIV treatment or have regular use of health services (Morrison et al., 
1997, Pach et al., 2003, Lloyd et al., 2005, Davey et al., 2007, Gyarmathy 
and Latkin, 2008, Sarin and Kerrigan, 2012, UNAIDS, 2014). Nevertheless, in 
the literature, the foci of drug users’ health behaviours predominantly relate 
to harm reduction programme, and detoxification services due to drug users’ 
risk behaviours (Morrison et al., 1997, Pach et al., 2003, Wood et al., 2004, 
Lloyd et al., 2005, Davey et al., 2007, Gyarmathy and Latkin, 2008, Sarin and 
Kerrigan, 2012, UNAIDS, 2014). 
Two cohort studies by Bell et al. (2006) in Australia and Beynon et al. (2006) 
in the UK indicated that drug users were more likely to have addiction 
treatment interruption and cycle in and out of the treatment. Drug users who 
sought addiction treatment were reported in the study by Morrison et al. 
(1997) in Glasgow to be more likely in situations where emergency or crisis 




were not in addiction treatment, normalising risky behaviours and 
unawareness of treatment necessity were found to be the main factors that 
impeded their treatment-seeking behaviours (Morrison et al., 1997). On the 
other hand, support from friends and perceived drug problem severity have 
been found in the studies by Lloyd et al. (2005), Davey et al. (2007) and 
Gyarmathy and Latkin (2008) in USA, to be significantly associated with 
participation in treatment programmes. Engaging in addiction treatment was 
also found in the studies by Davey et al. (2007) in USA, Roux et al. (2008) in 
France, and Rhodes and Sarang (2012) in Russia to facilitate drug users’ 
involvement in and adherence to HIV treatment.  
Reflecting on the findings of relevant literature, the primary focused question 
was related to the negative impact of illicit drugs on seeking addiction 
treatment or the effectiveness of addiction treatment programme on health 
behaviour. Nonetheless, there has been little attention on the holistic view of 
how drug users’ health behaviours are formed and sustained. It was evident 
in the literature that drug users’ health behaviours are socially constructed 
and shaped by an array of physical, mental, social, and structural facets 
(Lloyd et al., 2005, Krüsi et al., 2010, Sarin and Kerrigan, 2012). An improved 
understanding of the mechanism underlying drug users’ health behaviours 
requires further research likely to utilise novel methods of accessing an often 
hard-to-reach group. The in-depth understanding of drug users’ experiences 
of taking HAART in this study will enable laws that may overemphasise 
penalties towards illicit drug use to be re-evaluated and refined in order to 
foster a more health-oriented approach to meet their needs and to optimise 
global health.  
2.8. HIV prevention in Taiwan 
In an attempt to understand HIV-positive drug users’ experiences of taking 
HAART in this study, it is essential to gain insight into how HIV prevention 
and treatment are implemented in Taiwan. The first HIV case in Taiwan was 




taken many steps to prevent HIV incidence. Firstly, MSM Community Health 
Centres were established to provide Lesbian, Gay, Bisexual, and 
Transgender (LGBT) friendly health services (CDC, 2017b, MOHW, 2017). 
Educational materials are designed and tailored to meet the needs of a 
variety of HIV at-risk groups (MOHW, 2017, Twu et al., 2004). The 
government and Non-Governmental Organizations (NGOs) work together to 
reach out and distribute educational materials to the gay community, sex 
workers, adolescent detention centres and school (Twu et al., 2004). In 
addition, mass media is used as a means of promoting HIV education.  
Online opinion leaders and HIV testing advertisement are set up on mobile 
dating apps (CDC, 2017b, MOHW, 2017). Free hotlines have been 
established to provide immediate and accurate health information and 
counselling (CDC, 2017b). Free anonymous HIV testing is provided 
throughout hospitals and community settings (CDC, 2017b, MOHW, 2017, 
Twu et al., 2004). HIV screening is also provided for pregnant women 
(MOHW, 2017). Condom and self-testing kits vending machines are installed 
in venues frequented by the HIV risk populations, such as hotels, gay bars, 
clubs and parks. military draftees, prison inmates, and sex workers (CDC, 
2017b, MOHW, 2017, Twu et al., 2004). Individuals can get full redeem after 
logging in their test results online.  
Despite the progress made by the prevention programmes in Taiwan, there 
remain new HIV cases every year in Taiwan (CDC, 2017a). More efforts are 
needed to achieve the UNAIDS’s goal (2016) of ending HIV by 2030. In 
recent years, pre-exposure prophylaxis (PrEP: a course of antiretroviral 
medications taken by HIV-negative people at greater risk of HIV to prevent 
infection) has been the latest addition to efforts to expand prevention options 
(WHO, 2017c). Since 2017, PrEP has been approved to be provided free of 
charge in Scotland and Norway (Kelen and Cresswell, 2017, National Health 






2.9. Highly active antiretroviral therapy (HAART) 
In 1997, Taiwan adopted a policy to provide HIV-affected individuals with free 
HIV care, including HAART and inpatient care (Fang et al., 2004). HAART is 
a combination of different antiretroviral drugs used to suppress HIV viral load. 
In the early era, HAART regimens were often complex and comprised of up 
to 20 pills, while to date simple, once-daily and single-pill HAART regimens 
have become more widely available (Raboud et al., 2011, Cooke et al., 2014, 
Langebeek et al., 2014, Ramjan et al., 2014, Vitoria et al., 2014). However, 
the provision of HAART differs from country to country depending on national 
economy and policies (UNAIDS, 2014). In Taiwan, a single dose is 
commonly used by HIV-positive individuals.  
According to the WHO (2016), HIV-affected individuals are recommended to 
initiate HAART regardless of their clinical stage and CD4 cell count. Central 
to initiation of HAART is a detailed discussion about patients’ willingness and 
readiness to receive HAART. In doing so, the WHO (2016) suggested that 
health care providers should assess patients’ knowledge levels in relation to 
HIV and HAART, and their needs for psychosocial support.  
Global consensus and leadership have reinforced the determination to 
achieve the 90-90-90 treatment target by 2020, whereby 90% of HIV-positive 
individuals acknowledge their HIV status, 90% of HIV-positive individuals 
who know their HIV status receive HAART, and 90% of people who received 
HAART have suppression of HIV virus loads (UNAIDS, 2016). By 2015, the 
number of people living with HIV on HAART has increased by about a third, 
reaching 17 million in 2015 compared to 15 million in 2011 (UNAIDS, 2016). 
In other words, there were 46% of the global HIV population (36.7 million) 
receiving HAART. UK is very close to UNAIDS 909090 targets, 87%-96%-
94% (Public Health England, 2017). In Taiwan, these relevant data are not 
available on the Taiwanese government website. Without the data available, 
it increases the challenge of estimating the effectiveness of the delivery of 





2.10. The impact of adherence to HAART 
Having successful antiretroviral treatment is dependent critically on 
adherence. It is evidenced that 95% of prescribed doses are needed for 
complete viral suppression and CD4 recovery (Paterson et al., 2000, Lima et 
al., 2008, Ortego et al., 2011).  
Strict adherence to HAART for achieving optimal biomedical outcomes can 
pose a positive impact on public health and individuals’ health (Yang et al., 
2008a, Gonzalo et al., 2009, Montaner et al., 2010, WHO, 2013). At the 
population level, the effectiveness of HAART in achieving and maintaining 
viral load at an undetectable level has been reported to decrease HIV 
transmission in either serodiscordant couples or IDUs (AIDSinfo, 2015, Fang 
et al., 2004, Porco et al., 2004, Castilla et al., 2005, Montaner et al., 2006, 
Wood et al., 2012, WHO, 2016). Apart from this, sustaining viral suppression 
can also reduce the risk of resistance to HAART and its cross-resistance, 
consequently optimising treatment options (Little et al., 2002, Sethi et al., 
2003). 
At the individual level, although HAART cannot eradicate HIV infection, it has 
changed the clinical profile of HIV infection to a chronic disease (Hogg et al., 
2008). The number of people living with HIV aged 50 or older has been 
continuing to grow, representing 12% and 30% of people living with HIV in 
low-and-middle-income and high-income countries respectively (UNAIDS, 
2014). Congruently, Wu and her associates (2014) analysed medical records 
at a university hospital in Taiwan, and the results indicated more than 50 % 
of HIV-positive individuals were aged 50 or older. In addition to decreased 
mortality, HAART has been reported to increase patients’ quality of life (Fang 
et al., 2007, Simpson et al., 2007, Gonzalo et al., 2009). The Quality-
Adjusted-Life-Year (QALY) measures the extent of health gain that results 
from health interventions, which can be used to estimate the worth of 
interventions from an economic perspective. According to Fang et al. (2007), 
Gonzalo et al. (2009), and Miners et al. (2001), the Incremental Cost-




in the UK, $14,587 in the USA, $9,782 in Taiwan, $9,083 in Spain, $984 in 
South Africa. These results indicated that health expenditure on HAART is 
cost-effective, within savings being derived from not having to repeatedly 
treat patients with opportunistic infections and other societal costs (Miners et 
al., 2001, Gonzalo et al., 2009).  
Despite the effectiveness of HAART on HIV individuals’ health, there was a 
concern over the death caused by suicide among the HIV-positive individuals 
in Taiwan between 1994 and 2005 (Lu et al., 2006, and Yang et al., 2008a). 
In particular, HIV-positive IDUs had a higher rate of committing suicide and 
were less likely to seek medical care compared with the sexual transmission 
groups (Yang et al., 2008a, Lu et al., 2006). Drawing on such results, findings 
of this study can help to gain an in-depth understanding of the mechanism 
underlying HIV-positive IDUs’ health and risk behaviour. 
2.11. Summary 
The background information provided in this chapter is to enhance 
understanding the global and Taiwanese social context in relation to HIV, 
HAART, and illicit drug use. According to Fesmire (2003), human life in a 
society consists necessarily of ongoing activities that establish or portray 
structure and organisation. It is the world of the objects with which people are 
dealing and towards which they develop their actions and behaviours 
(Fesmire, 2003). In reference to the notions, historical, socio-cultural and 
political contexts in Taiwan are introduced in this chapter to gain insight into 
how the society is developed and structured. While the social context is 
independent of individual subjective understanding, it is accessible via 
individual interpretations (Ritchie and Lewis, 2003). External reality is 
multifaceted and diverse, and such diversity adds richness to our 
understanding of a variety of ways in which the reality is experienced, 
subsequently shaping an individual’s beliefs towards objects of interest and 
guiding behaviours (Ajzen and Fishbein, 1977, Blumer, 1986, Ritchie and 




Following the understandings of the global and Taiwanese social context, 
HIV-positive drug users’ risk and health behaviours in this chapter, the next 
chapter focuses on theoretical literature that reveal theoretical explanations 
of health behaviours, and that explain the concepts relevant to study findings, 




















CHAPTER THREE: THEORIES 
3.1. Introduction 
Research that focuses on the role of human behaviour, including health and 
risk behaviours, is essential for improving and optimising the health of 
populations (Painter et al., 2008). To date, several theories have been 
developed and applied to explain personal and social determinants of 
behaviour and to guide and refine health-related interventions (Munro et al., 
2007). However, there is an increased recognition of similar and overlapping 
constructs across theories and models of health behaviour (Noar and 
Zimmerman, 2005). Difficulties can arise when an attempt is made to apply 
one theory or model in a study. In prevention of such duplicates, providing 
comparative analyses of and building on existing theories and models can 
help drive new development (Noar and Zimmerman, 2005).  
In the current evidence base, few studies have focused on the effectiveness 
of the theories and models in understanding individuals’ general treatment 
adherence (Munro et al., 2007). Despite the limitation, several theories and 
models have the potential to improve understanding of adherence behaviour. 
Therefore, this chapter aims 1) to explore, discuss, and critique the existing 
theories and models suggested by the WHO (2003) that can influence health 
behaviour and 2) introduce the concepts of the self, self-identity and stigma 
due to their impact on HIV-positive drug users’ HAART-taking behaviour in 
this study.  
3.2. The self 
The looking-glass self theory developed by Charles Cooley (1902) describes 
the self as multi-dimensional. The self is shaped by our imagination of how 
we appear to others, of others’ judgement of ourselves based on our 
appearance and the way we present ourselves, and of how others feel about 




sense, Cooley (1902) encapsulated the idea that our sense of self, of who we 
are, is intimately shaped by those around us, by our emotion and by 
perceived judgements; therefore, suggesting that it changes depending on 
which society we grow up in and situate ourselves.  
George Herbert Mead (1934), uses conceptualising ideas of the separation 
between the “I” and the “Me”. He describes the “Me” as the organised set of 
attitudes of others which an individual assumes; the “I” is the response of an 
individual to others (Mead, 1934). Mead’s notion of the self (1934) is reliant 
on self-consciousness as the pre-condition for knowledge of others. This 
makes the development of self dependent on a concept of community. He 
describes self-identity along with Cooley (1902), explaining why we have 
several labelled identities. Several labelled identities define the reasons for 
our division of “self” into the “Me” and the “I”, which can shift from the one to 
the other. In other words, “the self” changes in different social situations as 
they each have changing responses through imagination which connect 
social and personal aspects (Mead, 1934). Furthering Cooley’s (1902) and 
Mead’s (1934) proposals, in Goffman’s “The presentation of self in Everyday 
life” (1959), he proposed a dramaturgical approach to the self, which he sees 
as a performance, with multiple roles which are both prescribed and 
improvised. Roles become a principal exercise when interacting with others, 
as is imposing identities on individuals (Goffman, 1959). In that regard, it was 
proposed by Goffman (1959) that roles and identities are subunits of the self. 
3.2.1. Self-identity  
Relevant to further elaboration of the self, Stryker and Burke (2000) in their 
identity theory focus on role identities, which implies a duality. Role is viewed 
by Stryker and Burke (2000) as external and linked to social positions. 
Identity is internal and consists of internalised meanings and expectations 
towards a role which is constructed within a system of values and beliefs and 
enacted through a person’s cognitive process and behaviour (Karnilowicz, 
2011, Stryker and Burke, 2000). The self is comprised of the interconnecting 




meanings.  From this perspective, a person is embedded in multiple role 
relationships in different contexts and has multiple identities (Tajfel, 1982). 
These roles and identities may reinforce one another, but may more often do 
not (Tajfel, 1982). Furthering Taifel’s notion, Goffman (1963) argues that 
social norms regarding social attributes do not determine a person’s acts but 
rather a person can exert control over the kind of information being taken into 
account. Identity is, therefore, a cognitive schema where the probability of 
behavioural choices is in accordance with the expectation of whether the 
identity, relative to other identities, incorporates into the self (Stryker and 
Burke, 2000).  
As a person reflexively interprets the identification that self and others bestow 
on the person self, a person’s sense of self changes (Pierce et al., 2003). In 
the development of sense of self, ownership becomes the symbol of the self. 
Pierce et al. (2003) maintain that ownership manifests itself in emotion and 
its meaning is often associated with “my” or “mine”. When an epiphany, a 
sudden or significant life event and experience, occurs, emotional ownership 
is instigated due to the influence of an epiphany on altering an individual’s 
fundamental meaning structures (Karnilowicz, 2011). In confronting the 
epiphanic illness experience, reassessing self-identity becomes at the core of 
illness narrative (Karnilowicz, 2011). The concept of illness narrative refers to 
a process of a continuous account of an illness (Williams, 1984). The 
emergence of an illness can take a biographical shift among affected 
individuals, from a perceived relatively controllable and predictable life course 
to interrupting and damaging one (Bury, 1982).  
According to biographical disruption by Bury (1982), at the earliest possible 
point of an illness trajectory, affected individuals can encounter problems in 
relation to the illness and changes in a life situation. Such uneasy balance is 
struck between seeing the disease as an external force but yet feeling its 
invasion into all aspects of an affected individual’s life (Bury, 1982). In an 
attempt to repair ruptures between self, body, and the world, the individual’s 




present, and imagined future (Williams, 1984). This rebuilding of identity is 
called narrative reconstruction proposed by Williams (1984). This attempt to 
change the narrative is in the form of self-management to control and 
discipline affected individuals’ lives or alternatively to accept, minimise, 
ignore or tolerate all that cannot be mastered (Kralik et al., 2004). 
When confronted with an epiphanic illness experience, individual’s self-
identity is often the subject of the greatest change (Karnilowicz, 2011). The 
effects of the illness experience can be deliberating. Thus, during the illness 
process, it requires affected individuals to gain control over its effects (Kralik 
et al., 2004). The positioning of illness ownership and regaining control are 
dependent on time, situation and negotiation (Karnilowicz, 2011).  
3.3. Stigma   
Goffman (1963) defined stigma as a discrediting and undesirable attribute 
that an individual possesses. In other words, when those undesirable 
attributes are incongruous with the stereotype of what a given type of 
individual should be, stigma can occur (Goffman, 1963). In conjunction with 
Goffman (1963), Jones et al (1984) defined stigma as a mark which spoils 
individual’s identity. This mark signifies undesirable characteristics or 
attributes. The individuals carrying this mark are perceived as responsible for 
creating the mark and deserving social ostracism and condemnation (Jones 
et al., 1984). Likewise, in 1998, Gilbert and his colleagues described stigma 
as characteristics of the individuals that convey a negative social identity in a 
social context. The costs of stigma affect not only the individuals but people 
surrounding them (Gilbert, Fiske and Lindzey, 1998). Based upon these 
historic definitions, the recent social psychologists summarise that stigma is 
an attribute that is marked as different and devalued in the eyes of others 
and it does not just occur within stigmatised individuals themselves but an 
entire social context as a whole (Major and O'Brien, 2005). 
Stigma against illness is largely rooted in misunderstanding, discomfort and 




society, social norms generated, reified and perpetuated by the collective 
values and discourses of the members of the society constrain acceptable 
ways to be (Cialdini and Trost, 1998). Any transgressions of such social 
norms are forms of deviance, and are subject to sanctions, which serve to 
minimise deviation from the collective (Scambler, 2008).  Illness is treated as 
a form of social deviance, with certain conditions facing intense 
stigmatisation because of the upheaval of behavioural norms that the 
condition brings about (Conrad and Barker, 2010).  
Stigmatisation of health conditions impacts individuals in a multitude of ways, 
predominantly dependent on the reasons behind its stigmatisation and the 
visibility of the condition (Seale, 1996). For instance, HIV and drug use are 
commonly associated with discrediting behaviours or characteristics that are 
deviant from social norms, such as promiscuity, crime, sex work, and 
homosexuality (Carr and Gramling, 2004; Logie et al., 2011). These historic 
associations can lead people to generate a negative impression and 
prejudice towards HIV-infected drug users (Carr and Gramling, 2004, 
Parsons et al., 2004). As a result of being seen as culpable for their 
conditions, others project blame and negativity onto the individuals for the 
ontological disruption their conditions bring about (Corrigan, 2004, Herek, 
2002). This discrimination is called an “enacted stigma”, and for those with 
visible signs of physical decay, the “discredited”, a risk of discrimination is 
ever-present (Malcolm et al., 1998, Mateu-Gaelabert et al., 2005, Scambler, 
2008). Individuals living with HIV and using drugs can also experience “felt 
stigma”, the internalized fear of discrimination and sense of shame that living 
with a stigmatised condition causes (Malcolm et al., 1998). This is particularly 
true for the “discreditable”, where the individual’s stigmatised condition is not 
publicly known, and who risk consequences from exposure (Scambler, 
2008). In order to combat stigma, those who possess a stigma may take 
action to hide HIV and drug use from others using one of two information 
control techniques: passing (in the case of discreditable stigma) or covering 
(in the case of discredited stigma) (Goffman, 1963). However, if these 




becoming an individual’s master status becomes a possibility (Seale, 1996). 
As a result, it can create barriers to seeking medical help, and lead to 
discrimination from medical staff and social ostracization (Alonzo and 
Reynolds, 1995, Crandall, 1991).  
In summary, misunderstandings about HIV and illicit drug use are largely 
rooted in lack of knowledge, moral judgement, and fear (Ahern et al., 2007, 
Herek, 2002, Malcolm et al., 1998). As a result, these all perpetuate the 
stigma against HIV-positive drug users and trap HIV-positive drug users in a 
vicious cycle of shame, secrecy and isolation. In the direction of combating 
stigma related to HIV and drug use, measure must be taken to re-evaluate 
policy and service design and push for increased education. 
3.4. Theories and models in relation to 
adherence/health behaviour 
Having gone through the theoretical literature, this review was organised and 
divided into two sections based on the foci that the theories and models 
placed on: Beliefs and motivation, and control and self-regulation. The 
conceptual model developed in this study is underpinned from the theories 
and models reviewed here. 
3.4.1. Beliefs and motivation 
The Health Belief Model (HBM), Information-Motivation-Behavioural skills 
model (IMB Model), and Protection Motivation Theory (PMT) all share a cost-
benefit analysis component in which an individual weighs pros and cons of 
taking an action, gains insight and develops beliefs through the cognitive 
process. In addition to the beliefs wherein the object of belief is judged to be 
true/false and good/bad, a value is also a belief wherein end of action is 
judged to be desirable/undesirable (Rokeach, 1973). All of these are key to 
determining the direction and intensity of an individual’s motivation to act 




3.4.1.1. Health Belief Model (HBM) 
The HBM was originally developed in the 1950s, attempting to explain and 
predict preventive health behaviour or sick role behaviour in terms of certain 
belief patterns (Becker, 1974, Janz and Becker, 1984, Rosenstock, 1974b). 
The HBM comprises four main constructs, perceived susceptibility, perceived 
barriers, perceived benefits, and perceived severity (Appendix 2). These 
constructs could lead to the desire to avoid an illness or the belief that a 
particular action will prevent an illness (Rosenstock, 1974a). The HBM is 
considered important due to its influence on individual’s behavioural 
motivation, and indirectly on behaviour (Strecher and Rosenstock, 1997). 
In the field of HIV, this model has been applied to explore HIV-risk behaviour, 
which has been shown to significantly influence individuals’ HIV-risk 
behaviour (Brown et al., 1991, Downing and Geisinger, 2009, Rosenstock et 
al., 1994, Lin et al., 2005). In terms of adherence to HAART, one cross-
sectional study with 72 HIV-positive participants by Gao et al. (2010) showed 
that decreased perceived severity was associated with poor adherence. In 
addition to HIV, this model has been used successfully in predicting 
treatment adherence among people with psychiatric issues, obstructive sleep 
apnoea, and diabetes with 20-30% of the total variance (Becker and Janz, 
1985, Kelly et al., 1987, Olsen et al., 2008). While the dimensions of the 
model exerted a significant influence on health behaviour in general, the 
effect size of the overall model for predicting health behaviour was small in 
two meta-analysis studies (Carpenter, 2010, Harrison et al., 1992). Drawing 
on the aforementioned studies, the variables in HBM tended to be discussed 
independently. Nonetheless, the relationships between the variables have 
not been explicitly spelt out (Armitage and Conner, 2000, Munro et al., 2007). 
Thus, it has been argued that the HBM is more a short list of 
constructs/variables than a theoretical model (Taylor et al., 2006). 
Furthermore, when applying this model to an individual’s long-term 
medication adherence, factors other than health beliefs could also heavily 
influence an individual’s adherence behaviour. For instance, cultural and 




limitations, this model provided valuable insight into the constructs of health 
beliefs for this study.   
3.4.1.2. Information-Motivation-Behavioural Skills model (IMB model)  
The IMB model was developed by Fisher and Fisher (1992). This model 
focuses on three main components that result in behaviour change: 
Information, motivation, and behaviour skills (Fisher and Fisher, 1992). The 
information and motivation components can directly influence health 
behaviour (Fisher and Fisher, 1992 and 2002). However, it must be noted 
that ‘information’ and ‘motivation’ are potentially independent constructs 
(Fisher and Fisher, 1992 and 2002). In other words, well-informed individuals 
are not necessarily motivated to engage in health behaviour. Likewise, well-
motivated individuals are not necessarily well informed about the health 
practice. Behavioural skills are an additional determinant of whether or not 
people would be capable of effectively bringing about that change (Fisher 
and Fisher, 1992 and 2002). Behaviour skills are dependent on a person’s 
willingness to learn and self-efficacy in carrying out health behaviour (Fisher 
and Fisher, 1992 and 2002). The components can also be moderated by a 
range of contextual factors, such as accessibility of care, or living conditions 
(Fisher and Fisher, 1992 and 2002).  
This model has been widely used in HIV-related behaviours, such as HIV-risk 
behaviour, adherence to antiretroviral medications, and AIDS-preventive 
behaviour by the original authors (Fisher et al., 1999, Fisher et al., 2002, 
Fisher et al., 2006, Rongkavilit et al., 2010). The empirical studies also 
showed the model was moderately effective in promoting adherence 
behaviour in people with diabetes, and has a predictive value for adherence 
to antiretroviral medications among people living with HIV (Amico et al., 
2005, Mayberry and Osborn, 2014, Starace et al., 2006, WHO, 2003). 
However, so far there are no meta-analyses identified to assess the effect of 
this model. In the model itself, it seems that this model does not offer a 
strong theoretical explanation with regards the definition of motivation and 




in this model served as sensitising concepts when analysing data in this 
study (Section 5.8.).  
3.4.1.3. Transtheoretical Model (TTM) 
The TTM is the most prominent theory when discussing the stages of 
behaviour change. The TTM construes behaviour change as an individual’s 
intentional process that unfolds over time and involves six discrete stages of 
change – Precontemplation, contemplation, preparation, action, 
maintenance, and termination (Prochaska and Velicer, 1997). These stages 
are not a linear but fluid process (Prochaska and Velicer, 1997). For 
instance, people may remain the behaviour change for the rest of their lives 
(termination stage), relapse (returning from action and maintenance stages to 
contemplation or preparation stages), or make several attempt to come back 
and forth between stages before their goals are realised.  
Overall, the TTM has appealing features. It is intuitive and provides us insight 
into the process of behaviour change. Marshall and Biddle’s (2001) meta-
analysis showed that participants were less likely to perform health behaviour 
at the pre-contemplation and contemplation stages, whereas experiential 
processes tended to peak at action and maintenance stages. This model has 
not been applied in examining adherence behaviour. However, in Hall and 
Rossi’s (2008) meta-analysis of pros and cons of change in 48 health 
behaviours (predominantly exercise and condom use behaviours), the results 
indicated that participants tended to focus on the cons of changing behaviour 
at pre-contemplation stage compared to at contemplation and preparation 
stages. It seems that the distinguishable stages in the model allow 
practitioners to design interventions easily. However, the main problem with 
the model lies in the lack of a clear specification of what leads to stage 
transitions. For instance, this model tells us little about in what 
context/situation the changes are more likely to occur. By taking into account 
social context and identifying turning points at each stage, it can facilitate 
understanding the dynamics of behaviour change in the process. In addition, 




understand adherence behaviour is beset. Behaviour/action is impacted by 
personal and social traits/factors an individual has/experiences (collectively 
and interactively), which can vary from person to person (Blumer, 1986). In 
that regard, the coverage and types of the process included in the model may 
not be able to explicitly and adequately explain human behaviour (Marshall 
and Biddle, 2001, Riemsma et al., 2003). Nevertheless, the stages of 
behaviour change proposed in this model can serve as a point of reference 
when looking for patterns and processes in HIV-positive drug users’ 
experiences of taking HAART. 
3.4.1.4. Protection motivation theory (PMT) 
The PMT was originally influenced by expectancy-value theory (Rogers, 
1975), in which behaviour is adopted due to an individual’s expectation 
regarding the consequences of the behaviour (Edwards, 1954). In the PMT, 
Rogers (1975 and 1983) proposed that one’s intention to protect self 
depends on three factors: The perceived severity of a threatening event, the 
probability of that event’s occurrence, the efficacy of the protective response. 
In the later years, Weinstein (1993) included perceived self-efficacy as the 
fourth component. Each of these components consists of cognitive 
mediational processes that are categorised as two forms – threat appraisal 
and coping appraisal (Rogers, 1975, Weinstein, 1993). Through these 
cognitive processes, people evaluate threats and select coping alternatives. 
It was proposed that rewards will increase the probability of selecting a 
maladaptive response, whereas threats will decrease the probability of 
selecting maladaptive response (Rogers, 1975, Weinstein, 1993). The 
selection of adaptive coping response will depend on one’s beliefs that 
adaptive response will work and personal ability can actually carry out the 
adaptive response (Rogers, 1975, Weinstein, 1993). On the other hand, 
perception of the costs of adaptive response will decrease the probability of 
selecting the adaptive response (Rogers, 1975, Weinstein, 1993).  
Two meta-analyses of 65 studies by Floyd et al. (2000) and of 21 studies by 




on health behaviour. Both threat and coping appraisal had modest utility in 
predicting an individual’s intention to protect oneself against health threat 
(Flynn et al., 1995, Floyd et al., 2000, Milne et al., 2000). In particular, coping 
appraisal has been reported in the two meta-analysis studies to have greater 
utility compared to threat appraisal (Floyd et al., 2000, Milne et al., 2000). 
Flynn et al. (1995), for example, applied PMT to examine medication 
adherence among patients with muscular dystrophy. The strongest finding of 
the study was that when perceiving treatment as effective, adherence 
behaviour was more likely to be enacted. Another study by Van der Velde 
and Van der Pligt (1991) tested the theory on HIV-related health behaviour 
related to safe sex. The result showed that the PMT fits adequately with 
individuals’ intentions to adopt recommended responses. Fear was 
particularly found to pose a direct and positive impact on behaviour 
intentions.  
Despite its usefulness, one major drawback is that the PMT does not take 
into account that behaviour is not always rational. An individual may not 
consciously re-evaluate all of their medication-taking behaviours. In addition, 
this theory mainly focuses on personal factors, whereas the influence of 
psychological and environmental factors may also need to be taken into 
consideration. Thus, it has been suggested by Van der Velde and Van der 
Pligt (1991) that this theory should expand to consider situational factors so 
as to enhance understanding HIV-related health behaviour. Threat and 
coping appraisal in PMT is similar to perceived benefits and perceived 
severity in HBM, all of which were found particularly useful when exploring 
HIV-positive drug users’ health beliefs and values in this study.  
3.4.2. Control and self-regulation 
In the previous section, it was discussed that personal beliefs and motivation 
play an important role in engaging in health behaviour. However, whether or 
not and how one’s beliefs and motivation can be translated into action is 




the theories or models in relation to control and self-regulation presented 
below have been proposed to help bridge the gap.  
3.4.2.1.Theory of planned behaviour (TPB) and health locus of control 
The TPB origins were derived from the Theory of Reasoned Action (TRA) to 
predict an individual’s intention in behaviour at a specific time and place 
(Ajzen, 1985, 1991 and 2002). Intention was assumed to capture an 
individual’s motivation that could subsequently influence behaviour (Ajzen, 
1991). An individual’s intention to perform a behaviour is influenced by the 
attitude towards the behaviour, including beliefs about the outcomes of the 
behaviour and evaluation of expected outcomes (Ajzen, 1991). In addition, 
one’s intention is also influenced by subjective norms, including one’s 
normative beliefs and motivation to comply (Ajzen, 1991, 2002).  
In the TRA, it omits that one’s behaviour may not always be under volitional 
control. Thus, Ajzen (1991) extended TPB by adding the concept of 
perceived behavioural control. Perceived behavioural control represents 
“one’s perception on the ease or difficulty of performing the behaviour of 
interest (Ajzen, 1991, p183).” Perceived behavioural control may serve as a 
proxy for actual control over the behaviour. Conceptually, perceived 
behavioural control is quite similar to perceived self-efficacy and internal 
health locus of control. Perceived self-efficacy refers to the belief in one’s 
ability to execute the courses of action required to obtain the attainments 
(Ajzen, 1991 and 2002, Bandura, 1991, Weinstein, 1993). Both perceived 
behavioural control and perceived self-efficacy are concerned with one’s 
perceived ability to perform the behaviour. However, there is still a subtle 
difference in meaning between the two concepts, perceived behavioural 
control places more emphasis on ‘control’ over the performance of behaviour 
(Ajzen, 1991). In terms of internal locus control, it is a generalised 
expectancy that remains stable across situations and forms of actions 
(Norman et al., 1998, Wallston et al., 1978). By contrast, perceived 
behavioural control usually varies across situation and actions (Ajzen, 1991 




outcomes can be determined by their own behaviour, which is internal locus 
control; yet at the same time, they can believe that their chance to be a 
lawyer is very unlikely, which is perceived behavioural control (Ajzen, 1991 
and 2002).  
In the current evidence base, the TPB has been widely used to explain and 
predict a wide range of health behaviours, and meta-analyses have 
supported the efficacy of the TPB for both intention and perceived 
behavioural control (Godin and Kok, 1996, Sheeran, 2002). The theory 
accounted for approximately 40-50% of the variance in intention, and 20-40% 
of the variance in behaviour in Godin and Kok’s meta-analysis of 56 studies 
with 58 health behaviours and Sheeran’s (2002) meta-analysis of 10 meta-
analyses. Despite its efficacy, there are several limitations. Firstly, this theory 
does not take into account emotional factors which could potentially influence 
one’s intention and behaviour (Munro et al., 2007). Secondly, this theory 
tended to assume that intention-behaviour is a linear process and does not 
consider it might change over time (Armitage and Conner, 2001). 
Furthermore, this theory assumes that ‘perceived’ behavioural control can 
influence one’s behaviour, whilst it did not clearly explain how one’s 
perceived behavioural control can influence one’s actual control over 
behaviour. In this study, behavioural control was found to be central to HIV-
positive drug users’ behavioural maintenance. Therefore, findings from this 
study can fill the gap and add new knowledge to the current evidence base. 
3.4.2.2. Social-cognitive theory – From the perspectives of self-
regulation and agency 
Self-regulation and agency are derived from social cognitive theory (Bandura, 
1989, 1991 and 2001). The social cognitive theory was developed by 
Bandura (1986), which advanced a view of human functioning that accords a 
central role to cognitive, self-regulatory, and self-reflective processes in one’s 
adaptation and change. In this theory, human functioning is considered as a 
product of a dynamic interplay of individual, behaviour, and environment 




From the perspective of self-regulation, an individual’s behaviour is motivated 
and regulated by the ongoing exercise of self-influence (Bandura, 1991). 
Three major features of self-regulation include self-monitoring of one’s 
behaviour and its effects, judgement of one’s behaviour with regards 
personal standards and environmental circumstances, and affective self-
evaluation that create motivators (Bandura, 1991). In addition, self-regulation 
also encompasses self-efficacy, which plays a crucial role in the exercise of 
human agency by its strong influence on thought, affect, motivation, and 
action (Bandura, 1991). Agency is defined by Bandura (2001) as “acts are 
done intentionally (p.6).” 
From the perspective of agency, the personal level involves consciousness, 
the purposive use of information and self-regulation to make desired things 
happen (Bandura, 2001). The function of consciousness involves assessing 
and processing of information for regulating and evaluating courses of action 
(Bandura, 2001). There are four main features in agency – intentionality, 
forethought, self-reactiveness, and self-reflectiveness (Bandura, 2001). In the 
domain of intentionality, individuals are viewed as having the ability to 
behave accommodatively and through the exercise of self-influence. In terms 
of forethought, it can be presented cognitively in the present, and the 
foreseeable future is converted into current motivator and regulator of 
behaviour (Bandura, 1991 and 2001). Aside from being a planner and 
forethinker, self-reactiveness emphasised the execution of self-regulation 
and self-evaluative performance of a behaviour and goal setting (Bandura, 
1991 and 2001). Self-reflectiveness focuses on self-examination of one’s 
capacity to exercise control over behaviour and over environmental events 
(Bandura, 1991 and 2001).  
To date, there is a paucity of empirical studies or meta-analysis that focused 
on the utility of social-cognitive theory in examining adherence behaviour. 
Few studies used this theory to understand or examine HIV risk sexual 
behaviour, breast-self-examination and dietary behaviour (Miller et al., 1996, 




However, these studies showed that this theory could not adequately explain 
participants’ behaviours, only accounting for small or medium proportions of 
variance in behaviour (Miller et al., 1996, Murphy et al., 1998, Safren et al., 
2010, Schwarzer and Renner, 2000). In addition, it was found that all of the 
studies applied different variables/constructs derived from the theory. Such 
inconsistency could be argued to be due to the complex interplay presented 
in the theory. Even so, this theory was particularly found useful while 
analysing data and this provided me with a greater insight into the 
mechanism underlying human behaviour.  
3.5. Summary 
Up to now, far too little attention has been paid to understand HIV-positive 
drug users’ experiences of taking HAART from a theoretical lens. Thus, 
theories and models reviewed here are in accordance to WHO’s (2003) 
guidebook to gain a better understanding of the existing theoretical 
knowledge that has been used to explain health behaviour in a broader 
sense. In so doing, it allowed me to identify inconsistency and gaps in the 
existing theories and/or models. Though the aforementioned theories and 
models have been widely applied to explain health behaviour, only the IMB 
model has been extensively employed to explain HIV-positive individuals’ 
adherence to HAART. However, this model does not provide an adequate 
theoretical explanation regarding how motivation is defined and the impact of 
psychological well-being on one’s adherence behaviour.  
To sum up, having gained insight into the theoretical knowledge on health 
behaviour, the review of empirical studies in the next chapter (Chapter 4) 
can facilitate understanding HIV-positive drug users’ adherence to HAART 
and how their experiences were constructed, and as a result, it helps to 





CHAPTER FOUR: INTEGRATED 
LITERATURE REVIEW 
4.1. Introduction 
The literature on HIV-positive individuals’ adherence to HAART tends to 
reveal the importance of strict adherence. A cut-off of ≥95% or better 
adherence has been identified as the appropriate threshold for clinical 
efficacy, and this finding is replete throughout empirical research and 
government publications (Lima et al., 2008, NCCSDO, 2005, Ortego et al., 
2011, Paterson et al., 2000, WHO, 2003). Individuals with poor adherence to 
long-term HAART could compromise the effectiveness of the treatment and 
pose a threat to the public, including incomplete viral suppression, increased 
HIV transmission, development of drug resistance, and limitation of treatment 
options (Little et al., 2002, NCCSDO, 2005, AIDSinfo, 2015).  
Despite the importance of adherence to HAART, there is a growing body of 
literature that recognises that among the general HIV population, HIV-
positive drug users have lower adherence rates compared to other HIV 
groups (Ingersoll, 2004, Kalichman et al., 2017, Malta et al., 2008, Martini et 
al., 2004, Ortego et al., 2011, Palepu et al., 2004a, Roca et al., 1999, Rosen 
et al., 2013, Stein et al., 2000, Yang et al., 2008b). While some research has 
identified drug users as a less adherent group, uncertainty remains as to why 
this HIV subgroup is less adherent compared to other HIV populations. In 
that regard, this review aims to critically review the international literature 
relating to HIV-positive drug users’ adherence to HAART. Through a review 
of the literature, important insights into HIV-positive drug users’ HAART-
taking behaviour were gained, any gaps and inconsistencies of the current 






Relevant studies in this review were selected by using a clear and explicit 
process of a literature search with pre-set inclusion and exclusion criteria. 
The final retrieved studies were critiqued, compared, contrasted, and 
synthesised based on their characteristics and findings. Through the 
literature review, gaps and inconsistencies were identified for generating 
research questions.     
4.3. Search strategy 
A search was performed using the databases of the Applied Social Sciences 
Index and Abstract (ASSIA), Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), Medline, Embase and PsycINFO (Ovid interface). The 
keywords used in the search were ‘antiretroviral’ OR ‘HAART’ AND 
‘adherence’ OR ‘adher*’ OR ‘compliance’ OR ‘non-adherence’ OR ’non-
compliance’ OR ‘concordance’ AND ‘HIV’ OR ‘AIDS’ AND ‘drug use’ OR 
‘intravenous drug use’ OR ‘injecting drug use’. 
4.3.1. Inclusion and exclusion criteria 
Inclusion criteria Exclusion Criteria 
1. Studies that involved HIV-positive drug 
users  
2. Study sample is at the age of 18 or older 
3. Published in English or Traditional Chinese  
4. Empirical studies that focus on adherence 
to HAART 
5. Qualitative, quantitative, and mixed-
methods studies, and dissertations (grey 
literature) 
6. With full text 
1. Studies that did not involve HIV-
positive drug users 
2. Study sample is less than18 
years old                                     
3. Simplified Chinese  
4. Unclear study methodology  
5. Studies that did not focus on 
adherence to HAART 
 
Table 2: Inclusion and exclusion criteria 
Articles published in traditional Chinese and dissertations set in the inclusion 
criteria are to maximise the chance of finding empirical studies relevant to the 
Taiwanese context. Dissertations have been categorised as grey literature 
(Hopewell et al., 2008), which refers to “publications issued by government, 
university, business and industry in print and electronic formats but not by 




dissertation was to reduce publication bias (Martin et al., 2005). In terms of 
the language selection, literature written in English and traditional Chinese, 
was included in the search.     
4.4. Reporting study selection 
Figure 2 shows the PRISMA diagram for the search that led to the final 
included studies in this review. This literature search included studies from 
2000 to July, 2018. The literature searched was restricted to dates from 2000 
onwards due to combined HAART regimens accelerated during the early 
2000s, called HAART era, and the overwhelming amount of quantitative 
literature relating to adherence to HAART (Davis, 2006, Lu et al., 2006). 
Through the search strategy, 3968 articles were generated from the 
databases. Based on the inclusion and exclusion criteria, 3848 articles were 
excluded during the title screening stage, leaving 120 studies. After removal 
of the articles that did not meet the criteria, abstract and full-text screening 
eliminated further 74 articles. Five articles were hand-searched and included, 
leaving 51 articles for inclusion in this review. At abstract and full-text 
screening stage, numerous quantitative studies in relation to HIV-positive 
drug users’ adherence to HAART were identified as opposed to qualitative 
studies.  The study selection process and the rationale for exclusion are 
shown in Figure 2. Summary of the selected studies is presented in 




































CINAHL (N=1074)   \          
ASSIA (N=756)                   
Ovid database (Medline, 
Embase, and PsycINFO):2137                         
Thesis: 
CINAHL (N=0)                
ASSIA (N=0)                       
Ovid (N=1)                                 
         
 
Reasons for excluding the articles 
during the title screening stage 
(N=3848):                                          
1. Intervention research                     
2. Children.                                        
3. Sample is not HIV-positive drug 
users                                                 
4. Not related to antiretroviral 
adherence or non-adherence                         
5. Duplicates 
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Reasons for excluding the articles 
(N=74):                                               
1. Small sample size of drug users 
group                                                   
2. Full text is not accessible                                   
3. Examining the effectiveness of 
interventions                                                                
4. Aims were to test adherence 
measurement                                      
5. Review literature                            
6. Did not define adherence or 
explain how 95% adherence was 
measured                                      
7. Unclear definition of substance 
abusers                                              
8. Not focusing on drug users, and 
simply reporting the association 
between adherence and drug use 
among general HIV population                                       
9. Results drawing from an 
intervention evaluation research,. 
Simply reporting the association 
between appearance concerns 
and non-adherence.                                         
10. Focusing on viral suppression 
or CD4 count not adherence                 
11. Dependent variable is 
acceptance of HAART or health 
seeking behaviour                      
12. Not drug users but persons 
with incarceration or sexual abuse  
13. Simply reporting the 
association between adherence 
and influencing factors without 


























Hand searched 3 articles 
from the reference lists of 
systematic review articles     
Two recently-published 







4.5.1. Characteristics of the included studies 
Of the retrieved quantitative studies (n=40), 13 were from Canada, 20 from 
the USA, 4 from France, 1 from the Netherlands, 1 from India and 1 from 
Vietnam (Appendix 3). Of the 13 articles from Canada, 11 were from the 
same prospective and ongoing research project in Vancouver. The 4 articles 
from France were also derived from the same prospective research project. 
In total, 26 articles were prospective studies (the follow-up period, ranging 
from 1 month to 91 months), 13 cross-sectional, and 1 secondary data 
analysis. There were 27 studies involving HIV-positive drug users (either illicit 
drug users or injecting drug users); 1 involving methadone maintained 
patients; 7 studies involving HIV-positive substance users with a clear 
sample description of what constitutes substance users;  5 studies involving 
HIV-positive individuals divided into subgroups (active drug users, past drug 
users, and non-drug users). All of the included quantitative studies recruited 
sample through convenient and/or snowball sampling.  
The retrieved quantitative studies predominantly focused on levels of 
adherence, and its influencing factors, however, these studies defined 
adherence in a variety of ways and used different measurement tools. Most 
studies measured participants’ levels of adherence to HAART through self-
report (continuous variable: doses taken/total prescribed doses during certain 
period of time, or ordinal variable: self-rating adherence level), pharmacy 
dispensation record (the number of days patients received HAART refills/the 
total number of days of medical follow-up), or electronic monitoring system 
(Medication Events Monitoring System caps, MEMS caps). Three studies 
focused on drug users’ discontinuation of HAART. Four measured the mean 
adherence rate across study participants. Of the studies measuring drug 
users’ adherence with a continuous scale, 19 studies defined adherence as 
taking ≥95% prescribed doses, 2 defined adherence as taking ≥90% 
prescribed doses, 4 defined adherence as taking 100% prescribed doses, 




related to adherence rates are discussed in Section 4.5.2. Quantitative and 
qualitative findings pertaining to the factors that influence adherence are 
synthesised and presented in Section 4.5.3. 
In terms of qualitative studies, 11 were retrieved for this review (Appendix 
3). There were a paucity of qualitative research focusing on HIV-positive drug 
users’ experiences of adherence to HAART at the literature screening stage. 
All the qualitative studies that involved HIV-positive drug users’ experiences 
of taking HAART were included in this review. Although some included 
studies had not gone much further than describing and summarising what 
participants said, participants’ statements presented in the studies still allows 
readers to see the voice of HIV-positive drug users regarding their HAART 
taking. In other words, the quality of these qualitative studies was assessed 
according to the degree to which authors represented the views of their 
participants (Thomas and Harden, 2008). Of the 11 qualitative studies, 2 
were from Canada, 3 from the USA, 1 from Spain, 2 from Russia, 1 from 
Ukraine, 1 from India, and 1 from the Netherlands. In other words, there is 
only one relevant qualitative study in Asia. Of the included studies, 4 studies 
used thematic analysis, 2 used framework analysis, 1 used content analysis, 
1 conducted ethnographic interviews, 2 followed Strauss and Corbin’s 
codification process (1998), and 1 followed Glaser and Strauss’s analytic 
approach (1967). The qualitative findings are discussed in Section 4.5.3.   
4.5.2. An estimate of adherence levels among HIV-positive 
drug users 
Ten studies involving only drug users and defining adherence as taking 
≥95% prescribed doses revealed that drug users who had ≥95% adherence 
ranged from 19.3% to 85.9% (French et al., 2011, Hayashi et al., 2016, 
Joseph et al., 2015, Lee et al., 2016, Mann et al., 2012, Nolan et al., 2011, 
Palepu et al., 2011, Palepu et al., 2006, Surratt et al., 2015, Turner et al., 
2003). However, this result largely represented the USA and Canada, 
because 7 out of the 10 studies were from Canada (Hayashi et al., 2016, 




Palepu et al., 2011, Palepu et al., 2006), and 3 were from the USA (French et 
al., 2011, Surratt et al., 2015, Turner et al., 2003). Two studies from France, 
involving IDUs and using 80% as the cut-off point for adherence, showed that 
65.2% of 164 IDUs in Moatti’s study (2000) and 70% of 210 IDUs in 
Bouhnik’s study (2002) had ≥ 80% adherence. One cross-sectional study by 
Arnsten et al. (2007) measured 636 HIV-positive drug users’ adherence rate 
with use of 90% as the cut-off point for good adherence, showing that 75% of 
them had ≥ 90% adherence. Two studies from the USA, involving HIV-
positive substance abusers (illicit drugs and alcohol abusers) and using 
100% as the cut-off point, showed that 46% of 1889 substance abusers in 
Tucker’s (2004) cross-sectional study and 55% of 1138 substance abusers in 
Mellins’s cohort study (2009) had 100% adherence. Two prospective studies 
by Kalichman et al. (2015) and Ti et al. (2014) measured the average 
adherence rate among 85 and 587 HIV-positive illicit drug users in the USA 
and Canada respectively, which were reported to be approximately 50%. 
Compared to former drug users and non-drug users, active drug users were 
reported to be significantly associated with poorer adherence to HAART 
(Arnsten et al., 2007, Arnsten et al., 2002, Cohn et al., 2011, French et al., 
2011, Hicks et al., 2007, Hinkin et al., 2007, Jordan et al., 2014, Lucas et al., 
2001, Moore et al., 2012, Shape et al., 2004).  
Drawing on the results, there was an indication that HIV-positive drug users 
had lower adherence rates. Nonetheless, a few included studies showed that 
HIV-positive drug users had high adherence rates. For example, one 
prospective study from Vietnam showed that 83% out of 100 HIV-positive 
drug users had perfect or very good adherence at some point (self-reported 
categorical scale) (Jordan et al., 2014). Another study from the USA reported 
that the mean adherence rates among low-income HIV-positive substance 
abusers ranged from 94.46%-97.97% (Magidson et al., 2015). The results 
are not consistent across the studies, and the aforementioned studies only 
measured HIV-positive drug users/substance abusers’ adherence at some 




There are four included studies, Mann et al. (2012) from Canada, Waldrop-
Valverde et al. (2013) and Hinkin et al. (2007) from the USA and Lambers et 
al. (2011) from the Netherlands, investigating the change in adherence 
levels.  
The study from the Netherlands showed that 25% of 102 drug users became 
less adherent (was defined by the authors as < 95% adherence) at some 
points during the study period (Lambers et al., 2011). This indicates that 
adherence to HAART does not always stay at the same level. Congruently, 
three quantitative studies from Canada and India investigated HIV-positive 
IDUs’ discontinuation of HAART (Hadland et al., 2012, Kerr, 2005, Sharma et 
al., 2007). These studies showed that 33.8% of 545 IDUs in Hadland’s study 
in Canada (2012), 44% of 160 IDUs in Kerr’s study in Canada (2005), and 
32.7% of 226 IDUs in Sharma’s study in India (2007) discontinued HAART 
during the follow-up period.   
In terms of the trend of HIV-positive drug users’ adherence levels over time, 
the prospective study from Mann et al. (2012) looked into pharmacy 
dispensation records, and the results showed that the proportion of achieving 
≥ 95% adherence among HIV-positive drug users increased over time, from 
19.3% in 1996 to 65.9% in 2009. By contrast, a prospective study from 
Waldrop-Valverde et al. (2013) investigated cocaine users’ adherence levels 
using an electronic monitoring device, and the results showed that there was 
a significant drop in adherence from Month 1 to Month 6. The reduction in 
percentage dose adherence was from 76.7% at Month 1 to 66.5% at Month 
6. The difference in the adherence rates over time was found to be due to 
personal factor in Waldrop-Valverde’s study (2013) and the advance of 
HAART in Mann’s study (2012). Mann’s study (2012) investigated drug users’ 
adherence levels over a longer period of time, from the early era of HAART 
to more recent era of HAART. The advance in HAART has changed the form 
of HAART regimens, contributing to increased adherence rates over that 
period of time (Mann et al., 2012). As opposed to Mann’s study (2012), the 




decrease in adherence rates among drug users was reported to be more 
associated with self-efficacy of taking HAART. In a longitudinal study by 
Hinkin et al. (2007), it was revealed that both drug positive and drug negative 
groups had a decrease in adherence rates over time. The mean adherence 
rate had dropped from 77.4% to 68.4% in the drug negative group, whereas 
there was a significant decrease in the adherence rate among the drug 
positive group, from 70.1% to 51.3%. The trend of the adherence rate in the 
entire sample was from 74.4% for the first 2 months, to 68.5% for month 3, 
and down to 62.6% for month 5 and 6.   
By and large, the results of the included quantitative studies demonstrated 
the adherence rates among HIV-positive drug users, and its dynamic 
process. However, it is not without limitations. Firstly, as most of the included 
studies used convenient sampling methods to recruit participants, the 
adherence rates cannot be representative of HIV-positive drug users (Grove 
et al., 2013). Secondly, most of the included studies used self-report or 
pharmacy dispensation records to assess adherence rates. Self-report 
measure may bring social desirability bias or recall bias in research (Van de 
Mortel, 2008). Nevertheless, it has been reported that drug users’ self-report 
was correlated with patients’ clinical outcomes, criminal records, and 
interviews, and it has been tested as a reliable method (Drake, 1998). In 
terms of measuring adherence by using pharmacy dispensation records, 
issues arise as to whether patients who refill medications actually take them. 
This pharmacy record method has been reported by Palepu et al. (2003) as 
unreliable because of the insignificant association between HIV-positive drug 
users’ adherence level and HIV-1 RNA suppression. Taking this into account, 
measuring adherence levels with more than one method may enhance the 
accuracy of adherence assessment. Furthermore, the included studies used 
various methods and standards to investigate drug users’ adherence levels. 
As a result, it increased the difficulty of estimating overall drug users’ 




4.5.3. Factors influencing adherence to HAART 
Having gained insight into HIV-positive drug users’ adherence rates in the 
current evidence base, this section focuses on its influencing factors. A 
multitude of influencing factors have been identified and explored in the 
included qualitative studies (n=11). Of the 11 qualitative studies, 8 involved 
HIV-positive individuals who had a history of injecting drugs (Chakrapani et 
al., 2014, de la Hera et al., 2011, Mimiaga et al., 2010, Pach et al., 2003, 
Rhodes and Sarang, 2012, Small et al., 2009, Witteveen and Ameijden, 
2002). One involved HIV-positive active drug users (smoked/ injecting drug 
use) (Ware et al., 2005). One involved IDUs who use methadone 
maintenance (Batchelder et al., 2013). One involved HIV-positive individuals 
who had a history of using drugs and treatment interruption for 30 days 
(McNeil et al., 2017).  By looking at the concepts developed from the 
included studies, findings were compared and contrasted, and were 
subsequently collated into concepts. In addition, the qualitative findings were 
compared with relevant quantitative results in an attempt to gain a 
comprehensive account of HIV-positive drug users’ experiences of taking 
HAART.  
Throughout the process of comparing findings across the included studies, 
six themes were identified—  
1) Stigmatisation in relation to HIV and illicit drug use 
2) The motivation for taking HAART 
3) Active drug use and HAART adherence 
4) Accessibility and conditionality of HIV and addiction treatment 
5) Side effects and complexity of HAART regimens 
6) Forgetting and not fitting HAART regimen into schedule.  




4.5.3.1. Stigmatisation in relation to HIV and illicit drug use 
Stigma was identified as one of the predominant themes. Seven studies 
reported that HIV-positive drug users/inmates had experienced stigmatisation 
and discrimination associated with HIV and illicit drug use (Batchelder et al., 
2013, Chakrapani et al., 2014, McNeil et al., 2017, Mimiaga et al., 2010, 
Rhodes and Sarang, 2012, Small et al., 2009, Ware et al., 2005). Some 
experienced violence in the prison settings (Small et al., 2009) and others 
were shunned and discriminated by family (Batchelder et al., 2013, 
Chakrapani et al., 2014, McNeil et al., 2017,Ware et al., 2005), police officers 
(Mimiaga et al., 2010) and health professionals (Chakrapani et al., 2014, 
Kiriazova et al., 2016, Rhodes and Sarang, 2012) due to their HIV status. In 
addition to HIV status, participants’ engagement in the everyday violence 
associated with their drug dependence appeared to exacerbate their negative 
image portrayed by society (McNeil et al., 2017).  
Two major factors that led to families’ and public stigmatisation and 
discrimination towards HIV-positive drug users emerged from participants’ 
statements across the included qualitative studies — lack of knowledge 
relating to HIV, and images of ‘HIV and illicit drug use’ discredited by society. 
As with lack of knowledge, misconceptions about the transmission routes of 
HIV were revealed to bring public fear and lead to estrangement. For 
example, HIV-positive drug-using participants in Mimiaga’s study (2010) 
reported that police officers in Ukraine were afraid of them, and avoided 
physical contact from them or even things they had touched. As a result, their 
experiences of stigmatisation had influenced their willingness to access care.  
Three qualitative studies from Ukraine (n=16), India (n=19), and Russia 
(n=42) revealed that health professionals held assumptions in relation to HIV-
positive drug users’ poor adherence and refused to treat them (Chakrapani et 
al., 2014, Kiriazova et al., 2016, Mimiaga et al., 2010, Rhodes and Sarang, 
2012). Aside from health professionals’ negative assumptions of drug users, 
Pach et al.’s (2003) (n=34) and Kiriazova et al.’s (2016) qualitative studies 




either. This created the barrier to accessing HIV care.  With a lack of 
engagement and trust in the health system, some drug users did not have 
adequate knowledge about HIV and HAART (Chakrapani et al., 2014, Pach 
et al., 2003, Ware et al., 2005). As a result, they were more likely to gain 
knowledge of HAART based on information circulating through social 
networks, and held negative assumptions and misinterpretation of HAART 
(Chakrapani et al., 2014, Pach et al., 2003, Ware et al., 2005). Congruently, 
Kelly’s study (2012) with the use of secondary data analysis (n=76) pointed 
out that having HIV-positive drug users in friend circles was associated with 
less adherence to HAART.  
Experiences of stigmatisation from families has also been reported in 
Chakrapani’s qualitative study (2014) in India, where being HIV positive and 
using illicit drugs were perceived by IDUs’ families to bring shame to the 
whole family. By holding negative perceptions of HIV and illicit drugs, some 
were forced by their families to move out of their house, leading to 
homelessness (Chakrapani et al., 2014). As a consequence, financial 
instabilities (e.g. lack of money, food and housing), social stigmatisation, and 
disruptions in drug users’ daily lives had affected their ability to follow 
treatment regimens (Pach et al., 2003, McNeil et al., 2017, Ware et al., 2005, 
Witteveen and van Ameijden, 2002). Several quantitative studies also 
showed the significant association between homelessness and 
nonadherence (Arnsten et al., 2002, Bouhnik et al., 2002, Hayashi et al., 
2016, Lambers et al., 2011, Palepu et al., 2006, Suratt et al., 2015). 
The impact of stigmas related to HIV and illicit drug use not only impeded 
HIV-positive drug users’ acquisition of support, but worsened their 
psychological distress, self-stigmatisation, and willingness to seek support 
(Batchelder et al., 2013, McNeil et al., 2017, Mimiaga et al., 2010, Witteveen 
and van Ameijden, 2002). With the feelings of denial, shame, and fear of 
stigmatisation, some tended to not disclose their HIV status, and were more 
likely to hide or not bring HAART medications with them (Batchelder et al., 




drug users articulated their low levels of motivation to live and take HAART 
(Mimiaga et al., 2010, McNeil et al., 2017, Witteveen and van Ameijden, 
2002).  
In line with the findings derived from the qualitative studies, the included 
quantitative studies indicated that HIV-positive drug users’ poor adherence to 
HAART was significantly associated with their psychological distress or 
depression (Arnsten et al., 2007, Mellins et al., 2009, Moore et al., 2012, 
Amsten et al., 2002, Carrieri et al., 2003). In addition, two studies from the 
USA by Magidson et al. (2015) and France by Moatti et al. (2000) indicated 
that environmental punishment (perception of being exposed to punishing 
experience) and frequency of negative life events were related to poor 
adherence to HAART. Of particular concern, environmental punishment was 
the mediator between depression and poor adherence (Magidson et al., 
2015). The results illustrated the influence of social environment on 
individuals’ psychological well-being and subsequent HAART-taking 
behaviour.  
In brief, it seemed that stigma related to HIV and illicit drug use could pose 
an impact on HIV-positive drug users’ acquisition of support. Without the 
support available for them, it can further increase drug users’ levels of 
perceived stigma and psychological distress. Social and self-stigmatisation 
was revealed to be linked to misunderstandings pertaining to HIV and illicit 
drug users, and the influence of social values.  
4.5.3.2. The motivation for taking HAART  
Despite the impact of stigma on HIV-positive drug users’ HAART-taking 
behaviour, some HIV-positive drug users appeared to be motivated to take 
HAART. Two factors were identified to enhance HIV-positive drug users’ 
motivation of taking HAART— acceptance of HIV status and acquisition of 
support from health professionals, family or friends (Batchelder et al., 2013, 
de la Hera et al., 2011, Pach et al., 2003, Mimiaga et al., 2010, Ware et al., 
2005, Witteveen and Ameijden, 2002). With the acquisition of support, it 




providing tangible support (Pach et al., 2003, Mimiaga et al., 2010, Ware et 
al., 2005). In addition, drug users having a stable job has been identified as a 
factor enhancing their sense of responsibility and level of motivation to 
adhere to HAART (Chitsaz et al., 2013, Ware et al., 2005).  
One qualitative study (n=23) by de la Hera et al. (2011) pointed out that 
maintaining a good relationship between health professional and HIV-positive 
drug users enhanced drug users’ knowledge related to HAART management. 
In turn, drug users with adequate knowledge were found to be more likely to 
be aware of their HAART-taking acts and managed HAART more 
consciously. Aside from external support, internally, drug users’ self-
acceptance and wanting to live longer were revealed to strengthen their will 
to adhere to HAART (Batchelder et al., 2013, Mimiaga et al., 2010, Ware et 
al., 2005). 
Drawing on the qualitative findings from the included studies, HIV-positive 
drug users’ motivation to take HAART seemed to be influenced by the 
degree of support they got and their self-acceptance. As such, it had helped 
drug users grow belief and confidence in their capacity for taking HAART 
(Batchelder et al., 2013, de la Hera et al., 2011).    
4.5.3.3. Active drug use and HAART adherence 
The majority of the included quantitative studies indicated that illicit drug use 
significantly and negatively affected HIV-positive drug users’ adherence to 
HAART (Arsten et al., 2002, Azar et al., 2015, Bouhnik et al., 2002, Carrieri 
et al., 2003, French et al., 2011, Hayashi et al., 2016, Hicks et al., 2007, 
Hinkin et al., 2007, Jordan et al., 2014, Joseph et al., 2015, Kalichman et al., 
2015, Magidson et l., 2015, Mellins et al., 2009, Moore et al., 2012, Palepu et 
al., 2006, Roux et al., 2008, Sharma et al., 2007, Wood et al., 2004). A 
longitudinal study conducted in New York by French et al. (2011) investigated 
the impact of the change in substance abuse on participants’ adherence to 
HAART. The result showed that participants who changed from no substance 
use at one interview to substance use at the follow-up interview were more 




does not specify the patterns of drug use among the participants. It would 
enhance understanding if this study had included more details about the 
dynamics of drug use as to whether participants experienced relapse or just 
started using illicit drugs. The tendency to use drugs to cope with stress was 
reported in Arnsten’s prospective study (2002) to be significantly associated 
with non-adherence to HAART. This indicates that drugs could be used as a 
coping strategy by users to deal with stress, resulting in poor adherence.  
Concerned about the impact of drug use on adherence, getting a fix was the 
heroin users’ main focus (Chakrapani et al., 2014, de la Hera et al., 2011, 
Mimiaga et al., 2010, Pach et al., 2003, Witteveen and Ameijden, 2002, Ware 
et al., 2005). The large amount of time active drug users spent on pursuing 
their next fix had affected their ability to access health care (Mimiaga et al., 
2010, Pach et al., 2003). In addition, the large sum of money spent on heroin 
placed HIV-positive drug users in poor financial circumstances (Witteveen 
and Ameijden, 2002, Ware et al., 2005). Drawing on the findings, both stigma 
and illicit drug use were revealed to collectively increase HIV-positive drug 
users’ vulnerability related to incarceration, employment, family relationships, 
mental health, and access to care, contributing to breakdowns in the 
continuity of HIV care (McNeil et al., 2017, Joseph et al., 2015, Kerr et al., 
2003, Lambers et al., 2011, Ware et al., 2005).  
Congruent with the qualitative research findings, Mellins et al. (2009) and 
Tucker et al. (2004) in their cross-sectional studies reported that HIV-positive 
drug users’ non-adherence to HAART was associated with low attendance 
rates at a medical appointment and poor integration of the medication 
regimens into their lifestyle. Wittveen and Ameijden (2002) in their 
ethnographic interviews noticed that the drug use patterns among drug-
taking adherers ranged from using drugs once a day to using drugs once a 
month. Although Wittveen and Ameijden (2002) did not further explain what 
enabled them to regularly use illicit drugs and take HAART medications, they 
pointed out that methadone had alleviated participants’ withdrawal symptoms 




In line with this, numerous included quantitative studies also reported 
methadone maintenance treatment was significantly related to adherence to 
HAART among HIV-positive drug users (Azar et al., 2015, Hicks et al., 2007, 
Joseph et al., 2015, Lambers et al., 2011, Lappalainen et al., 2015, Lee et 
al., 2016, Nolan et al., 2011, .Palepu et al., 2006, Roux et al., 2008, Turner et 
al., 2003). These findings are incongruent with the results of a cross-
sectional study with 133 methadone users by Shrestha and Copenhaver 
(2018) which indicated that methadone users were at high risk of undertaking 
risk-taking behaviour, and had suboptimal adherence and incomplete viral 
suppression.  
In summary, it seemed that the addictive effects of illicit drugs could disrupt 
HIV-positive drug users’ lifestyle and their ability to access HIV care, whereas 
methadone seemed to have the protective effect of alleviating their 
withdrawal symptoms. However, the impact of methadone use on affected 
individuals’ drug-taking and adherence behaviour remains complex, which 
requires future research on their complex interplay.  
4.5.3.4. Accessibility and conditionality of HIV and addiction treatment 
Though HAART and addiction treatments play an important role in facilitating 
HIV-positive individuals’ adherence to HAART, some drug users articulated 
the difficulty in accessing HIV and addiction care (Chakrapani et al., 2014, 
Kiriazova et al., 2016, McNeil et al., 2017, Pach et al., 2003, Rhodes and 
Sarang, 2012, Sharma et al., 2007, Small et al., 2009). The accessibility of 
HIV and addiction care varied from country to country. Sharma’s cross-
sectional study (2007) from India illustrated that the financial cost of HIV 
diagnostic testing, treatment of opportunistic infections, and transport 
significantly increased HIV-positive drug users’ financial burden and impeded 
their access to HAART. In correctional systems, issues in relation to difficulty 
accessing HIV medications were reported in two qualitative studies by McNeil 
et al. (2017) and Small et al. (2009) in Canada. In the two studies, some 
participants complained about the unavailability of HIV medication between 




sentence, and upon release from custody (McNeil et al., 2017, Small et al., 
2009). As such, these structural factors increased the challenge of drug 
users’ access to HIV care.    
In addition to these structural factors, two qualitative studies from Russian 
and India revealed that HIV treatment conditionality was a great hindrance of 
access to HIV care among HIV-positive drug users (Chakrapani et al., 2014, 
Rhodes and Sarang, 2012). In Chakrapani’s (2014) and Rhodes and 
Sarang’s (2012) studies, physicians’ provision of HAART to HIV-positive drug 
users appeared to be contingent. Physicians provided HAART to affected 
individuals, only when affected individuals could show evidence that they 
were reliable, deserved taking HAART, and were able to be in control of their 
drug use. Such value judgement was upheld by physicians’ concerns in an 
attempt to decrease drug resistance, maximise treatment outcomes, and 
adapt to economic constraints within healthcare (Chakrapani et al., 2014, 
Rhodes and Sarang, 2012). As a result, it had led to delayed access to care, 
treatment interruption, or disengagement from health care among HIV-
positive drug users (Chakrapani et al., 2014, Rhodes and Sarang, 2012).  
Such ways of treating HIV-positive drug users situated HAART as a relative 
priority in the hierarchy of immediate need where managing the ‘problems’ of 
illicit drug use came first. Moreover, this policy was revealed to be put in 
place due to physicians’ doubts of drug users’ capacity to adhere to HAART 
in the face of ongoing and untreated drug use (Chakrapani et al., 2014, 
Rhodes and Sarang, 2012).  In addition to the conditionality of access to HIV 
care, HIV-positive drug users’ accounts, in the qualitative studies by Pach et 
al. (2003) from the US (n=34 HIV+ IDUs), Chakrapani et al. (2014) from India 
(n=19 HIV+ IDUs), and Rhodes and Sarang (2012) from Russia (n=42 HIV+ 
IDUs), showed the inadequacy and ineffectiveness of addiction treatment, 
and a lack of effective linkage between HIV care and drug dependence 
treatment/needle syringe programme. In contrast to the findings from these 
studies, easy access to HAART was reported by HIV-positive drug users who 




la Hera et al. (2011) from Spain (n=23 HIV+ IDUs). Drawing on the findings 
from the aforementioned studies, it seemed that the accessibility of HIV care 
can also be linked to the establishment of the trusting relationship between 
health professionals and HIV-positive drug users.  
Infrastructure within healthcare varies from country to country. Nevertheless, 
this could create a barrier to individuals’ willingness to access care, 
especially for those who were in a financially disadvantaged situation. In 
addition, the distrusting relationship between healthcare providers and HIV-
positive drug users could also widen the accessibility gap.   
4.5.3.5. Side effects and complexity of HAART regimens  
Side effects have been reported by several qualitative studies and one cross-
sectional study as a barrier to adherence to HAART among HIV-positive drug 
users (Mimiaga et al., 2010, McNeil et al., 2017, Pach et al., 2003, Sharma et 
al., 2007, Wittveen and Ameijden, 2002). The commonly reported side effects 
were diarrhoea, fatigue, nausea, vomiting, and stomach-aches (Mimiaga et 
al., 2010, McNeil et al., 2017, Pach et al., 2003, Wittveen and Ameijden, 
2002). Some had treatment interruption due to the experience of side effects 
(Mimiaga et al., 2010, McNeil et al., 2017, Pach et al., 2003, Wittveen and 
Ameijden, 2002), and others did not receive HAART because of their 
misconception and concerns over the toxicity and danger of taking the 
treatment (McNeil et al., 2017, Pach et al., 2003). 
For HIV-positive drug users who started HAART in the early to mid-1990s or 
lived in a country where HAART options were limited (such as Ukraine), 
complexity of the treatment regimen was reported to influence their 
adherence to HAART (de la Hera et al., 2011, McNeil et al., 2017, Mimiaga et 
al., 2010, Wittveen and Ameijden, 2002). A qualitative study by Mimiaga et 
al. (2010) from Ukraine pointed out that several participants found it 
challenging to adhere to HAART due to high pill counts, the necessity of 
taking medications at specific times, and with food restrictions. Nonetheless, 




has transformed the treatment regimens into a more simplified form, which 
had enhanced participants’ adherence.  
To sum up, the advance in HAART regimen globally has simplified the way 
that individuals take HAART regimens, and has decreased individuals’ 
burden of taking HAART. Nonetheless, ‘side effects’ of HAART remained one 
of the major barriers to adherence to HAART in the included studies. 
Misconception and experience of side effects of HAART were found to exert 
an impact on receiving and/or continuing HAART among participants in the 
included studies.  
4.5.3.6. Forgetting and not fitting HAART regimen into schedule 
Fitting HAART regimen into daily schedules has been reported to bring 
challenges to adherence to HAART among drug users (Harzke et al., 2004, 
Mimiaga et al., 2010, Wittveen and Ameijden, 2002). Though this theme 
emerged in the included qualitative studies, there was a lack of explanation 
and exploration in the studies as to in what situations or how HIV-positive 
drug users were more likely to forget doses and not incorporate HAART into 
life.  
To avoid forgetfulness, some HIV-positive drug users, from Wittveen and 
Ameijden’s (2002), Mimiaga’s (2010), Ware’s (2005) qualitative studies, 
developed strategies to promoting adherence to treatment. The strategies 
included incorporating medication regimens into drug use routines, use of 
medication containers, phone alarms/alarm clocks, or stickers to remind their 
dosing schedules. Some took HIV medications with them all the time 
(Mimiaga et al., 2010, Wittveen and Ameijden, 2002).   
4.6. Discussion 
Evidence from the international literature has shown that HIV-positive 
individuals who use or inject illegal drugs were less likely to adhere to 
HAART and access to HIV care compared to the general HIV population 




2011, Palepu et al., 2004a, Roca et al., 1999, Rosen et al., 2013, Stein et al., 
2000, Yang et al., 2008b). Adverse effects of illegal drug use had been 
reported to be the major concern for non-adherence (Chakrapani et al., 2014, 
de la Hera et al., 2011, Mimiaga et al., 2010, Pach III, 2003, Witteveen and 
Ameijden, 2002). As a result, active drug use seemed to have increased the 
challenge of initiating and sustaining HAART use among HIV-positive drug 
users. 
Reflecting on the included studies, it was revealed that HIV-positive drug 
users’ HAART-taking is an ongoing and dynamic social process where the 
patterns of their HAART-taking behaviour did not remain the same but 
fluctuated over time  (Lambers et al., 2011, Mann et al., 2012, Waldrop-
Valverde et al., 2013). Although several attempts have been made to assess 
HIV-positive individuals’ adherence levels by using self-reported 
questionnaires, pharmacy dispensing records or electronic monitoring 
devices, current assessment tools cannot capture the dynamic process of 
drug users’ HAART-taking behaviour.  
There are qualitative studies aimed at understanding and exploring drug 
users’ experiences of taking HAART. In these qualitative studies, 
participants’ experiences of stigmatisation was shown to affect their 
psychological well-being, self-stigmatisation, and willingness to seek support 
and regularly receive HAART. By contrast, self-acceptance and acquisition of 
support were identified to enhance HIV-positive drug users’ motivation of 
taking HAART. In addition, active drug use, specifically heroin, was found to 
affect participants’ decision of prioritising needs. They tended to prioritise the 
need of getting fixed over enhancing health condition, resulting in decreasing 
their motivation of taking HAART. In response to stress, drug use was 
reported in Arnsten et al. (2002) prospective study as a coping strategy 
among HIV-positive drug users. These findings imply the complex 





Infrastructures within healthcare were another factor shown in the included 
studies to impede participants’ access to HIV and addiction treatment. 
Accessibility of care was particularly found to be linked to the economic 
constraints and value judgement towards drug users within the society. As for 
HAART regimens, concerns over side effects were revealed to shape 
participants’ preconception of HAART and decrease their willingness to take 
HAART. Not fitting HAART regimen into everyday life was reported to 
increase the chance of missing doses.  
Taken together, the findings from the included studies provide insight into the 
factors that influence HIV-positive drug users’ adherence to HAART. 
However, there is much less information as to whether there is an emotional 
or cognitive “process” involved in drug users’ HAART-taking behaviour. By 
understanding HIV-positive drug users’ transition in emotion, thinking and 
HAART-taking behaviour, and their coping of the contingent situations, this 
can facilitate capturing their behaviour change. In addition, there remains a 
lack of a comprehensive understanding of HIV-positive drug users’ 
experiences of taking HAART in the current evidence base. Uncertainty still 
exists about the interrelationships between factors that impact adherence, 
and how the factors collectively or interactively influence drug users’ HAART-
taking behaviour.  
Within the Asian context, research on drug users’ adherence to antiretroviral 
treatment has been focused on those countries who are members of the 
WHO and undertaken in low/middle-income South East Asian countries 
(Feelemyer et al, 2015, Wolfe et al., 2010). However, the classification of 
Taiwan, as a non-WHO member and high-income East Asian country, does 
not fit into the criteria of transitional low and middle income countries. This 
could be considered to be a contributing factor to the lack of research and 
literature in this area. The literature review conducted for this thesis has 
confirmed the dearth of research on this topic, therefore a study such as the 
one proposed here would be a useful contribution, providing new knowledge. 




Chapter 2 and the lack of research in this particular area as identified in 
Chapter 3, this research aims to explore Taiwanese HIV-positive drug users’ 




















METHODOLOGY AND METHOD 
5.1. Introduction 
In the previous chapter, I reviewed empirical literature on the topic of HIV-
positive drug users’ adherence to HAART. To date, HIV-positive drug users’ 
adherence to HAART has been predominantly approached from a 
quantitative perspective. The quantitative studies showed from the review 
that HIV-positive drug users’ HAART-taking behaviour tended to be dynamic 
and fluid where their HAART-taking did not stay consistent but fluctuated 
over the course of their treatment process. The existing qualitative evidence 
provided insight into HIV-positive drug users’ experiences of taking HAART 
and its influencing factors. So far, however, there remains a paucity of 
evidence on how the factors interactively and collectively affect their HAART-
taking behaviour during the treatment trajectory. In addition, there is a lack of 
theoretical underpinnings of adherence behaviour and its process. Taking 
these into account, it is needed to develop a conceptual model underpinned 
from existing theories to facilitate understanding HIV-positive drug users’ 
experiences of taking HAART. In this chapter, I firstly discuss the qualitative 
method used in this study, and then moves on to discuss participant 
recruitment, data collection and analysis methods, and ethical issues. Lastly, 
the criteria I followed for enhancing the quality of this qualitative research is 
discussed. 
5.2. Research aims  
This study set out to explore HIV-positive drug users’ experiences of taking 
HAART, and develop a conceptual model that can unpack the complexity of 




5.3. Research questions 
The research questions in this study began in an open-ended way to 
optimise the analytic opportunities of the study phenomenon (Charmaz, 
2014, Denzin and Lincoln, 2018, Creswell and Poth, 2018). As the study 
progressed, questions were gradually narrowed down. The following 
research questions were initially formulated to explore HIV-positive drug 
users’ experiences of taking HAART in Taiwan.  
Main research question: 
What are the experiences of taking HAART among HIV-positive drug users? 
Four underpinning sub-questions: 
1. What meanings do HIV-positive drug users attribute to their experiences of 
taking HAART? 
2. What is the process of their HAART-taking behaviour?  
3. How are meanings of HIV-positive drug users’ experiences relating to 
HAART taking constructed through its process? 
4. What contributes to the stability and change of HIV-positive drug users’ 
HAART-taking behaviour? Under what conditions? 
These questions were used to explore HIV-positive drug users’ experiences 
of their engagement with HAART taking in the context of illicit drug use. 
Since HIV infection is a long-term health condition, this study also focuses on 
“process” to identify the dynamics of HIV-positive drug users’ HAART taking. 
“Process” was depicted by Birks and Mills (2011) and Corbin and Strauss 
(2008) as not being limited by conceptions of time, phases or stages but 
seen as occurring in all aspects of the dynamic nature of life. Taking this 
notion into account, the non-linear conceptualisation of ‘process’ might fit well 
with the chaos observed in HIV-positive drug users’ lives based on my 
previous work experience. Some drug users whom I took care of appeared to 




Thus, with this in mind, it allowed me to consider chaos as ‘process’. In this 
study, I would not just look for stages or phases of HIV-positive drug users’ 
HAART-taking but explore its dynamics.   
5.4. Theoretical perspectives of this study 
5.4.1. The study of experience 
Qualitative research is a major research method of inquiry in social sciences, 
encompassing a wide range of phenomena (Daher et al., 2017, Silverman, 
2016). Drawing on the research questions discussed in the last section, this 
study focuses on participants’ experiences of taking HAART.  Experience is a 
crucial concept for obtaining a deeper understanding of an individual’s 
perspective, and improving qualitative comprehension of the phenomenon 
being studied (Daher et al., 2017, Polkinghorne, 2005, Silverman, 2016). 
According to Dilthey (1989), experience has two aspects in it, inner 
experience, which addresses the experience of inner thoughts and feelings, 
and outer experience, which relates to outside world.  While inner and outer 
experience can be defined independently, it is important to note that both are 
connected and formed as a continuous whole (Daher et al., 2017, Dilthey, 
1989). In other words, understanding an individual’s experience involves a 
process of reflective thinking about the world and constructing meanings 
based on the individual’s accumulated experiences (Daher et al., 2017, 
Dilthey, 1989).  
Experience has its depth, and the use of quantitative research is often 
inadequate to capture the richness and fullness of participant’s experience 
(Denzin and Lincoln, 2018). Instead, the experience of an individual is often 
the area that qualitative research is designed to study (Polkinghorne, 2005, 
Silverman, 2016). However, the interpretive nature of experience means that 
it is internal not visible to the other except through interaction (Laing, 1967). 
Experience is most commonly visible through narrative means; people create 
and express their experience by constructing them in a narrative form (Gee, 




gather self-report data often using interviews (Berger and Luckmann, 1966, 
Denzin and Lincoln, 2018, Polkinghorne, 2005, Silverman, 2016).  
This exploration of participants’ experiences results in data which are not 
formed simply by single words but by interrelated words combined into 
sentences, forming into discourses (Clake, 2005, Polkinghorne, 2005). In 
discourses, they are context-specific, reflecting participants’ interactions with 
society, shaping meanings of their experiences being constructed (Blumer, 
1986, Clarke, 2005, Denzin and Lincoln, 2011, Mishler, 1986, Sliverman, 
2016). Such interconnections and complex relations and layers of 
participants’ experiences presented in the data are an ongoing flow, not 
rigidly ordered, and are eternally incomplete (James, 1975). Due to the 
ongoing flow of experience and meaning-making, researchers can but 
capture it as a reflection, as a memory of what was (Schutz, 1967).  
This study strives to learn the meanings of participants’ experiences of taking 
HAART within the Taiwanese context. However, meanings a person has for 
HAART taking may differ from person to person (Berger and Luckmann, 
1966, Blumer, 1986). Meanings are created in each individual’s encounters 
with the world and his/her interactions with others, and the meanings are 
used as the basis for directing the actions (Blumer, 1986, Clarke, 2005, 
Daher et al., 2017). In that regard, there is no single reality for a thing, but 
rather the reality of everyday life is characterised by a coexistence of multiple 
realities in the context (Berger and Luckmann, 1966).  
Drawing on these standpoints, HIV-positive drug users’ HAART-taking 
behaviour is constructed through the meanings they attached to HAART. The 
meanings participants hold for HAART taking may differ depending on their 
interactions and communications with the social environment. In an attempt 
to make sense and gain insight into participants’ HAART-taking experiences 
in terms of the meaning they bring to it, this qualitative study illuminates  HIV-
positive drug users’ multiple perspectives on HAART taking and their social 




5.4.2. Social constructionism 
Social constructionism is rooted in symbolic interactionism, and started to 
have its hold after Berger and Luckman (1966) published “The social 
construction of reality” (Hibberd, 2005). In their book, it was argued that 
social phenomena are socially constructed by people through social practices 
(Burr, 2015). In the same vein, ontology and epistemology with their root in 
social constructionism follow relativism and subjectivism, which emphasise 
the impact of history and culture on knowledge formation and the role of 
language (Burr, 2015, King and Horrocks, 2010). Within social 
constructionism, it argues that the ways individuals understand the world are 
culturally and historically specific, and its aim of social inquiry is towards a 
consideration of how knowledge is formed by people in interaction (Burr, 
2015, Creswell and Poth, 2018). As for its focus on the role of language, that 
is the belief that language itself has its potential to construct a reality, and the 
reality interpreted by researchers through language is already a form of 
subjectivity and is not value-free (Ritchie et al., 2014, King and Horrocks, 
2010). In that sense, rather than having meanings of the world that exist 
independently from researcher’s interpretation, constructionists assert that 
knowledge is co-constructed by the researcher and the researched (Denzin 
and Lincoln, 2018, King and Horrocks, 2010). Researchers cannot separate 
themselves from the world and view the world with no position (King and 
Horrocks, 2010). This contrasts with positivism where knowledge is objective 
and separate from the person and the world (King and Horrocks, 2010).  
Another notion emphasised in social constructionism is that a social reality 
cannot be understood completely (Ritchie et al., 2014). At different times or 
places, there would also be different interpretations of the same phenomenon 
(King and Horrocks, 2010). In a similar vein, Ritchie et al. (2003) maintained 
that meanings attached to individual thinking and behaviour are a product of 
time and place, and are not fixed. Reality, therefore, acts as a point of 
reference but is always in a continuous state of construction, and still awaits 




Drawing on the ideology of constructionism, in this study, I looked for the 
complexity of views rather than narrowed the meanings into few ideas. The 
diversity of perspectives could add richness to the understanding of various 
ways in which the reality of taking HAART was experienced by HIV-positive 
drug users (Ritchie et al., 2003). Given the emphasis placed on socially-
constructed realities in social constructionism, I recognised that people’s 
contextual circumstances can shape their interpretation of taking HAART 
(Denzin and Lincoln, 2018). Thus, while collecting and analysing data, this 
study took into account the contexts in which HIV-positive drug users lived, 
and how they interacted and negotiated with the environment.  
5.4.3. Drawing on constructivist grounded theory approach 
Among all the qualitative research methods, grounded theory approach was 
drawn from for this qualitative study. Because this method provides the 
guideline to identify categories, analyse and situate processes, identify what 
contributes to stability and change, demonstrate contexts, make links and 
relationships between categories, refine and integrate them to ultimately 
develop a conceptual model (Charmaz, 2006, Denzin and Lincoln, 2011). 
Grounded theory included five essential elements (theoretical sensitivity, 
constant comparison, memo writing, theoretical sampling, and theoretical 
saturation) and coding principles (initial coding and focused coding). These 
elements are unpacked in the later sections when introducing data collection 
and analysis methods. This section aims to discuss as to why constructivist 
grounded theory approach was drawn from.  
In grounded theory, there are two major types of grounded theory approach, 
one with positivist tradition and the other with constructivist tradition. In 
contrast to the positivist approach of grounded theory by Glaser and Strauss 
(1967), Charmaz (2006 and 2014) emphasises constructivism in grounded 
theory. Constructivist grounded theory lies in the interpretive tradition. 
Interpretive tradition views theoretical understandings as abstract and 
interpretive rather than explanatory (Charmaz, 2006 and 2014). 




participants, but also acknowledges that the resulting theory also involves 
researcher’s interpretation (Charmaz, 2006 and 2014). In addition, 
constructivist grounded theory stresses that any analysis is contextually 
situated in time, place, culture, and context, seeing that facts and values as 
linked (Charmaz, 2006 and 2014). By locating knowledge in this way, it links 
the subjective and the social. Considering Charmaz’s (2014) grounded theory 
underpinned by constructivism, this study drew on her approach to 
interpreting data (Section 5.8.4.).  
Under the influence of Charmaz’s constructivist grounded theory (2006), 
Corbin and Strauss’s latest edition of Basics of Qualitative Research (2008) 
showed that there is a shift away from the objectivist stance. Corbin and 
Strauss’s (2008) emphasis of bringing ‘process’ and ‘context’ into the 
analysis is congruent with the standpoints in social constructionism. Corbin 
and Strauss (2008) take into account action/interaction, its movement, 
sequence, and change as well as how it changes in response to 
contingencies. They notice how context and conditions influence the 
outcomes of a set of actions/interactions (Strauss and Corbin, 1998). As a 
result, Corbin and Strauss (2008) have moved further from postpositivism 
and more towards social constructionism (Charmaz, 2014). Their approach of 
data contextualisation and process recognition provides a clear account of 
how to contextualise the data and identify a process within the data, which 
was found particularly useful when analysing data in this study (Section 
5.8.4.).  
One of the main differences between Charmaz’s approach (2014) and Corbin 
and Strauss’s (2008) approach is “abduction”. Grounded theory is generally 
regarded by constructivist grounded theorists as an inductive and deductive 
approach (Charmaz, 2014, Corbin and Strauss, 2008). Theory is grounded 
from data, whilst interpretation is also a form of deduction (Clarke, 2005). 
Nonetheless, abduction has been recently noted and embraced by Charmaz 
(2014), which is defined as “all plausible theoretical explanations during the 




possible explanation, and checking these hypotheses empirically by 
examining data to arrive at the most plausible explanation (p.201).” As 
opposed to Charmaz (2014), reviewing theoretical literature after data 
collection is embraced by Corbin and Strauss’s (2008). In this study, the 
inductive and deductive approaches were used during data collection and 
analysis. I did not draw on abductive reasoning during data collection, but 
instead, I started reviewing theoretical literature after data collection and 
preliminary data analysis (Section 5.4.4.). This allowed me, as a novice 
researcher, to not be immensely influenced by existing theories, and 
provided a space for creative thinking during preliminary data analysis.  
In summary, due to social constructionism held in this study, Charmaz’s 
(2014) and Corbin and Strauss’s (2008) grounded theory approach provided 
suitable guidance for answering the research questions of this study. Birks 
and Mills (2011) suggested that it is not necessary to subscribe to one 
particular school of grounded theory throughout the study. A researcher with 
a particular philosophical position can determine whether the researcher 
aligns herself with one particular author, or perhaps draw from each of the 
grounded theory approaches to varying degrees in the application of 
essential grounded theory methods (Birks and Mills, 2011). Given this notion, 
I relished the flexible and unrestricted potential that it afforded me. In the 
meantime, I exploited a grounded theory approach with the constructivist 
position where practical to allow the research problem to become delineated 
as I engaged with the data. 
5.4.4. Theoretical sensitivity 
To conduct qualitative research drawn from grounded theory approach, 
researchers should be equipped with theoretical sensitivity (Charmaz, 2014). 
Theoretical sensitivity is defined by Strauss and Corbin (1998) as ‘having 
insight into, and being able to give meaning to, the events and happenings in 
data (p.46).’ A literature review can be used as a possible source of 
inspiration, creative ideas, critical reflection and multiple lenses to examine 




addition, during the study process, researchers can gain theoretical 
sensitivity through looking into studied life from multiple vantage points, 
making a comparison and contrast, following leads, and building on ideas 
(Charmaz, 2014). As opposed to Glaser and Strauss’s (1967) notion that 
grounded theorists should stay objective and not review literature during the 
study, both Corbin and Strauss (2008) and Charmaz (2014) embrace 
literature review during the study. Comparing the two schools, Charmaz 
(2014) suggested literature review during theoretical sampling which is called 
informed grounded theory by Thornberg (2012). 
However, Corbin and Strauss (2008) maintained research studies can be 
reviewed before the study starts, but theoretical literature should be reviewed 
at the later stage of the study to avoid limiting researchers’ analytic thinking. 
The timing of the literature review in this study accords with Corbin and 
Strauss’s (2008) notions. Before this study started, I reviewed empirical 
studies to formulate research questions (Corbin and Strauss, 2008). The 
literature provided insight into and guided where I should go to investigate 
HIV-positive drug users’ experiences of taking HAART. Then after completion 
of data collection and preliminary data analysis, I turned to empirical and 
theoretical literature. At the later stage of data analysis (full and detailed 
analysis), I compared findings with existing theoretical literature to identify 
similarities and differences, and added new knowledge to the current 
evidence base. Similarly, Corbin and Strauss (2008) suggested that the 
review of theoretical literature at the later stage of the study can help confirm 
the findings in the writing stage. 
As a novice researcher, I believe that if I had read many theories before and 
during data collection and preliminary data analysis I would be easily 
influenced and guided by the relevant theories. Creativity is one of the 
important elements in qualitative research (Patton, 2005). Analysing data 
requires researchers to see data from different angles, and reading 




might impede the open endedness and exploratory character of coding and 
close off my innovative analytic contribution (Van den Berg, 2008).  
I acknowledge that without reviewing theoretical literature during data 
collection and preliminary data analysis I might run the risk of being 
theoretically insensitive and rehashing old empirical problems (Charmaz, 
2014).  
5.4.5. Reflexivity   
To develop theoretical sensitivity, reflexivity should be applied throughout the 
research process (Charmaz, 2014). Reflexivity is defined as “the researcher’s 
ability to be able to self-consciously refer to her or himself in relation to the 
production of knowledge about research topics (Roulston, 2010, p. 116).” In 
qualitative research, the idea of reflexivity has evolved due to large debates 
over problems of representation in research (Creswell and Poth, 2018). The 
key concern is that findings in qualitative research are not as straightforward 
as those in quantitative research (Charmaz, 2014).  
As discussed earlier, constructivist tradition emphasises that researchers are 
an integral part of the research process (Charmaz, 2014, Creswell and Poth, 
2018, Denzin and Lincoln, 2018). In that sense, researchers should be 
reflexive about their background, pre-conceived ideas and assumptions, 
positions and power dynamics with research participants, decisions relating 
to sampling and interview questions, and how data are interpreted (England, 
1994, Mauthner and Doucet, 2003, Pillow, 2003, Roulston, 2010). Without 
examining researchers’ preconceptions, their biases, assumptions, or beliefs 
could intrude into the analysis and impose a pre-existing frame on it 
(Charmaz, 2014, England, 1994). To minimise the intrusion of taken-for-
granted assumptions, I wrote research memos constantly during the study 
process. In doing so, it contributed to not only producing knowledge that 
facilitated understanding HIV-positive drug users’ experiences of taking 
HAART but also giving insight into how such knowledge was situated and 
produced (Pillow, 2003). Individuals’ reflexivity can be informed by the 




(Mauthner and Doucet, 2003, Roulston, 2010). In light of Roulston (2010), my 
clinical background and particular ontological and epistemological 
assumptions held guided what I have brought to research inquiry, how I have 
situated myself in this study, and my decisions with regards the methods of 
data collection and analysis used in this study.  
As reflexivity was applied throughout the research process, I reported my 
personal influence and justifications for important procedural decisions 
regarding sampling, data collection, and data analysis. Given this notion, 
reflexivity has been used by many scholars in qualitative research for the 
purpose of increasing transparency and trustworthiness of research findings 
(Charmaz, 2014, Doucet, 2008, England, 1994, Gentles et al., 2014, 
Mauthner and Doucet, 2003, Pillow, 2003, Roulston, 2010). 
5.5. Ethical principles 
Any research that includes participants, including vulnerable groups, requires 
an awareness of ethical principles (Orb et al., 2001). Prior to collecting data, 
obtaining the permission of Research Ethics Committee (REC) is a key 
activity that allows researchers to carry out a study (Creswell and Poth, 
2018). The purpose of such an activity is to safeguard the rights and welfare 
of research subjects (Polit and Beck, 2008).  
This study followed four common ethical principles, including autonomy, 
justice, beneficence and non-maleficence. Six potential ethical issues, 
including voluntary participation, informed consent, confidentiality, data 
management, the relationship between participants and researchers, and 
dissemination of the findings, were taken into account and delineated in the 
consent forms (Appendix 4) (Orb et al., 2001, Polit and Beck, 2008, Pollock, 
2012). 
During study recruitment, participants were introduced to me by health 
professionals and social workers in the hospital and NGOs (Section 5.6.5.). 




involve vulnerable groups, where gatekeepers’ close relationships with and 
knowledge of prospective participants can ensure that appropriate 
approaches are made (Ritchie and Lewis, 2014). In respect of participants’ 
autonomy, prospective participants were informed of the purposes and 
procedure of the study along with a written notice, and were given one or two 
weeks to think if they would like to take part in this study. Taking part in this 
research was completely voluntary, and thus prospective participants were 
informed that they could refuse to participate or withdraw at any time without 
penalty.  
Justice places an emphasis on treating participants equally unless there is an 
ethical justification for treating them differently (Gostin, 1991). In thinking 
about justice towards study participants, this study ensured that HIV-positive 
drug users were selected as equitably as possible and recruited based on the 
factors that were clearly relevant to this study (Section 5.6.5: Sampling 
method).   
In accordance with the principles of non-maleficence and beneficence which 
emphasise ‘do-no-harm’ and benefits to participants (Orb et al., 2001; 
Pollock, 2012), prospective participants were informed that this research 
would not bring direct benefits to participants but indirect benefits, such as 
contribution to society’s knowledge. They were reassured about the 
confidentiality of their responses and identity. However, there was a limit to 
confidentiality due to the concerns over participants’ disclosure of the 
information that was related to harms to others. In an attempt to prevent 
participants and others from harms and ethical dilemmas, participants were 
informed to not disclose any instances of harm to other people or illegal 
activity for which they have not already been convicted.  In doing so, it 
allowed participants to have some control of agenda and prevent over-
disclosure. During interviews, participants were treated in a non-judgmental 
and confidential manner with dignity, respect and justice (Mamotte, 2012). If 
any issue occurs during interviews, such as psychological distress, 




listener and to provide referrals to appropriate services (Mamotte, 2012). A 
list of community services was available for them. 
When transcribing interview data, participants were given code numbers 
(Polit and Beck, 2008). The list of participants’ names and code numbers 
were kept separate to protect their anonymity (Grove et al., 2013). During 
data analysis, I would ensure the findings were developed transparently and 
grounded from the data. Misinterpretation of the data would lose the value of 
truly conveying their concerns and voices. Data files were encrypted in the 
VeraCrypt and participants’ informed consents and personal information were 
kept separately and securely in locked cabinets at the School of Health in 
Social Science, only available to Szu-Szu Ho (the researcher). According to 
Information Commissioner’s Office, ICO (2018), data can be kept for longer if 
researchers keep it for public interest archiving, scientific/historic research or 
statistical purposes. This study is not bound to any funder’s policy relating to 
data retention periods, and thus anonymised digital data will be retained 
intact by the researcher indefinitely for future research and publication. Hard 
copies will be destroyed upon the completion of PhD study. Participants were 
told that findings would be disseminated anonymously through journals and 
conferences.  
Following the detailed explanation of the study information, if participants 
decided to take part in the study, a copy of the completed consent forms was 
agreed and retained by both parties. If participants had any questions 
regarding this research, my contact information was provided in the informed 
consent form. 
Having gone through the review of research ethics committees of a medical 
centre in Taiwan and the University of Edinburgh, this study was approved 
and data were collected at the hospital and NGO settings over the period 





5.6. Recruitment and sampling  
5.6.1. Sample— Inclusion and exclusion criteria 
The following criteria were used to identify suitable participants and meet the 
research aims. 
Table 3: Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
Individuals are eligible to participate in the 
study if they are: 
1) HIV-positive 
2) at least 20 years old (individuals under 
20 are under the care of a legal guardian) 
3) able to complete the interviews in  
Mandarin  
4) illicit drug users (current and past) 
5) have been on HAART regimens 
Individuals are not eligible if they are: 1) 
HIV-negative 
2) less than 20 years old  
3) not illicit drug users 
4) currently hospitalised or in prison 
6) unable to give informed consent 
7) not on HAART 
 
In an attempt to understand HIV-positive drug users’ medication adherence 
behaviours, affected individuals who were hospitalised and in prison were not 
included because their HAART medications were administered by nurses 
instead of themselves.  
5.6.2. Study settings 
HIV-positive drug users were recruited from three sites, HIV outpatient 
settings at a hospital, an HIV association, and addiction support association 
in Taiwan.  
The medical centre is a largest and renowned referral hospital in the capital 
city of Taiwan, which provides comprehensive services for people with HIV. 
Patients attend their routine consultation every 3-4 months. I recruited 
participants at this site due to my connection with the HIV specialists in the 
hospital. The HIV association and addiction support association are the 
largest HIV and addiction support associations in Taiwan where drug users 
with HIV are mainly referred. The HIV association is an NGO, which provides 
a range of HIV services, including temporary housing, outreach services, 




individuals and their families. Services are run by a team of social workers in 
the central and northern city of Taiwan. The addiction support association is 
also an NGO, which is operated to help illicit drug users to have the correct 
concept of health, and to provide them with housing, emotional and spiritual 
support. The addiction association provided support to drug users, which is 
operated across Taiwan.  
5.6.3. Access to study sites 
Taiwan is considered as a highly collective and hierarchical society (Zhang et 
al., 2005). Such collectivism and hierarchy had an impact on facilitating and 
limiting access to study sites. Due to the requirements of Taiwan research 
ethics, finding a clinical supervisor was part of the research process. 
However, the limited number of physicians I know at the hospital increased 
the challenge of finding a clinical supervisor. Firstly, I invited Doctor A, who I 
have known for years, to be the clinical supervisor of this project. Yet, he was 
not able to be the clinical supervisor. The reason he gave was that he did not 
have many heterosexual HIV-positive intravenous drug users but MSM. 
However, he was willing to introduce another physician to me (Doctor B). 
Doctor B is specialised in infectious diseases and is a deputy director of 
Department of Internal Medicine at the hospital. Through the introduction of 
Doctor A, Doctor B agreed to be the clinical supervisor after going through 
my CV, research proposal, and supporting documents. In addition, Doctor B 
introduced me to an HIV nurse specialist, asked her to assist me in recruiting 
participants, and the HIV nurse specialist agreed to help me.  
After the clinical supervisor was confirmed, I started to negotiate with 
managers at addiction and HIV associations. I firstly introduced myself and 
the study to them, told them that this study was supported by Doctor B and 
the HIV nurse specialist, and it would go through ethics committees for 
research ethics review at the University of Edinburgh and the hospital. The 
managers permitted that I could recruit participants at their associations 




Given the context described above, it shows that I have employed social 
networking strategies to gain support and access to research sites. In the 
Taiwanese society, there is an emphasis placed on interpersonal harmony 
and hierarchical relations (Su et al., 2012, Zhang et al., 2005). Through the 
Doctor A’s introduction about me to Doctor B, Doctor B appeared to be more 
likely to take into account of being a clinical supervisor of this study 
concerning his relationship with Doctor A. Doctor B is experienced and 
renowned in Taiwan, and the managers at the associations acknowledged 
him. With Doctor B’s support, the managers appeared to trust me, and thus 
allowed me to recruit participants at the associations. And the HIV nurse 
specialist was willing to help me to recruit participants due to her relationship 
with Doctor B. This implies that the use of interpersonal skills can facilitate 
approaching people with ‘the power of authority’. In turn, people with ‘the 
power of authority’ were more likely to carefully consider if they wanted to 
support this study. In addition, it was a reciprocal relation. For example, the 
managers of the HIV association and HIV specialist invited me to deliver 
workshops for social workers and nurses. I also travelled to an addiction 
association in Southern Taiwan to deliver a workshop regarding HAART 
taking for HIV-positive drug users after my data collection there. Taken 
together, the chain of social relations was built through the process of 
constant negotiation and interaction with people, resulting in gaining access 
to study sites.        
5.6.4. Sampling method— adapted theoretical sampling 
Glaser and Strauss (1967) define theoretical sampling as the process of data 
collection for generating theory whereby ideas about the data are examined 
to explicate categories and concepts. In other words, sampling decisions 
should be guided by emerging gaps identified from previous coding 
(Charmaz, 2014, Glaser and Strauss, 1967, Strauss and Corbin, 1998). In 
contrast to Glaser and Strauss (1967) and Corbin and Strauss (2008), 
Charmaz (2014) places an emphasis on the concurrent use of abductive 
reasoning and theoretical sampling until theoretical saturation is reached. 




reasoning in theoretical sampling concerning the amount of time I, as an 
international student, would have had to invest in the fieldwork (Section 
5.4.3.). Therefore, the adapted theoretical sampling here is similar to 
Charmaz’s notion (2014) but without the use of abductive reasoning. As a 
consequence, theoretical saturation (Section 5.8.5.) was not confirmed 
during data collection and preliminary data analysis but after data collection, 
the full and detailed data analysis, and the review of theoretical literature. 
During the process of data collection, I drew on theoretical sampling 
techniques of collecting, coding, and analysing data, and deciding which data 
to collect next and where to find them. These techniques used allowed me to 
learn more about how the process developed and changed, and further help 
to develop a conceptual model as it emerged. Both theoretical sampling and 
purposeful sampling are regarded by Morse (1991) as being synonymous 
where researchers select participants according to study needs.  
The sampling methods for this study started with convenient sampling to 
explore participants’ experiences and to lead me to establish sampling 
criteria for people, situations and settings (Charmaz, 2014, Oktay, 2012). 
Once obtaining data and constructing tentative ideas about the data through 
constant comparison and memo writing, adapted theoretical sampling was 
used to fill incomplete categories and gaps (Charmaz, 2014, Glaser and 
Strauss, 1967, Strauss and Corbin, 1998). At a later stage, this adapted 
theoretical sampling also helped to find links among categories (Charmaz, 
2014).  
While implementing the sampling strategy in this study, a large proportion of 
HIV-positive MSM who use drugs was not anticipated. Before starting the 
recruitment, I presumed HIV-positive drug users in Taiwan were mainly 
intravenous drug users concerning the HIV transmission route. However, 
during the sampling process, I became aware that a number of HIV-positive 
MSM used drugs to enhance sexual stimulation. The number of HIV-positive 
MSM who use drugs is currently not documented in the government website, 




were MSM as opposed to IDUs. This led to the difficulty of maximising 
differences and variations among comparison subgroups while sampling 
(Glaser and Strauss, 1967). In an attempt to identify the variations and 
patterns of taking HAART across different subgroups with different treatment 
and drug-using backgrounds (Section 5.6.6: Sample description), and for 
pragmatic reasons, recruitment strategies (Section 5.6.5: Recruitment 
strategies) were applied resulting in the transition to a purposeful sampling 
approach. As a result, 22 participants (12 MSM, 7 male IDUs and 3 female 
IDUs) were proportionally recruited in accordance to the HIV epidemiology in 
Taiwan (Section 2.5.2.).       
5.6.5. Recruitment strategies  
In an attempt to maximise the chance of recruiting HIV-positive drug users 
during sampling, two recruitment strategies were applied, recruiting 
participants through health and social care professionals’ introduction of me 
(n=22), and participants’ delivery of this study information to their peers 
(n=0).  
5.6.5.1. Recruiting participants through health and social care 
professionals 
Before starting recruitment, I had a meeting with physicians and HIV nurse 
specialists at the hospital, and managers (social workers) at the associations 
individually, discussing my research and the inclusion and exclusion criteria. 
Physicians and HIV nurse specialists agreed that if they had any cases who 
met my sampling criteria in outpatient settings they would give the potential 
participants the information sheets with my contact details on the sheets. If 
participants agreed to take part, the health professionals would call me. I 
would come to the outpatient settings and then the health professionals 
would introduce me to them. I would explain the details of this research to 
potential participants, and give them time to ask questions. If they were 
interested in the research and agreed to take part after my explanation of this 
research and reading the information sheet, I would give them time to think 




ask them if they were fine to have an interview in a private room of the 
hospital library or a meeting room of the hospital wards. All of them agreed 
and preferred to have an interview at the hospital. It seemed that it provided 
them with a sense of security if the interviews took place at the hospital. 
Since I was not sure when HIV-positive drug users came to outpatient 
services, I stayed at the hospital every weekday waiting for health 
professionals’ calls until the services were finished.  
In the addiction support association, the manager firstly introduced me to 
their staff members. The meetings at the associations involved the manager 
and staff members (social workers) who closely worked with HIV-positive 
drug users. In the meetings, I discussed with them my intention to volunteer 
there and to have prolonged engagement with HIV-positive drug users. 
However, the social workers told me that the volunteers here only helped out 
with office work and were less likely to engage with HIV-positive drug users. 
Social workers said that the only way that I could recruit participants was 
through them. If they had any cases, they would give the potential 
participants information sheets and asked them if they would like to take part 
in this research. If participants agreed to take part, the social workers (or the 
potential participants) would call me and tell me the potential participants’ 
available times. I would accommodate my schedule to meet participants’ 
schedule. In reality, most participants preferred to be contacted by health or 
social professionals rather than to contact me directly. The reason was that 
they did not want to disclose their contact number, and were afraid that it 
could be a catch, or the police would trace the phone number to find them. 
For these reasons, whether to fill in contact information in the consent forms 
was optional. None of the participants left their contact information on the 
consent form.  
5.6.5.2. Recruiting prospective participants through participants’ 
referrals  
In the fieldwork, I asked participants if they could deliver study information to 




snowball sampling wherein a study sample is yielded through referrals made 
by individuals who possess similar characteristics (Biernacki and Waldorf, 
1981). However, the strategy of recruiting participants through participants’ 
referrals was challenging. Most participants were mainly concerned about 
their own privacy, and few were keen to carry this extra task. There were two 
participants stating that they could ask their peers if they wanted to take part 
in this study. If their peers would like to take part, they would contact me via 
the health or social professionals. However, either their peers rejected to take 
part or I did not hear any news from the participants.    
5.6.5.3. Ethical issues encountered during study recruitment 
During study recruitment, it seemed that some participants’ willingness to 
participate in this study were due to their desire to please health 
professionals instead of their true interest in this study. This question arose 
because some participants (P2 and P16) quickly agreed to take part in this 
study and wanted to have the interview on the same day of recruitment. For 
example, during the interview, P2 appeared to be suspicious and did not 
want to answer some of the interview questions. I had a hard time to deeply 
explore P2’s experience with HAART and drug taking, because P2 had set 
the boundary between him and me. However, P2 articulated his thankfulness 
for health professionals’ support. P2’s responses during the interview 
conveyed that participating in this study could be due to his gratefulness of 
health professionals’ support but not his interest.  
In the case of P16, he had missed appointments a couple of times, and was 
hard to reach. One day, P16, finally, came to the doctor and nurse 
specialist’s appointment. In our first meeting, he articulated that “Of course, 
no problem. You [HIV specialist] have given me so much support. Yes. (Field 
notes, P16, male heterosexual, 42y, 3/4/2016)” Due to his preference to have 
an interview on the same day, the interview took place on the day of 
explaining the research information with the information sheet. In addition to 
his prompt agreement, there was another sign that might imply his disinterest 




The storage of the recorder was full and some interview data were not 
recorded. Thus, I asked him if I could arrange a second meeting with him. 
P16 agreed and said no problem, but he did not show up for the next 
arranged meeting. Fortunately, I usually started transcribing the interview 
data and wrote memos right after the interview. P16 was open to sharing his 
experience with HAART and drug taking during the interview, whereas he 
wore his hat and surgical mask throughout the interview to cover his face. It 
seemed that he did not want to be recognised, and having a mask on 
seemed to give him a sense of security. Though there was no tension or 
distressing moments in the interview, his actions pertaining to missing the 
next arranged meeting might indicate that his participation in this study was 
not in accordance with his interest or free will. Rather, his agreement was 
due to his trust and thankfulness for health professionals’ support.               
By and large, recruiting HIV-positive drug users and gaining their trust were 
not an easy task in this study. Ethically, it is advised to let HIV-positive drug 
users freely and happily agree to take part in a study and without pressure 
(Orb et al., 2001, Pollock, 2012). In this study, the strategy of recruiting 
participants through gatekeepers’ introduction might have already given 
participants feelings of obligation to participate in this study due to 
participants’ trust and grateful feeling towards health and social care 
professionals. In addition, it could also be owing to the emphasis of social 
relations in the Taiwanese society. As such, a good relationship with health 
professionals might make participants feel the difficulty in rejecting the 
invitation, and compelled to participate. However, there are some missing 
cases in this study, which means that people were able to make their own 
decision of not participating (Table 4).  
Table 4: List of non-participation cases 
Missing Case Reason 
1 Missing appointments 





3 (Coupled with 2) Show up in the outpatient 
setting unexpectedly and 
left quickly 
4 Hospitalisation, and low 
CD4 cell count 
5 (Coupled with 6) Could not reach her 
6 (Coupled with 5) Could not reach him 
 
5.6.6. Sample description 
The introduction of sample description here is to demonstrate how the 
sampling decisions were framed and how the study sample was distributed. 
The purpose of this purposive sampling strategy was to obtain data to help 
explicate the categories in this study (Charmaz, 2014, Strauss and Corbin, 
1988). As data collection and analysis progressed, four characteristics of the 
participants were identified to influence their HAART-taking behaviour, and 
thus were taken into account for framing sampling decisions: Transmission 
route, drug-using dynamics, gender, and length of being HIV positive and on 
HAART.  
Table 5: Summary of HIV-positive drug-using participants (Details of socio-demographic 
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5.6.6.1. Transmission route  
In this study, the sample consists of 22 HIV-positive drug users, aged 
between 26 and 53. Of these, 12 participants were infected with HIV through 
homosexual contact, and 10 participants were infected with HIV through 
using contaminated injecting equipment (Table 5). The 12 participants who 
were infected with HIV through homosexual contact had a history of 
engaging in chemsex. The 10 participants who were infected with HIV 





I recognised the difference in subculture between HIV-positive MSM who use 
drugs and HIV-positive heterosexual drug users. HIV-positive MSM who used 
drugs in this study tended to engage in chemsex, with the use of 
Amphetamine, MDMA, and Ketamine (Table 5). Recreational drugs were 
used by participants to enhance sex. On the other hand, HIV-positive 
heterosexual drug users in this study tended to use heroin, and all of them 
have committed crimes, such as robbery, murder, sex trade, drug dealing, or 
illegal gambling. Having identified the difference in subculture between the 
two groups, I was particularly aware of the importance of sampling the two 
groups to understand their experiences of taking HAART. 
5.6.6.2. Drug-using dynamics 
Table 5 shows that all of the participants were polydrug users, which means 
they used more than one type of drugs at the same time and/or different 
times. Considering that their drug use tended to be fluid and dynamic, it 
made it difficult to document how long they have been taking illicit drugs, 
Moreover, participants did not generally fall into the category of current or 
past drug users. In that sense, to understand and gain insight into their 
experiences of drug taking is more likely to capture participants’ drug using 
dynamics than simply classify them as current or past drug users.   
By looking at the routes of drug use across the participants, it was revealed 
in social demographic information that heterosexual HIV-positive drug users 
were more likely to inject heroin, whereas homosexual HIV-positive drug 
users were more likely to choose the non-injection routes of drug use. 
Heterosexual HIV-positive drug users appeared to have a higher frequency 
of drug use in comparison with the homosexual group. Most heterosexual 
HIV-positive drug users used heroin for more than 10-15 times/per day, 
whilst HIV-positive MSM tended to use amphetamine and MDMA for 1-6 
times/week or month, or Ketamine for 4-6 times/day. In terms of withdrawal 
symptoms, all of the heterosexual HIV-positive drug users reported they had 
experienced severe heroin withdrawal symptoms, but homosexual drug users 




and craving for sensational stimulation. The severe addictive effects of heroin 
were described by participants as making it harder for them to quit heroin, 
forming a circular process of injecting heroin, feeling happy, experiencing 
withdrawals, finding money or committing crimes to get money, buying 
expensive heroin, and injecting heroin to get fixed. Due to the nature of 
severe addictive effects of heroin and engagement of illegal activities, I found 
that heterosexual active IDUs were more hidden, which led to the challenge 
of recruiting them. In summary, the drug using dynamics between 
heterosexual and homosexual groups are quite different and can influence 
participants’ HAART-taking behaviour. Thus, their illicit drug use was framed 
into my sampling decisions. 
5.6.6.3. Gender  
Of the 22 participants, 11 were MSM, 7 male heterosexuals, 3 female 
heterosexuals, and 1 male bisexual. While sampling, I encountered the 
difficulty of finding female HIV-positive drug users. One issue was addressed 
by nurse specialists at the hospital and staff members at addiction support 
association. That is, there was a lack of addiction support services tailored 
for female HIV-positive drug users. The support services in the addiction 
support association, where I recruited participants, were mainly for male and 
female drug users and male HIV-positive drug users. Another issue brought 
up by social workers at the HIV association was the low number of female 
HIV-positive drug users who accessed care. Such low number causes the 
difficulty of running support services for this group. As documented in the 
CDC (2017), there were reported 917 female HIV cases across Taiwan, 
which could include those in jail, those not receiving HAART, and those not in 
the hospital or associations where I recruited participants. In addition, 
concerned about the nature of illegal drug users and social expectation of 
being female in Taiwan, it might also have led to the difficulty of recruiting 




5.6.6.4. Length of being HIV positive and on HAART 
Among the participants, the length of being diagnosed with HIV ranged from 
2 months to 16 years, and the length of being on HAART ranged from 2 
months to 15 years. Participants had a time gap between being diagnosed 
with HIV and being on HAART, ranging from 1 year to 11 years. By 
comparing the time gap between being diagnosed with HIV and on HAART 
across participants, it was revealed that heterosexual HIV-positive IDUs were 
more likely to delay their treatment as opposed to homosexual HIV-positive 
drug users. Eight out of the 10 heterosexual participants had a more than 5-
year gap compared to 2 out of the 12 homosexual participants who had a 
more than 3-year gap. Of the 8 heterosexual participants, 1 had treatment 
interruption for around 3 years, and another received HAART before but was 
currently having treatment interruption. It could be argued that heterosexual 
group’s delayed access to care is linked to their addiction to heroin and 
engagement of illegal activities.  
5.7. Data collection 
5.7.1. Voices of vulnerable groups in qualitative inquiry  
The WHO (2013) has sought to promote active involvement of HIV-positive 
individuals in health and social care. This policy background is often 
accompanied by growing attention of social injustice for people living with 
HIV (Henrickson and Fouché, 2017). Although levels of vulnerability and 
marginalisation may vary from culture to culture, people living with HIV are 
generally considered both marginalised and vulnerable (Henrickson and 
Fouché, 2017). In people labelled marginalised or vulnerable, they tend to 
struggle to find a voice with which to speak in the public realm (Fisher, 2012, 
and Henrickson and Fouché, 2017). When not exercising the rights to seek 
social justice, the voices of the individuals can be silenced (Li, 2004). Silence 
is defined as an absence or inadequacy of language to express in life 
(Hedges and Fishkin, 1994). Such silence is affected by social positions and 




silence becomes their coping approach in many circumstances (Fisher, 2012, 
Hedges and Fishkin, 1994, Li, 2004). Without recognising vulnerable and 
silenced people’s agency to speak for themselves, a liberating effort to 
reclaim their silenced voices may become groundless (Li, 2004). Qualitative 
research can serve as a means for marginalised people to voice (Bryman, 
2012, Denzin and Lincoln, 2011, Fisher, 2012). Through qualitative inquiry, it 
can contribute to marginalised people’ visibility in the public sphere, and 
thereby provide a forum for their voices that can inform social and political 
debates (Fisher, 2012).  
5.7.2. Face-to-face in-depth semi-structured interviews 
To elicit multiple meanings relies on the use of language and communication 
(Berger and Luckmann, 1966, Charmaz, 2014). Thus, interview was chosen 
in this study to understand HIV-positive drug users’ experiences of taking 
HAART, to unfold the meaning of their experiences, and to uncover their 
lived world. Creswell and Poth (2018) defined an interview as a social 
interaction based on conversation. In this study, data were collected by using 
face-to-face semi-structured in-depth interviews. A face-to-face interview was 
for the researcher and the researched being physically located in the same 
private room and talking face-to-face (Creswell and Poth, 2018). To deeply 
understand participants’ experiences of HAART taking and their lived world, 
the discussion with participants during the interviews involved their 
experiences of being HIV positive, taking HAART, and illicit drug use, all of 
which tended to be sensitive topics. As such, concerning participants’ 
confidentiality and the sensitive issues being raised during interviews, face-
to-face interviews provided a more private and secure space for participants 
to share their personal experience as opposed to focus groups (Grove et al., 
2013).  
The in-depth semi-structured interviews are exploratory and at the same time 
offer depth through probing (Creswell and Poth, 2018). Probing techniques 
were used to further explore participants’ experiences of taking HAART by 




study, interview questions were open-ended, general, and focused on the 
central phenomenon relating to HIV, HAART taking, and illicit drug use.  As 
the interview progressed, the interview questions were revised or added to 
depending on participants’ answer to the questions, and interview situations 
observed. These approaches helped me to deeply explore participants’ 
experiences of taking HAART, to clarify any relevant issues raised by 
respondents, and to fill the knowledge gaps identified during the data 
collection and analysis process (Barriball and While, 1994, Charmaz, 2014, 
Elmir et al., 2011).  
In addition, this approach provided interactive opportunities between 
participants and me, helping to establish a sense of rapport with HIV-affected 
drug users and to reduce the likelihood of obtaining socially desirable 
answers (Barriball and While, 1994, Elmir et al., 2011). For example, P9, at 
the beginning of the interview, appeared to open up less and share less of 
his personal experience of how he was infected with HIV. Initially, he said  
“I protected myself very well while engaging in sex, but I do not know 
how it happened. It has happened, and thus I would just accept this 
truth of being HIV positive.” (P9, MSM, 35y)  
Once P9 trusted me as the interview progressed, P9 gradually opened up.  
Interviewer: “What do you mean by it? Sorry, I don’t understand. Could 
you tell me more about it.” 
“Actually, one time my drink was spiked. I went meet one online friend. 
He gave me a drink. After drinking it, I felt sleepy and hot. I was 
innocent and did not know it would happen. I knew it after the incident.” 
(P9, MSM, 35y) 
Drawing on the research experience, it indicates that knowledge was 
constructed through the interaction and constant negotiation between 
participants and me. Rephrasing interview questions and restating 




technique was also used in the interview with P2, as he sometimes appeared 
to hold words back and was not sure how to answer. When rephrasing 
questions in a different way, P2 could continue with additional content.  
Together, by using the one-on-one in-depth semi-structured interviews, it 
allowed me to explore participants’ experiences deeply, and to reach a level 
of shared understandings that would permit relevant and adequate 
responses (Mishler, 1991). In this study, the length of in-depth interviews 
ranged from 1 hour to 2 hours. 
5.7.3. Interview guide 
An in-depth interview is based on the ability of the researcher to establish a 
good rapport with participants (Denzin and Lincoln, 2018). A good rapport 
with participants is achieved where the researcher can seek to put 
participants at ease and create a climate of trust (Ritchie and Lewis, 2003). 
This involves being able to demonstrate interest, respect, understanding, and 
sympathy (Doody and Noonan, 2013, Elmir et al., 2011). In this study, the 
stories participants shared with me were often quite sensitive, and some 
participants tended to be shy and less articulate. Thus, my task was to ease 
them and make them feel comfortable throughout the interview process. The 
beginning of the interviews was designed to have a conversation with 
participants in an informal way, such as “How are you?”   
Once opening up the conversation with participants, I started to collect 
participants’ socio-demographic background (Appendix 5). Collecting 
background information at the beginning provided me with an opportunity to 
collect important context information and questions formation for the following 
in-depth interviews. When collecting socio-demographic information, it was 
done without digital recording with the aim to set the scene of the interviews 
in which participants could get to familiarise with me and build trust and 
rapport. Once participants seemed comfortable with the interview process, 
and collecting background information was complete, the in-depth interviews 




The aim of the in-depth interviews was to achieve the breadth and depth of 
participants’ experiences of taking HAART. During the interviews, I, initially, 
asked broader and more general questions (Appendix 6), such as “Please 
tell me your experience of living with HIV”, “Please describe your experience 
of using drugs”, and “Please tell me your experience of taking HAART”. 
Following these broad questions, probing was used to focus on the breadth 
and depth of coverage across and within the research topic. The follow-up 
questions I asked in the interviews depended on participants’ answer (Ritchie 
and Lewis, 2003). However, there are basic principles I applied in the 
interviews. In probing, two types of questions were yielded— content 
mapping and content mining questions. Content mapping questions were 
used to open up research territory and identify the dimensions that are 
relevant to participants’ experience of being HIV, taking HAART, and drug 
use (Ritchie and Lewis, 2003). In the interviews, this type of questions 
involved what, process, extent, changes in perception, perspective, and 
HAART-taking, or understanding the contexts, such as “ What makes you 
think that HIV is horrific”, “How about now? Has your perception of HIV and 
cocktail therapy changed over time? [Both Cocktail therapy/treatment and 
HAART are often used interchangeably among Taiwanese people]“, “How 
has the cocktail therapy (or drug use or HIV) influenced your life?”, “Tell me 
about your family”, “What impeded and facilitated your medication-taking?”, 
or “Earlier in the interview, you told me you have been diagnosed with HIV for 
11 years but you have taken the treatment for only 1 year. Tell me more 
about it and what affected your decision to receive and not receive the 
treatment”.  
Content mining questions were used in this study to explore the depth of 
participants’ stories (exploratory and explanatory probes) and to clarify the 
meaning of terms used by participants (clarificatory probes) (Ritchie and 
Lewis, 2003). These type of questions in the interviews involved probing for 
reasons, consequences of actions, and underlying meanings constructed by 
participants, such as “What does cocktail medications mean to you?”, “Why 




me how living with HIV (and the treatment) has affected you”, or “Earlier you 
told me that using amphetamine has greatly affected your medication-taking 
over the last 3-6 months, whereas you have used this type of drugs for a 
year. Why did not amphetamine affect your medication taking in the first 6 
months of using it?” By asking these type of questions, it not only helped me 
to obtain a full description and understanding of participants’ experiences of 
taking HAART but assisted in challenging inconsistency in participants’ 
account and minimising my taken-for-granted assumptions. 
The ending questions were used to bring participants back to a normal 
conversational level, and left them feeling positive about this interview 
(Charmaz, 2014, Ritchie and Lewis, 2003). Examples of the ending questions 
used in the interviews were “Is there anything else you want to share with me 
and let me know?”, “Based on the experiences you shared with me, do you 
have any advice?”, and “Do you have any question you want to ask me?”. 
5.7.4. Environment and timing of interviews 
Interviews were conducted at the time most convenient for participants and in 
places that were agreed by both participants and the researcher and free 
from interruptions (Elmir et al., 2011, Doody and Noonan, 2013). There is an 
agreement in the literature that care should be taken to create interview 
environments as comfortable as possible (Creswell and Poth, 2018, Ritchie 
and Lewis, 2003). In this study, interviews were taken place at a meeting or 
conference room at the hospital library, associations, or inpatient wards. 
These rooms were quiet and private. Though the options of these rooms 
were given to participants, they were not restricted to have an interview in 
these rooms. They could choose any public locations where there was a 
private room, such as public libraries. All of the participants preferred to have 
their interviews at the hospital or associations due to a sense of security 
given by these trusting places. Five participants had their interviews in a 
private room of the hospital library; nine participants were interviewed at a 
private meeting room on wards; eight participants were interviewed in a 




place at the aforementioned sites was quiet and did not interrupt my 
interviews with the participants.  
During data collection, it was sometimes challenging to find a private room at 
the hospital, because some rooms were in use or booked by others. I would 
need to book a room in advance. When participants came to outpatient 
services unexpectedly and preferred to have the interviews on the same day, 
I would need to quickly find an available room. At that time, health 
professionals were supportive and helped me to find a room that was private 
and quiet. At the associations, social workers would arrange the time and 
place of interviews for me, and thus I did not encounter difficulty in finding a 
venue. In terms of the timing of interviews, health professionals and social 
workers quite protected the privacy of HIV-positive drug users. I could not 
directly contact potential participants. Instead, I needed to keep in touch with 
potential participants through health professionals and social workers. 
The interviews in this study were digitally recorded for five reasons: 1) 
helping to correct the natural limitations of my memories, 2) allowing me to 
examine what participants said more thoroughly, 3) permitting repeated 
examination of participants’ answers, 4) opening up the data to public 
scrutiny, and 5) identifying the nuances of the conversation, such as voice or 
tone (Bryman, 2012, Halcomb and Davidson, 2006).  
Despite the advantages of recording interviews, I had been concerned about 
the interview atmosphere. Even though all of the participants agreed that I 
could record the interviews, the use of a recorder might disconcert 
participants and increase the challenge of building rapport and gaining trust. 
In an attempt to build a rapport with participants, I intended to establish a 
friendlier and less tense interview atmosphere by not recording while asking 
socio-demographic information and making the conversation ease. Such a 
decision was made, because recording one’s voice while asking close-ended 
questions with regards illicit drug use might be too intrusive from my 
viewpoint (e.g. questions on current/past drug user, and types of drug used). 




gain the participants’ trust and create a positive impression was considered 
important, especially at the beginning of the interviews. If participants shared 
additional information while asking their socio-demographic background, I 
took notes and explored further later during the interviews. As a 
consequence, it helped to build the research rapport between participants 
and me.     
5.7.5. The impact of power on accessing data 
5.7.5.1. Gaining the trust of participants 
This study involved sensitive topics, such as HIV and illegal drug use, which 
could be potentially challenging to gain HIV-positive drug users’ trust and 
build rapport. In that sense, I was particularly aware of my positionality and 
the power dynamics during the interviews.  
I am positioned by gender, age, educational background, and sexual identity, 
all of which might have influenced certain insights in the study. However, the 
complexity of positionalities and power dynamics cannot be explained just by 
each one of the elements (Merriam et al., 2001, Rose, 1997).  These 
elements are relational and interactive to influence how participants 
perceived and positioned me (Rose, 1997). Participants, themselves, might 
weigh each factor differently, subsequently influencing what they wanted to 
tell me. This resonates with Rose’s (1997) notion. That is, each one of the 
socio-demographic elements is relational, and it is based on “difference from 
others but not on separation from others (Rose, 1997, P.314).” The 
Taiwanese society values hierarchy and social relations (Su et al., 2012, 
Zhang et al., 2005). In healthcare settings, health professionals are often 
respected and viewed as trustworthy by patients. Due to this reason, through 
health professionals’ introduction of me and my nursing background, 
participants appeared to respect me and were willing to open up themselves. 
One example from P4 is provided as below: 




P4: “I have deleted everything….It is not easy to tackle the issues that 
happened in the circle. I feel thankful for having you here, listening to 
me. Because I cannot disclose these things to others….I don’t know 
where to disclose those things that have been kept deep down in my 
heart. I know that kind of hopelessness…This is the darkest side of the 
society. Drugs aren’t good. They were given the drugs and couldn’t 
control themselves. Then our laws are enacted to punish them instead 
of understanding them. No one thinks about it. This society just curbs 
violence with violence. Some people just wanted to have fun and be 
happy. They didn’t intend to harm others. But indeed there are other 
people who just want to harm others.”  
Memo: In terms of my interaction with him, I could sense that he trusted 
me by the way he treated me with respect and the amount of 
information he shared with me. The excerpt —  “I feel thankful for 
having you here, listening to me.”— also illustrated his trust in me… By 
gaining insight into his experience, it strengthens my will and 
determination of working in the field of drug addiction. Personally, I 
have never used illicit drugs before and do not have drug friends. In my 
previous clinical experience, I had never deeply explored their 
experiences with regard their personal networks. This was new to me. 
My background made me be a complete outsider of the topic in relation 
to illicit drug use and gay subculture. This resonates with participants’ 
narrative — “No one thinks about it. “. Drawing on P4’s statement, “this 
society just curbs violence with violence”, it seems that the past me only 
saw the surface of the problems... (Analytic memos, P4, MSM, 26y, 
01/12/2016).  
This was one of many examples that participants showed their respect and 
trust in me. My interactions with participants, over the period from health 
professionals’ introduction of me to interview completion, played some roles 
in their perception of me and ultimately influenced the depth and breadth of 




have accrued weight to my side of the power equation, I approached the 
unequal power relations in the research encounter by treating participants 
with respect and non-judgemental attitude. This helped to create a secure 
and welcoming environment for them to respond to during interviews. 
Participants could decide when the interview was held and what information 
they wanted to share. This was a way of conveying that they are important in 
this project. In addition, I demonstrated my interest in their stories, and 
encouraged them to explore further, which showed part of my position as 
unknown and participants as the knowers. Collectively, such approaches had 
helped to ease tensions, and build bridges and trusting relations (Marshall 
and Rossman, 2016).  
In addition, my position had emerged gradually, beginning with my roots in 
constructionism and then adopting feminist standpoints. This allowed 
vulnerable participants’ voices to be heard and assisted in merging 
scholarship with politics to work against the forces of oppression, which is 
greatly emphasised by the feminist theory (Denzin and Lincoln, 2018, 
Mascia-Lees et al., 1989). This resonates with Rose’s (1997) notion that “The 
researcher holds power, she/he can also give it away. She/He is positioned 
in power rather than constituted by it (P.310).” In that regard, it seemed that 
positionality and power relations are not static, but dynamic and could shift, 
which required constant negotiation during the research process.  
5.7.5.2. Failing to gain the trust of a participant 
From my view, it seemed that there was one participant who presented his 
distrust in me throughout the interview, frequently held back his words, and 
gave socially desirable answers.  
Memo: ….Sometimes, he would avoid some interview questions and 
eye contact, especially when asking questions relating to illicit drug use 
and HAART use. I told him no need to answer the questions if he did 
not want to. However, I could sense that he had his guard up and did 
not trust me. Although before the interview he told me that he was fine 




became the other way around. His excerpt— “I don’t want to go back to 
jail. I am afraid of being caught”— implies that he tried to protect himself 
and avoided any possible harm. His suspicion did not only happen in 
this interview, but before the interview, an HIV specialist told me that P2 
sometimes questioned her, asking why she wanted to know it… 
However, in the interview, P2 told me that the nurse specialist was the 
biggest supporter and motivator in his life, and he felt thankful for that. 
In that regard, it seems that his self-protective acts might not 
necessarily speak for his perception towards the persons (Field notes, 
P2, MSM, 32y, 25/09/2015).  
Drawing on the field notes, it explicitly shows that P2 perceived that this 
interview might expose him to greater risk. Asking about his illegal drug use 
and HAART taking is intrusive and potentially exploitative. Concerning 
confidentiality, it seemed to have led him to feel uncomfortable and insecure 
about the questions asked pertaining to his HAART taking and drug use, and 
thus chose to skip answering some of the questions. With his guard up, it 
blocked the channel of my negotiation with him and the rapport built through 
it, despite my efforts of gaining his trust and providing information of how his 
data will be managed. I cannot translate the situation and his response 
precisely, and I admit my limits to acknowledge and understand his personal 
locations. In line with my admission of such limited ability to fully understand 
P2, Merriam et al. (2001), Pillow (2003), and Rose (1997) embraced writing 
uncertainties into research due to the impossibility of complete translation of 
knowledge. Because language itself is already a translation from a non-
verbal world (Rose, 1997). Reflexivity should be pushed towards the 
uncomfortable and cannot be just a simple story of participants, subjectivity, 
and self-indulging telling (Pillow, 2003).   
In this study, there were moments of struggling with gaining P2’s trust, and 
understanding him. This has influenced how I could deeply explore his 
experience. To address such issues, some scholars classified researchers 




role’s influence on how knowledge is situated— insider and outsider. Being 
an insider means having a better access to the implicit and introspective 
meanings of a person/group’s experience (Merton, 1978). On the other hand, 
being an outsider means being more objective, and having the ability to see 
things that may not be evident to insiders (Merriam et al., 2001). Both 
insiders and outsiders have their own weaknesses. Insiders are considered 
to be too close to the culture to identify issues that may have been taken for 
granted, leading to inherent biases; outsiders were less likely to capture the 
implicit meanings of the experience participants share (Merriam et al., 2001). 
In this study, I am equipped with the knowledge of HIV and HAART. 
Nonetheless, when it comes to participants’ personal encounters, I was not 
able to fully understand what and how they have been through. As such, this 
might have led to P2’s distrust of me. 
To sum up, positionality and power relations in the research process can 
exert an impact on how knowledge is produced and interpreted (Doucet, 
2008). In this study, the fieldwork experiences revealed complex power 
dynamics and multiple positionalities, whereby the relation between 
participants and I was constantly negotiated in the research process. From 
my locations, all my understandings become subjectively biased and forged 
through the interactions within the fields of the power relations. Hence, the 
task of situating and constructing knowledge is to be reflexive throughout the 
research process so as to make this study more transparent (Bryman, 2012, 
Denzin and Lincoln, 2018, England, 1994, Pillow, 2003).  
5.8. Data analysis 
5.8.1. Transcribing data 
Transcribing data is an integral process of the analysis of language data in 
qualitative research (Lapadat and Lindsay, 1999). Transcribing is defined as 
“the process of reproducing spoken words, from a recorded interview, into 
written text (Halcomb and Davidson, 2006, p.38)”. According to Halcomb and 




used in a study affect the way data are transcribed for the study. This study 
aims to explore HIV-positive drug users’ experiences of taking HAART 
drawing on constructivist grounded theory approach. Grounded theory 
approach places a great emphasis on the closeness between the researcher 
and the text. Therefore, transcription of interview data was used in facilitating 
data analysis by bringing analysts closer to the data (Halcomb and Davidson, 
2006).      
I digitally recorded all the interviews and then transcribed the recording 
verbatim in Mandarin myself, including non-verbal information (such as facial 
expressions), as soon as possible after interviews were finished. It took about 
3 days to transcribe data/per interview. Though transcribing data was time-
consuming, it offered great benefits in terms of allowing me to familiarise 
myself with and get closer to the data (Bryman, 2012, Halcomb and 
Davidson, 200 6). Given that I have the first-hand knowledge from my 
involvement in the interview process, I could review my field notes and 
compared these with transcripts. This allowed me to expand on my 
impression of the interaction with participants with more considered thoughts 
and accurate reflection (Lapadat and Lindsay, 1999).   
Transcription is a form of interpretation (Poland, 1995 and Mishler, 1991). To 
ensure the accurate transcripts possible for the analytic process, the 
recordings were not left behind after transcription was complete. When I 
wasn’t sure about the data, or wanted to recall what was happening during 
the interviews, I returned to repeatedly listen to the original recordings to 







5.8.2. Translating transcripts 
 
Figure 3: Procedure of analysing data in Mandarin and English 
Interpreting the meaning of participant’s experience is the core of qualitative 
research (Esposito, 2001, Mishler, 1991, Polkinghorne, 2005, Riessman, 
1993). Nevertheless, researchers do not have the direct access to 
participant’s experience (Polkinghorne, 2005, Riessman, 1993), but instead, 
we understand the meaning of participant’s experience through their 
language (Berger and Luckmann, 1966). Although language is as a way of 
understanding participants’ experience, meaning shifts to some extent 
because of participants’ limited capacity to recollect their experiences and 
researchers’ involvement in the interpretation of participants’ experiences 
(Polkinghorne, 2005, Riessman, 1993). In that sense, language itself in its 
essence is already a translation of participants’ experiences (Merriam et al., 
2001, Polkinghorne, 2005, Riessman, 1993). In the same vein, translation 
between two different languages also involves interpretation (Van Nes et al., 
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2010). The difference in language can generate additional challenges that 
could hinder the transfer of meanings, and might cause loss of meanings and 
undermine the credibility of the study (Van Nes et al., 2010).  
In reference to current literature, it was suggested to analyse data in an 
original language as long and as much as possible to avoid potential 
limitations of understanding the meaning of participant’s experience (Chen 
and Boore, 2010, Van Nes et al., 2010). Taking this advice into account, I 
analysed the data in Mandarin during the process of data collection and 
preliminary data analysis. Once sub-categories and categories in Mandarin 
were developed, I found that translating the developed categories to English 
remained complex due to a lack of equivalent concepts. In an attempt to 
develop meaning-based translation, I checked the interpretations by 1) going 
back to the coded data, 2) translating these data into English, 3) coding the 
translated data in English, 4) developing subcategories and categories in 
English, 5) comparing the translated codes, subcategories and categories 
with the ones in Mandarin version (Figure 3). When analysing the translated 
data, I would go back to check the data in Mandarin to capture the context 
and ensure the meaning was not lost. While analysing and interpreting 
translated data, I would think in English and explain in English. On the other 
hand, while analysing the data in Mandarin, I would think in Mandarin. This 
assisted in a better understanding of subtle meaning differences and coming 
to the English wordings that are close to the data in Mandarin. To help find 
the best wording, I also used dictionaries to understand terms and discussed 
with supervisors about the suitable terms for naming the codes, 
subcategories and categories.    
During the process of translating data, the challenge I encountered was to 
convey meaning using equivalent terminology rather than word-for-word 
translation. Congruently, as noted by Chen and Boore  (2010), Esposito 
(2001), Twinn (1997), and Van Nes et al. (2010), not all concepts and 
expressions are universal and translatable due to cultural nuances attending 




“In the past, I needed to take 4-5 pills at one time. It was painful.” (P9, 
MSM, 35y) 
The direct translation of the Mandarin word, "痛 (Tong)”, into an English word 
is “painful”. However, “painful” used in Mandarin by P9 implicitly means his 
feeling of suffering while taking many pills. In that sense, it indicates that 
word-for-word translation could potentially lead to loss of meaning. Without 
making sense of the data both in Mandarin and English, the direct translation 
of codes, subcategories and categories from Mandarin to English may not 
completely convey the meaning of participant’s experience. With this in mind, 
I translated the coded data, and looked deeply into the data again, coded the 
data in English, and then developed subcategories and categories. The full 
analysis of the original and translated data allowed me to think about the data 
differently by making sense of the data in both Mandarin and English, 
developing my analytical thinking, and naming the codes, subcategories, and 
categories more appropriately.  
Another challenge was to translate concepts for which culturally-bound words 
were used by participants. For example, idioms in Mandarin are often 
unintelligible without explanation. At school in Taiwan, idioms are learned 
through the understandings of the historical context from which idioms were 
born, which are used frequently in a daily life. Without understanding the 
context, meanings of the idioms cannot be understood by simply looking at 
the words, because meanings were developed through the context not the 
words. One example presented below is derived from P9. 
“Those friends from the drug circle are just nodding acquaintances. You 
know. One who mixes with vermilion will turn red, one who touches 
pitch shall be defiled therewith. As long as I can control myself well, I 
would try to avoid those friends as much as possible.” (P9, MSM, 35y) 
“One who mixes with vermilion will turn red, one who touches pitch shall be 
defiled therewith.“ is a Chinese idiom, meaning good companions have good 




an ancient story where a mother who moved to many places in an attempt to 
find a better learning environment for her son. By directly translating the 
words of the idiom, it could not convey the meaning explicitly. Therefore, this 
study placed an emphasis on conveying the meanings represented in the 
texts rather than marks in the transcripts (Polkinghorne, 2005). Having a 
proficient understanding of Mandarin and the intimate knowledge of 
Taiwanese culture facilitated capturing the meanings of participants’ 
experiences.          
5.8.3. Analytic techniques – Constant comparison and 
memoing 
In this study, data were analysed by using NVivo software (version 10 and 
11). By a means of NVivo, it has made the analytic work more efficient, 
whereas to deepen the analysis in the research process over time still relied 
on me to move into and around the data, codes, and memos. In this section, I 
will introduce the analytic techniques I used during data analysis— constant 
comparison and memo writing. 
Constant comparison involves making comparison between incidents or 
cases at the property or dimensional level, looking for similarities and 
differences within data, codes, categories and memos, integrating categories 
and properties, defining properties of categories, and writing the theory 
(Charmaz, 2014, Glaser and Strauss, 1967, Strauss and Corbin, 1998). This 
technique serves to identify gaps within data and to explain variations and 
patterns (Bitsch, 2005). By doing so, it helps to capture the dynamic flow of 
events and complex nature of relationships, advancing conceptual 
understandings of a social phenomenon (Charmaz, 2014, Strauss and 
Corbin, 1998).  
Memo-writing is the pivotal intermediate step in data collection and analysis 
(Charmaz, 2014, Corbin and Strauss, 2008). During a research process, 
memo writing offers a space for researchers to actively engage in research 
data (Charmaz, 2014). The use of memo writing helps to capture the 




directions for further investigation, and to provide an immediate illustration of 
an idea (Charmaz, 2014, Glaser and Strauss, 1967, Strauss and Corbin, 
1998).  
Throughout this study process, research memos were written to help me to 
stimulate my thinking, clarify and direct my subsequent coding, and keep 
engaging in analysis and increase the level of abstraction of my ideas. I 
wrote memos in informal language and for my personal use rather than for 
public consumption. The way I wrote memos was based on what I thought 
worked and made sense for me (Charmaz, 2014). The research memos were 
sorted by participant number to keep track of what had happened before, 
during and after each interview (e.g. observation, interaction and incident), 
questions being raised, decision being made, my reflection on each interview 
and participant, and my ideas (Birks and Mills, 2011). In that sense, memos 
can be a source of displaying a written record of reflexivity, allowing me to 
analyse data reflexively.   
Initially, the memos were more tentative and less theoretical. At the later 
stage of data collection and analysis, the memos tended to be abstract. At 
the middle and later stage of memo writing, I started to draw some diagrams 
in an attempt to organise my thoughts of how to sort and integrate codes, 
categories, and concepts, and to find relations between categories. In terms 
of memo sorting, I maintained a folder charting the chronological order of my 
memos. Whenever new contents were added in the memos, those added 
content were dated.  
5.8.4. Coding 
Coding is defined by Charmaz (2014) as ”naming segments of data with a 
label that simultaneously categorises, summarises, and accounts for each 
piece of data (p.111).” Coding should begin with basic description and moves 
to conceptual ordering and abstracting and then on to theorising (Charmaz, 
2014). In this study, I followed Charmaz’s (2014) coding principles when 
analysing data, which consist of two phases — an initial coding phase and a 




5.8.4.1. Initial coding 
An initial phase of coding involves word-by-word coding, line-by-line coding, 
and coding incident to incident (Thorne, 2000). At this phase, researchers 
should remain open to all possible directions indicated by the data being 
read, and coding should remain open and close to the data (Charmaz, 2014). 
In the initial coding, I stuck closely to the data, and coded everything early in 
the analysis to see where it took me as I proceeded. Staying open-minded 
was also employed in the study in an attempt to explore the theoretical 
possibilities I could discern in the data. Firstly, I started with line-by-line 
coding, but sometimes directly did segment-by-segment coding or incident-by 
incident coding depending on the content participants provided. A big chunk 
of data provided the context, which enabled me to get the essence of what 
was being said in the data and understand what the underlying issues were. 
Each chunk of data was examined closely and could contain more than one 
code (Table 6).  By looking at a chunk of data, it not only provided the 
context, but allowed me to make sense of the meanings participants 
constructed, to see the interrelationship between codes, and how the codes 
interactively to influence participants’ HAART taking behaviour.  
Table 6: An example of initial coding from this study 
Codes Data 
Complexity of HAART 
regimen 
 
Unwilling to reveal anti-HIV 
medications  
Not taking HAART with him 
Not taking HAART on time 
 
 
“My previous regimen was taken twice a 
day. Different types of medications were 
taken at different times. When you didn’t 
want to let others know what you are 
taking, taking medications with you and 
on time was challenging.” (P9, MSM, 35y) 
The complexity of a HAART 
regimen 
“Some medications need to be taken 





Took the medications for her 
baby during pregnancy 
 
complicated. I had taken the treatment 
until the end of my pregnancy. After my 
baby was born, I didn’t continue the 
treatment.” (P10, Female heterosexual, 
33y) 
The simplicity of a HAART 
regimen 
The complexity of a HAART 
regimen 
Forgetting 
The complexity of a HAART 
regimen 
 
“I feel thankful that the medication 
regimens are more simplified. In the past, 
I needed to take medications twice a 
day. And this caused me to forget doses 
sometimes. Because the regimen was 
more complicated. Two pills in the 
morning, three pills in the evening.” 
(P20, Female heterosexual, 36y) 
 
This line-by-line, segment-by-segment, and incident-by-incident coding 
facilitated generation of ideas on which I could build. In the case of P9 from 
the table, he did not want anyone to see his antiretroviral medications, 
leading to skipping doses. A question was raised as to whether his 
perception of HIV was linked to his perception of antiretroviral medications, 
leading to his decision to skip doses. Such a question was prompted during 
the interview for further exploration and clarification. In addition, it also led to 
formulating questions for the following interviews or locating the sources of 
needed data, such as whether there are people who perceive antiretroviral 
treatment positively, and whether participants’ perception of being HIV 
positive and the treatment changed over time.  
Some questions were raised by looking into the context and process in data 
analysis (Charmaz, 2014, Corbin and Strauss, 2008). These helped to 
stimulate my thoughts with regards the wide range of possible conditions and 
consequences that could enter into context. Subsequently, the context gave 
rise to problems to which individuals could respond by means of 




process, which is strongly suggested by Charmaz (2014) and Corbin and 
Strauss (2008). Studying a process fostered my efforts to develop a 
conceptual model. In addition to ‘context’ and ‘process’, some sensitising 
concepts identified from existing empirical studies served as tentative tools 
(rather than definitive concepts) for opening up inquiry (Charmaz, 2014), 
such as forgetfulness, support, coping, drug use, and side effects. Together, 
these analytic techniques served as a guide to deepen my analyses and to 
discover ideas but it did not determine its content (Charmaz, 2014, Corbin 
and Strauss, 1998 and 2008).  
During initial coding, situational maps were drawn to help me provoke 
analysis of relations among different codes (Figure 4 and 5). This type of 
mapping was developed by Adele Clarke (2005) as an extension of a 
grounded theory approach. Within a grounded theory approach, the major 
use of situational maps is to open up the data and interrogate in a fresh way 
(Clarke, 2005). The organisation and hierarchical outlining of the parent and 
children codes also gave me a handle on them (Figure 5). By virtue of 
visualising the emerging codes through mapping and linking them, it had 
stimulated my thinking (Clarke and Charmaz, 2014). Moreover, the codes 
were named and defined based on the data, whereas these codes did not 
always stay the same but were renamed and redefined as analysis 
proceeded.  
Memos were written throughout the process of data collection and analysis. 
When engaging in mapping and coding, I constantly compared data with 
data, data with codes, data with memos, one incident with another, and one 
interview with another. This prompted me to keep interacting with data, 
making sense of participants’ experiences. The analysis in this study was not 
structured or static, but rather I moved back and forth between data, codes, 
cases, memos, and sociodemographic information. By looking into HIV-
positive drug users’ experiences of taking HAART from different vantage 




sensitivity of the research topic had grown to help increase levels of 
















5.8.4.2. Focused coding 
The focused phase involves using significant or frequent initial codes to 
synthesize, integrate, and organize large segments of data (Charmaz, 2014, 
Thorne, 2000). Theoretical integration and formation begin with focused 
coding and proceeds through the subsequent analytic process (Charmaz, 
2014). During focused coding, I used the codes to sort, synthesise, and shift 
around to analyse the data, grasp ideas from different angles of perception, 
and make decisions about which initial codes made the most analytic sense 
to categorise (Charmaz, 2014). Similar codes were assembled together to 
analyse their commonalities, attributed meanings to the organisation, and 
then layered my analysis into increasing levels of abstractions from codes, 
subcategories, categories, to concepts, to the interrelationship of the 
concepts, and to a larger conceptual model (Saldaña, 2015). These were 
done by collapsing and expanding categories, adding and deleting some of 
them. 
Social world maps and positional maps were used to help to deepen an 
understanding of participants’ experiences and meanings attached to them. 
Social worlds maps (Figure 6) allowed me to gather my thoughts by locating 
participant’s HARRT-taking behaviour contextually within the range of social, 
political and health environments and making collective sociological sense 
(Clarke, 2005, Corbin and Strauss, 2008). In contrast to the ecological Model 
by Bronfenbrenner (1979) treating various contextual influences as isolated, 








Figure 6: Social worlds map: locating HAART-taking behaviour contextually 
Positional maps (Figure 7) are particularly helpful when the study topic is 
very complicated (Clarke, 2005). Positional maps were used frequently to 
compare case with case, incident with incident, or situations with actions. 
Figure 7 is an example which I used to compare case with case with regards 
length of HAART taking and the regularity of HAART use among participants. 
The main point of drawing maps or diagrams was to mine the data, dig 
beneath the surface to discover hidden meanings that are within the data, 





Figure 7: Positional map: Length of HAART taking by its regularity  
The diagrams presented above are not finished products, but rather they 
were part of the analytic journey. In this study, initial coding and focused 
coding appeared to be a nonlinear process. I went back to re-do initial coding 
when analysing translated data, which helped me to study participants’ 
experiences afresh. Through continued engagement with data, codes, 
categories, cases, and memos, my theoretical sensitivity was developed. As 
analysis progressed, all categories gradually came together and became 
systematically integrated around the core category. Core category was 
described by Corbin and Strauss (2008) and Creswell (2013) as having the 
ability to pull all the other categories together, and the other categories 
centred around and related to the core category. At an early phase of 
focused coding, participants’ attitude was classified as the core category, 
whereas during the analysis of translated data, it was revealed that the 
Mandarin concept “心態 (a combination of heart and attitude)” could not be 
translated directly into English. Thus, in the end, the core category emerged 
as a new word, value, that subsumes all of the other categories and without 


























































Though analytic techniques of grounded theory were used in this study, 
grounded theory has been criticised for fracturing the data and violating the 
integrity of participants’ narratives (Clarke and Charmaz, 2014). As such, it 
could lead to eliminating the sequential and structural features that 
characterise narrative accounts (Clarke and Charmaz, 2014, Riessman, 
1993). Nevertheless, grounded theory approaches are mainly used for 
theorising social action at a collective level (Clarke and Charmaz, 2014). The 
emphasis of sequential and structural features in narrative analysis does not 
fit for “the topics and theories in which the characteristics of actors as active 
subjects remain unexplored or implicit” (Riessman, 1993, p.5).  
5.8.5. Theoretical saturation 
Theoretical saturation refers to no additional data that have been found to 
develop properties of a category and no theoretical insights that have been 
found (Charmaz, 2014, Corbin and Strauss, 2008). Reaching saturation 
should be based on the widest possible data that have been reached in a 
category (Charmaz, 2014, Corbin and Strauss, 2008). Charmaz (2014) 
suggested the combined use of theoretical sampling and abductive reasoning 
to reach theoretical saturation. In this study, I did not treat theoretical 
saturation in conjunction with Charmaz’s (2014) definition of theoretical 
sampling. The decision to stop collecting data was based on no properties of 
the categories found during the preliminary data analysis and when gathering 
data no longer sparked new insights. During the process of the full data 
analysis (after data collection), I re-examined the codes, subcategories, and 
categories in both Mandarin and English, and linked categories around the 
core category. The review of relevant theoretical literature was conducted 
during the full data analysis to compare and contrast existing theories and 
study findings (Corbin and Strauss, 2008).  By the end of the data analysis, I 
did not find the need to collect more data. The reason could be that most of 
the interviews in this study lasted for two hours and the target groups in the 
sample were proportionally recruited considering the HIV epidemiology in 
Taiwan. In that regard, the rigour and efforts I invested in the data collection 




data. Through the comparisons, differences identified were added to the 
current evidence base, resulting in creating new knowledge and building on 
the prior knowledge.  
5.9. The quality of this qualitative study  
Quality of qualitative research is produced and enhanced based on the 
transparency of the whole research process (Flick, 2007). Transparency is 
referred by Flick (2007) as “making the research process, in its steps and in 
the decisions that influenced how data and results were produced, 
understandable to readers in the broadest sense (p.137).” In that sense, the 
emphasis of transparency in qualitative research is placed on explicit 
documentation and being transparent to the readers what has been done, 
how it was done, and the result to which it led. However, in reviewing the 
criteria of qualitative research, it was revealed that its criteria vary within 
qualitative communities (Creswell and Poth, 2018, Charmaz, 2014, Chiovitti 
and Piran, 2003, Guba, 1981).  Theoretical underpinnings or special 
purposes for a qualitative inquiry could generate different standards for 
evaluating the quality of qualitative research (Creswell and Poth, 2018). 
Congruently, Flick (2014) claimed that the issues relating to how to assess 
qualitative research remain unsolved.  
To ensure the quality of this qualitative study, four criteria were taken into 
account− credibility, transferability, dependability and confirmability (Guba, 
1981, Chiovitti and Piran, 2003). 
5.9.1. Credibility 
Credibility refers to “the trustworthiness and plausibility of the research 
findings (Tracy, 2010, p.842)”. The credibility of qualitative research can be 
achieved through thick description, crystallisation and multivocality (Tracy, 
2010). Thick description means that researchers should take into account 
data’s complexity, and provide enough details that readers can understand 
the context and meanings (Tracy, 2010). During data collection, I treated 




their trust. Having participants’ trust seemed to increase their willingness to 
expand their experiences in depth and breadth, contributing to in-depth 
illustration that explicated culturally situated meanings and abundant details 
(Trancy, 2010).  
Crystallisation means that if researchers collect two or more sources of data 
or use theoretical frameworks, the conclusion in the research is more 
credible (Tracy, 2010). In this study, I took observation notes during and after 
interviews to document participants’ non-verbal languages, the interaction 
between me and participants, and the interview environment. These notes 
were used to compare with interview data, and socio-demographic 
information during data analysis, which helped to open up a more complex 
and in-depth understanding of participants’ experiences.  
Multivocality means that researchers can provide space for a variety of 
opinions. In this study, the use of theoretical sampling techniques allowed me 
to see the data from the perspectives of participants with different 
backgrounds, and thus the emerging conceptual model can be refined to all 
possible cases (Bitsch, 2005, Charmaz, 2014, Oktay, 2012). In addition, any 
uncertainties and questions regarding this project or participants were 
discussed with supervisors and attending physicians to seek different 
perspectives.  
5.9.2. Transferability 
Transferability is defined as “the applicability of the findings to other settings 
(Oktay, 2012, p.80).” To enhance the transferability of this research, constant 
comparison and adapted theoretical sampling approach were used to help to 
identify the variation in a category or process, and fill the gaps (Charmaz, 
2014). The recruitment of HIV-positive drug users at different recruitment 
sites also helped to develop a conceptual model that can be generally 






Dependability refers to “the stability of findings over time (Bitsch, 2005, 
p.86).” Due to the nature of grounded theory approaches, changes in 
concepts, interview questions and the focus of research are part of maturing 
and succeeding qualitative research processes (Charmaz, 2014). To ensure 
the stability of research findings, I kept track of the research process, my 
thoughts and questions raised during the study process, and any 
methodological decisions being made through memo-writing (Charmaz, 
2014). These strategies were used to ensure the dependability of this study. 
5.9.4. Confirmability 
Confirmability is in parallel to objectivity, which is to deal with the issues 
related to bias and prejudices of researchers (Bitsch, 2005). This can be 
achieved by demonstrating transparency and sincerity (Tracy, 2010). To 
minimise the researcher’s taken-for-granted assumptions and false 
information, reflexivity was employed throughout the project via memo-writing 
to trace the development of ideas and decisions with regards how concepts 
were defined, how and why participants were selected, how interview 
questions were developed, and how categories or concepts were generated 
(Chiovitti and Piran, 2003, Oktay, 2012).   
Following the four criteria, I strived to demonstrate reasoned reflection and 
principled conviction. By doing so, it assisted this study in conceptualising 
and conveying what is meaningful in the field of illicit drug use, HIV and 








In this chapter, I have provided a detailed account of how this study was 
conducted. Issues and experience relating to recruiting and interviewing HIV-
positive drug users, and the ways that I dealt with the issues were 
addressed. Recruiting HIV-positive drug users was challenging and required 
to gain access to their social networks. To do so, my relations with health 
professionals, social workers and potential participants needed to be 
constantly negotiated so that I could conduct adapted theoretical sampling. 
During interviews, establishing rapport with participants and gaining their 
trust were crucial. With their trust in me, they appeared to be more likely to 
open up themselves and share their stories. In turn, it assisted in achieving 
intimate familiarity with the research topic.  
In terms of data analysis, it was evidenced that there is no standardised way 
of analysing data when translation to English occurs (Chen and Boore, 
2010). Whether to analyse data in Mandarin or English was an important 
decision considering the meanings of participants’ experiences were 
understood through their language. When involving translation, it added 
challenges to convey the meanings to readers with trustworthiness and 
transparency. In an attempt to minimise this risk, data in Mandarin were 
analysed first to capture the meanings in the original language. Then, the 
coded data in Mandarin were translated into English and re-coded and re-
categorised in English to find the English terminology that is equivalent to the 
meaning of participant’s experience. This analytic process was not linear, but 
rather it required me to trace back and forth between the data in Mandarin 
and English, the codes in Mandarin and English, socio-demographic 
information, and memos.  
The preliminary data analysis in this study was done in Mandarin during my 
data collection, whereas the full and detailed data analysis was complete 
after data collection. Once deepening the analysis and developing categories 
(full data analysis), a review of theoretical literature was conducted to 




(Chapter 6-8). This decision was made to minimise the risk of narrowing my 
thinking and blocking creativity (Strauss and Corbin, 1998). After the full data 
analysis and a review of theoretical literature, I did not find the need to recruit 
more participants. 
Taken together, this chapter discusses the qualitative research methods 
used for this study and the process of data collection and analysis. The next 
three chapters that follow move on to focus on the research findings 
developed during data analysis— Chapter 6: HIV-positive identity as part of 
self-identity, Chapter 7: Value attached to HAART, and Chapter 8: 
Conscious actions. The integration of the three concepts along with how 
value emerged as the central category is discussed in the conclusion chapter 

















CHAPTER SIX: HIV-POSITIVE 
IDENTITY AS PART OF SELF-
IDENTITY 
6.1. Introduction 
Data revealed that HIV was perceived as stigmatising and discrediting in the 
Taiwanese society. By living in the Taiwanese culture where HIV is highly 
stigmatised, participants appeared to internalise the social stigma and 
experience feelings of shame, denial, fear, uncertainty, desperation and 
hopelessness. These emotions participants experienced had affected the 
way they perceived themselves as HIV positive; handled the reality of being 
HIV positive and the consequences brought by it; managed HAART taking. 
During the process of identity re-construction following the new HIV 
diagnosis, participants’ sense of self developed and changed over time. The 
greater degree to which they engaged with the social world the more resilient 
and self-accepting participants were more likely to be.  
In this chapter, I begin by addressing the emotional impact of HIV diagnosis 
among HIV-positive drug users, followed by discussing how their HIV-positive 
identity as part of self-identity disrupted/facilitated their engagement with 
HAART taking.   
6.2. HIV-positive identity as part of self-identity 
HIV is a chronic and long-term health condition requiring participants to live 
with it for the rest of their lives. To live with it, affected individuals may need 
to reconcile their sense of self with the implications of HIV infection and 
impose coherence on an uncertain future. However, when losing sight of the 




feelings of uncertainty, fear, anxiety, shame and desperation, and threatened 
their ability to face themselves and the realities, to connect with others, and 
to cope with their HIV and its treatment.  
The topic relating to new HIV diagnosis, and its emotional impact and impact 
on HAART taking are addressed under two main sub-categories— emotional 
impact of HIV-positive diagnosis, and new identity construction in response to 
HIV diagnosis within the Taiwanese context.  An overview of the concept— 
HIV-positive identity as part of self-identity— is presented in Table 7 with 
categories and sub-categories. 
Table 7: Constructs of HIV-positive identity as part of self-identity  
Concept Category Sub-category 
6.2. HIV-positive identity 
as part of self-identity  
6.2.1. The emotional impact of 
HIV-positive diagnosis 
6.2.1.1. Feeling of 
uncertainty 
6.2.1.2. Avoidance of 
difficult emotions 

















6.2.2.1.1. Shame and 
self-stigma 
6.2.2.1.2. Non-disclosure 





6.2.2.2.1. Accepting HIV 
status 
6.2.2.2.2. Selective 







Figure 8 presents HIV-positive drug-taking participants’ self-identity re-
construction conceptually as a framework to build on and to ultimately 
develop a model for sustaining HIV-positive drug users’ HAART-taking 
behaviour (Figure 9 and 11). 
 
Figure 8: Self-identity reconstruction 
6.2.1 The emotional impact of HIV-positive diagnosis 
This section firstly discusses the emotional impact of receiving an HIV-
positive diagnosis on participants and how such emotional impact had 
affected their HAART taking.     
6.2.1.1. Feeling of uncertainty 
In this study, upon diagnosis of HIV, participants, on the whole, demonstrated 
a general sense of uncertainty, and by association fear and anxiety. Their 
fear and anxiety appeared to be derived from the perceived stigma attached 
to HIV, and not knowing what to do and how other people would view them or 
react towards their HIV status.  
“If I want to be in a relationship with a person, I need to respect him. I 
am afraid that the person would keep distance with me. I don’t want 
people to view me differently.” (P4, MSM, 26y) 
“I just feel HIV doesn’t sound good. I am afraid that other people will 
view me differently. Psychologically, I cannot get over it. Being with 
people with HIV in jail, I didn’t need to hide my status. Since I was out of 




will accidentally reveal my HIV status to other people and how they will 
react.” (P18, Female heterosexual, 32y) 
HIV is stigmatising in the Taiwanese society, and thus living with HIV has 
brought fear and anxiety to some participants. In the cases of P4 and P18, 
their sense of uncertainty appeared to be internal as they were unsure and 
feared the negative consequences of living with HIV and how it would affect 
their relationships with others. Such feelings were revealed within data to 
create barriers to seeking out support. The finding is congruent with Bury’s 
(1982) biographical disruption. In this theory, Bury (1982) contended that the 
emergence of a chronic illness can shift an individual’s perception of life from 
a normal and relatively predictable to an abnormal and inwardly damaging. 
When viewing the condition as an outside force, affected individuals could 
feel its invasion into all aspects of their life, leading to the feeling of fear, 
anxiety, and uncertainty, especially about their future (Bury, 1982). 
‘Uncertainty’ has been defined by Mishel (1988) as “the inability to determine 
the meaning of illness-related events (p.225).” ‘Diagnosis’ is principally 
epiphanic as a moment of change (Karnilowicz, 2011), which can be 
regarded as positive or negative experience (King et al., 2003). Such 
experience can alter an individual’s fundamental meaning structures and 
change the concept of self (King et al., 2003).  
By the same token, P5, P10 and P12’s statements shown below alluded to 
the notion that they were not able to envision their future as positive with their 
past and present realities. The development of negative emotions is due in 
part to the mismatch or increasing discrepancy between meanings perceived 
in the situation and meanings held in the desirable prospects, causing status 
inconsistency and role conflict (Stryker and Macke, 1978). P5’s accounts 
below illustrated his past experience of public stigma, and fear of family’ 
rejection. His past experiences of stigmatisation and seeing others with HIV 
influenced how he perceived himself as HIV-positive. As a result, such 
experiences intensified his feeling of uncertainty about the future and 




P12’s narrative also showed his sense of uncertainty upon the diagnosis of 
HIV. The epiphanic illness experience triggered his emotional response and 
created the conflicts between his sense of self and perception of the new 
HIV-positive identity. 
“I am so afraid that my family will discover my HIV. I feel ashamed to tell 
them. I cannot face it. If I can deal with it on my own, I will just do it on 
my own…I am still against this reality. Before, when I went on trial, the 
clerk of court handed over a document to me, like this [Fieldnote: P5 
demonstrated the clerk’s gesture. Her gesture was like she didn’t want 
to touch him. She kept her hand as far away from his hand as possible. 
After handing over a paper to him, she cleaned her hand with her cloth]. 
I thought whether I was still a human being.” [Later in the interview, he 
stated] “I have seen HIV- positive people who were severely ill. I helped 
those people in the charity. And I started to think about my future. If I 
am like them, being abandoned by family and not being supported by 
anyone, I will feel sad. I am worried about my future.”  (P5, Male 
heterosexual, 45y) 
“After my HIV status was confirmed, I was thinking what I should do 
next. My mind went blank for two days. I didn’t know what to do. My 
mind was absent. At the time, I just finished my master programme. 
Then I was hesitating if I should go to the hospital and receive 
treatment. This emotion lasted for one to two weeks” (P12, MSM, 35y) 
On the other hand, the extract presented below from P10, “Afterwards 
because my ex-mother-in-law accepted me, I started to accept myself”, 
shows that with the support from others, it seemed to provide a sense of 
continuity in her life, thereby reducing the amount of perceived uncertainty. 
Congruently, Bury (1982), Gergen (2001) and Riley and Burke (1995) 
supported the importance of maintaining good relationships with others 
during the illness trajectory. The extent to which a person can verify his/her 
self-identity depends on the identities of others, how others respond to 




to align perceived self-meanings with identity standards (the identity goals 
that an individual wants to achieve in a situation) (Riley and Burke, 1995).  By 
bridging the gap between perceived self-meanings and identity standards, it 
can enhance an individual’s psychological well-being, motivational force, and 
satisfaction with the identity (Riley and Burke, 1995). 
 “While I was pregnant, I just knew that I have HIV. I felt like I was in 
miserable having HIV. I was also afraid and concerned about whether 
my baby would be infected. Sometimes, I really wanted to take this 
unborn baby with me and committed suicide. Afterwards, because my 
ex-mother-in-law accepted me, I started to accept myself. [Earlier in the 
interview, she stated] “I started to use illicit drugs at the age of 17, and 
then I used heroin and smoked at the age of 18. Then I injected heroin 
at 19. Before 2003 I wasn’t infected with HIV, because it is mandatory 
to have HIV screening. Then I was released. I found I was infected after 
I was caught by police again and being put in jail in 2005. I was at the 
8th month of pregnancy at that time. The staff at jail referred me to a 
doctor and had screening tests for my pregnancy. HIV screening was 
positive. Thus, I started the treatment at the 8th month of pregnancy” 
(P10, Female heterosexual 33y) 
The data presented so far provide an important insight that in face of new 
HIV diagnosis, some participants felt anxious and uncertain about how to live 
with HIV and how it would impact on them. Their feelings of anxiety and fear 
were often combined with other negative emotions depending on personal 
circumstances. When the emotions were too overpowering, it affected how 
participants handled the situations and dealt with their emotions, which is 
discussed in the next section.  
6.2.1.2. Avoidance of difficult emotions 
Participants’ emotion is a multi-layered process in which their feeling of 
uncertainty about life with HIV often tightly coupled with other emotions. 
There were a number of participants who tended to avoid handling the 




illicit drug use. Their denial of HIV status and the impact of drug use on their 
lives appeared to pose a negative impact on their HAART-taking behaviour. 
This section firstly focuses on participants’ self-denial of HIV status, followed 
by their lifestyle behaviours, and how avoidance of difficult emotions affected 
their engagement with HAART-taking. 
6.2.1.2.1. Self-denial of HIV status 
At an early stage of HIV, it seems that HIV could impact on an individual’s 
original sense of self and result in an imbalance between an original sense of 
self and this new HIV identity, leading to a denial of HIV status. In this study, 
many participants unwillingly faced the reality of being HIV positive and 
accepted it upon the diagnosis. Data revealed that most participants had 
developed negative emotions towards their HIV diagnosis. The negative 
emotions were particularly intense at the beginning of the HIV trajectory.  
“When I was diagnosed with HIV at the first one or two months, I was 
really emotionally unstable. HIV didn’t sound good. It made me feel 
guilty and defined myself negatively.”  (P12, MSM, 35y) 
“At the beginning, it was painful to accept it. It was shameful. I was in 
denial. I might have viewed HIV as a horrible disease. It was like you 
still held the earlier value of what HIV was.” (P14, MSM, 36y) 
The excerpt from P14, ‘it was like you still held the earlier value of what HIV 
was’, indicated that his perception of HIV was influenced by the social image 
of HIV portrayed by the Taiwanese society. The social value was deeply 
ingrained in his mind. By holding the negative perceptions of HIV, his 
possession of the new HIV status appeared to trigger his negative emotions 
towards it.  The transcript extracts from P12 and P14 — ‘HIV didn’t sound 
good’, ‘it made me feel guilty’, ‘it was shameful’, ‘viewed HIV as a horrible 
disease, and ‘defined myself negatively’ — illustrated that participants’ 
negative emotions towards HIV exerted an impact on the way they evaluated 
themselves as HIV positive. When not being emotionally prepared to live with 




 “I think it is important to accept self. They don’t accept themselves, and 
keep avoiding the HIV specialist. They are still in that drug circle. I kind 
of understand them. In the past, the nurse called me back. I kept 
avoiding her. I can understand that kind of feeling. I just didn’t want to 
face it. ” (P4, MSM, 26y) 
“HIV is negative…I couldn’t accept it. Felt why me why me…I felt 
hatred, why that person didn’t inform me and then transmited the virus 
to me.” (P2, MSM, 32y)   
In Matsumoto and Juang’s book (2008), Culture and Psychology, they 
pointed out that culture can influence an individual’s way of perceiving things 
and interpreting information. The extract from P2, “why me. why me” and 
“that person didn’t inform me”, reveals his anger and the unexpectedness of 
getting HIV infection.  The negative emotion and unexpectedness seemed to 
affect how he viewed HIV and his readiness to face such reality. It has been 
proposed that the unplanned or uncontrollable acquisition of the illness can 
obstruct the re-shaping of self-identity, which is especially fundamental when 
making a transition to incorporate chronic illnesses into life (Hyden, 1997, 
Karnilowicz, 2011, Telford et al., 2006). This notion resonates with P2’s 
statements of “HIV is negative” and “I cannot accept it”, showing his negative 
perception of HIV and unacceptance of the epiphanic experience of being 
HIV positive. As a result, an illness could lead to moments of psychological 
vulnerability and loss of personal power and control (Gergen, 2001, Pierce et 
al., 2003). Vulnerability can be real or imaginary, negatively affecting an 
individual’s feeling of self-worth and self-confidence (Gergen, 2001). 
Consequently, affected individuals may present a feeling of denial (Telford et 
al., 2006). 
Apart from P2 and P4, it was evident within the data that by not accepting the 
persons they were as HIV positive, P12 and P14 tended to care less about 




 “I thought why I needed to accept it. It was humiliating. I kept telling 
myself I didn’t have it. I denied that I have been infected with HIV, and 
thus I didn’t receive treatment. I had that transition period of denying my 
HIV status.” (P14, MSM, 36y) 
“At the very beginning, I was in denial and refused to take the 
medications. I was internally struggling and having many negative 
emotions.” (P12, MSM, 35y) 
By and large, participants’ internal struggles and denial of HIV infection 
influenced their readiness to receive HAART and/or ability to manage regular 
HAART use.     
6.2.1.2.2. Lifestyle behaviours as coping strategies 
Upon learning the new HIV status, some participants developed negative 
emotions and were unready to face this reality. This is exemplified by P8’s 
and P13’s narratives presented below. The findings show that their negative 
emotions and unwillingness to deal with stress led them to start or continue 
using drugs in an attempt to avoid dealing with the unpleasant things that 
happened to them. 
“Drugs can make you want to avoid and be lazy. You wouldn’t want to 
face anything outside. I sometimes used drugs to avoid and not face 
reality. When you encountered something and didn’t know how to 
handle, you would inject it [heroin]. Once it is injected, you would feel 
drowsy and sleepy and not do anything, becoming a lazy person. To 
avoid reality, I would use it.” (P8, Male heterosexual, 49y) 
 “My grandnanny had a stroke, and was bedridden, and plus I am 
infected with HIV. I felt really distressed. Using Ketamine made me 
indulge in its effects and feel relaxed. It made me keep using it, 
avoiding things.” (P13, MSM, 31y) 
Participants’ accounts illustrated that there were some challenges they have 




family crises, some drug-using participants tended to avoid facing their 
negative emotions and the hard truths. The findings are closely linked to a 
paper by Anderson (2003) in which he described when the situations do not 
meet a person’s choice, the person is more likely to avoid or to seek an easy 
way out that involves no change, in hopes of mitigating negative emotions. 
Congruently, it was evident from the data that drugs were a source of 
obtaining happiness and avoiding stress. Such rewarding effects led them to 
repeatedly use drugs, forming a circular process of feeling down, using 
drugs, and feeling happy.  
“In the past, my gangster life was all about stealing, robbery, and killing. 
During that period of time, I would use heroin whenever I wasn’t in a 
good mood. Once I repeatedly used drugs, I was addicted to it and 
couldn’t live without it.” [Later in the interview, he said] “After I got HIV, I 
couldn’t face it. I couldn’t bear it. I felt ashamed. I didn’t have the 
courage to seek HIV care. During that time, I had many convictions. I 
was under arrest and Centre for Disease Control was also looking for 
me.” (P5, Male heterosexual, 45y),  
”Walking on this path [HIV] is tough and lonely.”[Asked about his 
family’s support, he stated that] “Although on the surface they didn’t 
give up on me, psychologically I still feel they hold the grudges…My life 
has been changed, being HIV positive, losing my job, breaking up with 
my partner, and my family.” [Later in the interview, he talked about his 
experience of his amphetamine use] “It smelled good, like lavender 
having healing effects. It was healing. Then gradually I am used to 
it…When using it, it was pleasurable. Afterwards, I felt empty again. It 
wasn’t okay afterwards, because it wasn’t real. I think now I am 
controlled by drugs…When I used drugs, my use of medications might 
be irregular. I don’t know. I don’t remember. I want to quit drugs. 
Seriously. Now I don’t have a partner. I need a partner so that we can 




Sinha (2001) examined empirical evidence on whether the exposure to stress 
could increase drug use. He concluded that stress may increase one’s 
vulnerability to drug abuse and alter stress response and coping, whereas he 
claimed that the mechanism underlying the associations is unclear. In this 
study, P2’s and P5’s narratives presented above— “I would use it whenever I 
wasn’t in a good mood”, “having healing effects”, “it was pleasurable”, 
“Afterwards I felt empty again” illustrated that in response to difficult emotions 
they used drugs to pursue happiness and fill a void of emptiness.  
Data presented below show that P7 and P12’s use of drugs as coping 
strategies and psychological dependence undermined their ability to control 
their drug use. As a result, their lack of self-control over drug use influenced 
medication taking.  
“I started to use a large amount of amphetamine after I broke up with 
my boyfriend. I kept thinking and working crazily. I felt unhappy and 
down. During that time my family just discovered my situation [HIV], but 
I wasn’t willing to listen to any positive encouragement. I only listened to 
my negative thoughts. I became very negative. I wasn’t good enough. 
Thought that no one liked me. Since October, you can see that I have 
stopped taking medications for a month. I didn’t go refill the 
medications. In the end of October, I just realised that I haven’t taken 
medications for a month.” (P12, MSM, 35y)  
“When using amphetamine, I would find that. I mean when using too 
much of it, I would dwell on my unhappiness and not take medications. 
Then my viral load would go up.” (P7, MSM, 30y) 
In line with the findings, it has been documented in Baler and Volkow’s  
(2006) paper that the reinforcement of drug effects can negatively impact 
users’ ability to cognitively control themselves and to make a rational 
decision (Baler and Volkow, 2006, De Wit, 2008). Moreover, the transcript 




dependence and experiences of withdrawal symptoms resulted in being 
trapped in a vicious cycle of using drugs and finding drugs.   
“Heroin’s withdrawal symptoms would make you crazily tried to find 
heroin until you found it. No matter how much time you spent on finding 
it you would do it until you found it. It was impossible to let myself in 
pain too long. I wouldn’t think of the treatment. Wouldn’t think that far. 
We would just want to solve current issues. That wasn’t an immediate 
need.” (P18, Female heterosexual, 32y) 
“I would rather spend money for drugs. After injecting drugs, I only 
thought of my next dose of drugs and how I could get money. To have a 
regular life was difficult. Generally speaking, people would normally 
care about their birthday. When using drugs, we wouldn’t celebrate a 
birthday and even couldn’t remember it. Even on Chinese New Year, all 
I thought about was drugs and next doses of drugs.” (P20, Female 
heterosexual, 36y)  
According to De Wit (2009), drug users’ negative mood states were linked to 
self-regulation of behaviour where emotion may impair their ability to focus 
on long-term goals by increasing their bias towards immediate pleasure. This 
notion is congruent with P18’s and P20’s statements— “I wouldn’t think of the 
treatment. Wouldn’t think that far “ and “I only thought of my next dose of 
drugs.” Consequently, their psychological and physical dependence on drugs 
appeared to collectively increase the difficulty of caring about their health.  
By shifting focus onto finding and using drugs, participants’ comments 
illustrated that establishing a regular lifestyle became challenging because of 
the amount of time, and physical and conscious efforts they spent on 
using/finding drugs and chemsex.  
“When I used drugs, to take the treatment was almost impossible. I 
couldn’t have time to handle the withdrawals, how come I would think of 




because it is required to visit a doctor every three months.”  (P15, Male 
heterosexual, 53y) 
“I used Ketamine and then fell asleep. I would wake up whenever I 
wanted to. I never cared about the time.  When I woke up, it didn’t 
matter what time it was. I did whatever I wanted and then fell asleep 
again. During the sleeping times, I am not sure if I have missed doses. 
Using drugs made me lose appetite. I was quite skinny at that time. I 
lost 5-10 kg. I didn’t regularly have meals, and I didn’t want to eat. How 
come I would want to take medications?” (P13, MSM, 31y) 
“When using drugs, my lifestyle wouldn’t be regular. I wouldn’t sleep at 
night. Didn’t sleep much. I didn’t even eat meals regularly. So my intake 
of medications would be erratic.” (P4, MSM, 26y) 
In living a life with HIV and illicit drug use, another concern brought up by 
participants was the illegality of drugs. Their lifestyle appeared to be chaotic 
not only due to the influence of drug taking but fear of being caught by the 
police. Collectively, participants’ fear of facing negative emotions and difficult 
realities, such as dealing with HIV, drug dependence, and law enforcement, 
appeared to leave them no choice but live in the shadows. Subsequently, the 
adversities participants encountered in their life with HIV and drug use had 
created a multi-layered barrier to receiving or regularly taking HAART. The 
findings are in line with De Wit’s (2009) study that disruptive environment 
was associated with inappropriate or maladaptive behaviours among drug 
users.   
“I have many friends who had that experience. They went see a doctor 
but were caught by police. Or the police would wait outside the hospital. 
Don’t you think it would be affected? Police officers were really good at 
tracking. If he still uses drugs, you can see if he will still come to the 
hospital. They must not have the gut to come. They’d rather not take 
antiretroviral treatment. If I am still using drugs, it is impossible for me to 




“The main problem is drugs. They cannot quit drugs. How come they 
want to see a doctor? They just cannot quit drugs. How can they 
manage to see a doctor? Some have been caught by police. They 
would be afraid it was a trap. Others would think why you wanted to 
treat me well. Will you sabotage me? I have tried to encourage 5-6 
people to come see a doctor. But failed every time. I couldn’t persuade 
them. Some have seen a doctor but escaped. It is very complex. There 
are many things that are linked to influence our medication taking.” (P4, 
MSM, 26y)       
In summary, though drugs were acknowledged by many to bring negative 
consequences, such as withdrawal symptoms and psychiatric symptoms, 
most described their experiences of using illicit drugs was positive and hard 
to be replaced. Participants’ use of drugs and its impact on HAART taking 
was particularly found to be prominent in the situation where they had 
difficulty handling their negative emotion. In turn, drug use appeared to 
provide a comforting and soothing space where they could lie in an attempt 
to avoid stress, find happiness, and meet immediate physical needs of 
avoiding withdrawal symptoms.    
6.2.1.3. Desperation 
Karnilowicz (2010) in his paper discussed that the effects of an illness can be 
debilitating and confronting, and over the course of the illness, it requires an 
individual to gain control over its effects by having some levels of 
psychological ownership. However, in this study, upon receiving an HIV 
diagnosis, many participants felt distressed and despair.   
“After the diagnosis of HIV, I rarely got in touch with other people. I 
locked myself in my room. At that time, I felt depressed.” (P4, MSM, 
26y) 
 “HIV is negative and the medications make me think of HIV. Thinking of 





“When I was diagnosed with HIV at the first one or two months, I was 
really emotionally unstable.” (P12, MSM, 35y) 
Data presented above revealed that the state of desperation could warp 
participants’ thinking, allowing them to dwell on negative thoughts, such as “I 
deserve it because I am promiscuous” (P2, MSM, 32y) and “why should I 
take those pills and why should I live long” (P11, MSM, 31y). With the feeling 
of desperation, some perceived themselves negatively and viewed their 
future with uncertainty. By repressing their emotions to support negative 
thoughts, they seemed to have fallen prey to such thoughts.  
“When alone, I would be more negative, thinking this illness is not 
curable. Thought that why I should take those pills and why I should live 
long.”(P11, MSM, 31y) 
“I knew that HIV won’t make me die, and the treatment can prolong my 
life. However, my first reaction was like I am done. This is the first 
reaction. Second, I couldn’t handle a family crisis. My grandmother had 
a stroke and lied on the bed but nothing I could do about it. I wanted to 
die. ” (P13, MSM, 31y) 
In the case of P13, he was emotionally affected not only by HIV status but his 
family crisis. His exposure to multiple adversities had increased his stress 
level and led to feelings of desperation and inability to cope with the 
emotions. This indicates the close and ongoing interaction between individual 
psychological state and social environment (Pierce et al., 2003).   
In turn, it was evident within the data that participants’ negative thinking along 
with feelings of desperation could sow the seeds for eventual hopelessness. 
 “I don’t blame others for why I got HIV but myself. When I just got it, I 
felt hopeless. In the past, we called it as a black disease. It’s not like 




“I was about to commit suicide. I felt hopeless. I was down. I was under 
arrest. I had committed many crimes. Also, I was sick. I completely sank 
into despair.” (P20, Female heterosexual, 36y) 
Participants’ accounts alluded to the notion that when in desperation some 
felt that they failed in some way or they were the cause of their own issues. 
Eventually, such intense feelings of desperation and hopelessness led them 
to feel stuck in life with no way out.    
6.2.1.4. Suicidality 
During the process of HIV and HAART trajectory, some participants had 
encountered difficulties in life, such as HIV-related health issues, financial 
difficulties, or family rejection. According to participants’ statements, these 
circumstances appeared to overwhelm them.  
“I wasn’t in a good mood. I thought why I was in such a bad luck, having 
HIV and nasopharyngeal cancer.” (P22, Male heterosexual, 50y) 
“I felt down. I didn’t want to live anymore. I was just recently back from 
jail. I wasn’t well. My spine wasn’t well, and I couldn’t work. My financial 
status wasn’t good.” (P17, Male heterosexual, 37y) 
Data revealed that experiencing one setback after another increased 
participants’ sense of worthlessness in life, and caused to question whether 
their lives have any meaning or hope.  
“I went to have HIV screening at the second time. It was positive. I don’t 
remember which doctor. Anyway, I felt nothing was more important than 
drugs. At that time, my dad, mum, sister and brother were really 
disappointed in me and I let them down. They asked me if I wanted to 
quit drugs, and I said yes. But later I was craving for heroin. They said if 
I used it again they would kick me out of the house. Then I told my mum 
I wanted drugs. I didn’t want mum and dad. Then I ran away. I lived in a 
park or houses that were under construction. After a while, because of 




and let me live in my sister’s apartment on my own. They sometimes 
secretly put food and snacks in the apartment. But at that time I didn’t 
have money to buy drugs. I was left to fend for myself. I remember one 
day I walked on the riverside, and I thought why my life became like 
this. I thought of suicide” (P19, Male heterosexual, 43y) 
“Why all the bad things happened to me. I didn’t want to receive 
treatment. Just let it go. Taking chemotherapy medications was 
suffering. I thought of not taking any of my medications [Including 
HAART].” (P22, Male heterosexual, 50y) 
The participants’ accounts also pointed to the notion that their feelings of 
worthlessness led them to not see any aspects of life as positive and not 
believe there was the prospect of improvement.   
“I’ve never thought of my future. If I die by not taking the treatment, then 
just let it be. Just passively waiting for death’s coming.” (P18, Female 
heterosexual, 32y) 
“I started to give up myself, looked for negative things and imposed 
those on myself. Thought negatively and let myself go and did whatever 
I wanted.” (P7, MSM, 30y) 
When not seeing worth in their life some participants did not lead their life 
proactively, and this could translate into engaging in self-destructive 
behaviours.  
“Since I got it [HIV], I have felt hopeless. I had a wonderful family, my 
ex-wife and kids. Since I got it, my wife and kids were gone. I started to 
live my life in a destructive way.” (P17, Male heterosexual, 37y) 
“I wanted to die, but I was afraid of pain. I thought if I used a large 
amount of ketamine to let myself die without experiencing pain. But I 




There was a small number of participants having support from family and/or 
friends but feeling unmotivated to move forward in life. In the example of P18, 
during her pregnancy, she received HAART. After delivery, she had 
treatment interruption. The reasons behind her decision of not receiving the 
treatment were later revealed to be due to her perceived stigma related to 
HIV (Section 6.2.2.1.1.), feeling of hopelessness, and perceived 
burdensomeness  (e.g. “I feel this disease is awful and not curable", “Yes, I 
don’t want to give them [family] burden.”, “I feel I am different from them.”). 
Based on her narratives below, her dwelling on negative emotion towards 
living with HIV seemed to strike her. In turn, the disruptions caused by HIV-
positive identity influenced how she coped with HIV and its treatment 
(Section 6.2.2.1).  
“I was caught by the police. Then they took me to have screening tests. 
The result was positive. In the morning, I found I was pregnant, and in 
the afternoon I found I was HIV positive. Then I received cocktail 
treatment in jail during my pregnancy. My child is negative.” [When I 
asked the reason she stopped taking the treatment after baby delivery. 
She said] “I don’t know. Just don’t want to take it” [Later the interview 
we discussed her family, and she told me] “My mum, from the very 
beginning, took care of me, and took me wherever I wanted to go. My 
dad didn’t say much, but once he told me privately that whatever I 
wanted he would buy it for me. My partner also cares about me. But I 
still feel we are living in the different world…I can’t get over it [HIV]…I 
want to die. A long time ago I have already thought that. I feel this 
disease is awful and not curable…If I die by not taking the treatment, 
then just let it be. Just passively waiting for death’s coming.” [I further 
asked if she did not want to give her family burdens] “(nodding) Yes, I 
don’t want to give them a burden. And I feel I am different from 
them.”(P18, Female heterosexual, 32y)  
“Keeping encouraging may not work. Outsiders’ encouragement is 




on an individual himself/herself. Some did not have life aspirations and 
gave up taking the medications, even though their family accompanied 
them and refilled the medications for them.” (P20, Female heterosexual, 
36y) 
The findings presented so far are supported by the interpersonal theory of 
suicide by Van Orden et al. (2010). They proposed that thwarted 
belongingness (beliefs that individuals’ needs are unmet) and perceived 
burdensomeness (the extent to which individuals perceive to be a burden on 
others) are dynamic interpersonal states that could engender suicidal 
thoughts and attempts. 
Based on participants’ statements, though participants had support at hand, 
when not taking the support into their heart they could still be emotionally 
oriented by what concerned them the most. In other words, it seems that 
when individuals are not accepting and supporting themselves, and feeling 
worthless, no amount of argument could compel them to see the world 
differently. As a result, those who felt life was not worth living tended to be 
passive, and less engaged in medical care and general socialisation. 
Similarly, in the current evidence base, empirical studies have shown that 
depression and suicide were common among the HIV positive population, 
and related to lack of social support and HIV-related stigma (Carrico et al., 
2007, Heckman et al., 2004, Sherr et al., 2008).  
“I am HIV positive. Then I also get cancer. I oftentimes thought of 
suicide. I didn’t receive any treatment. Just let myself go. At that time, I 
didn’t come to infectious diseases outpatient services for several 
months.” [During the interview, he also stated his suicidal attempts] “I 
was very negative. I often thought of suicide. I even burned charcoal to 





“I don’t want to receive the treatment. I want to give up. I don’t like to go 
out. Previously, people couldn’t find me. I was hard to find.” (P18, 
Female heterosexual, 32y) 
In short, based on the data, it implies that as outside circumstances become 
less and less bearable, it increased participants’ tendency of perceiving as if 
they had no significance or purpose of living in this world. Consequently, their 
inner sense of worth diminished, leading to suicidal attempt and behaviour. 
Such negative perception might result from their mal-adaptation of negative 
emotions towards stress.  
6.2.2. Identity re-construction in response to HIV diagnosis in 
the Taiwanese society 
At the time of HIV diagnosis, participants needed to face this reality and learn 
how to live with it. Their emotional response to their HIV and perception of 
the meaning attached to this influenced their sense of self. In the dynamic 
process of identity re-construction over the course of HIV trajectory, whether 
or not participants integrated HIV into self-identity emerged within analysis to 
influence their ability to manage their HIV and HAART.  
6.2.2.1. Non-integrated self-identity  
In this study, HIV infection was portrayed negatively in the Taiwanese 
society. When not viewing HIV as part of self, participants were inclined to 
feel ashamed and not disclose their HIV status; thereby it could be proposed 
that this undermined their internal strength to manage HIV and its treatment. 
This section first discusses how participants’ sense of shame and self-stigma 
were constructed, and then moves on to discuss the impact of self-stigma on 
participants’ decision to not disclose HIV status and seek support, and then 
looks at how these elements of non-integrated identity collectively influenced 
participants’ HAART-taking.    
6.2.2.1.1. Shame and self-stigma 
In a systematic review by Katz et al. (2013), HIV-related stigma was found to 




revealed that HIV was portrayed by the Taiwanese society as being 
equivalent to other attributes, such as promiscuity, homosexuality, and illicit 
drug use. Public perceptions of HIV surfaced mainly in respect to the ways 
affected individuals were infected. It is exemplified by participants’ 
experiences presented below regarding their perception of how the public 
perceived HIV:  
“Getting HIV meant that my life was ruined, because when I was little 
ads said that HIV infection was caused by promiscuity. The ads 
educated us to not have sex with many people and to remember 
wearing condoms; otherwise, you would get HIV. This was the aim of 
the ads. That’s why I felt HIV was a shameful disease.” (P10, Female 
heterosexual, 33y) 
“The public thinks that HIV means gay men. I also think so. There is a 
reason behind it. You can see that why HIV prevalence among 
heterosexuals is so low. There must be a reason behind it. This is not 
the public view solely on homosexuality but on sexual behaviours 
related to HIV in gay men. In this society, sexualism is no longer an 
issue. The main problem is gay men themselves. If we don’t change our 
perception and behaviour the rate of HIV infection will continue 
increasing. This is not public prejudice.” (P1, MSM, 28y) 
“HIV. HIV. You told people you are HIV. They may think how you got it. 
It is awful even just hearing this word.” (P15, Male heterosexual, 53y) 
“In the past, my son warned that many drug users got HIV and wanted 
me to not use drugs.” (P5, Male heterosexual, 45y) 
These accounts point to the notion that the negative image of HIV is not only 
created by HIV itself but the socially-unacceptable behaviours attached to it. 
As a way in which to explain participants’ behaviours, they were classified 
into different social groups in society. Congruent with the findings, Goffman 
(1963) termed ‘stigma’ as a ‘moral career’ where it occurs as a new social 




are regarded as marginalized populations in society and are closely related 
to HIV infection.    
“People with HIV and drug users are quite similar. They are regarded as 
marginalised populations. They are related, in terms of their social 
status and their experiences of unfair treatment from society. Even you 
don’t have HIV, they may think you have. In the same logic, being gay, 
people may think you have HIV.” (P6, MSM, 52y) 
Stigma is embedded in one’s interpretation of social context, which involves 
cultural meanings, psychological states, roles and ideal types (Yang et al., 
2007). The multi-layered and negative social images of HIV were revealed 
within the data to influence the way participants evaluated themselves as HIV 
positive. For example, participants’ statements “I felt HIV was a shameful 
disease” (P10, female heterosexual, 33y), “It is awful even just hear this 
word” (P15, Male heterosexual, 53y), and “It is a shameful disease” (P16, 
male heterosexual, 42y) presented their feelings of shame by carrying the 
stigmatizing HIV-positive identity. When participants’ emotions towards 
“stigmatising HIV” were overpowering, the amount of knowledge they have 
learned relating to HIV was completely subsumed. This is exemplified by P2 
and P19. 
“HIV is a chronic illness. If not controlling it well, it can develop AIDS. If 
it is controlled well by medications, we can live longer. It is just a 
statement. You feel like you still live with it day by day.” (P2, MSM, 32y) 
“It is social value. While current medical technology is advancing, HIV is 
just a chronic disease, however, when it comes to social value, I think 
how to solve the issue of HIV stigma becomes difficult and 
unanswerable.” (P19, Male heterosexual, 43y) 
In addition to self-perception of HIV, personal experience of discrimination 





 “One time, I asked my mother to come with me to visit the HIV 
specialist. After this visit, she eventually chose to not get over it [HIV]. 
Because at the beginning her first reaction was like if it could affect her. 
That was her reaction! Then the HIV specialist said from the bright side 
she at least didn’t give up on you. I felt that she didn’t give up on me on 
the surface, but maybe psychologically she still… Because previously 
she had warned me to not be gay.” (P2, MSM, 32y) 
“After I told my family about my HIV status, they kicked me out of the 
house. Then I rented a shared flat outside. During that period of time, I 
often forgot my medications because I was living sinfully and kept 
dwelling on negative thoughts.” (P7, MSM, 30y) 
Stigma is viewed as a moral issue by anthropologists, in which stigmatised 
condition could threaten what matters for affected individuals and intensify 
the sense that life is not certain and is dangerous (Yang et al., 2007). In the 
case of HIV, the cultural images of HIV connect the social values into an 
affected individual’s inner world of feelings (e.g. shame) and physical 
experience (e.g. loss of social position and ostracisation) (Yang et al., 2007). 
In that regard, stigma is emergent not only as responses of psychological 
defence but in the moral and existential experience that an individual is 
threatened.  
Participants who perceived themselves negatively were inclined to lose their 
sense of self with HIV (inwardly), which further impacted their engagement 
with HAART taking (outwardly). Commenting on this, some participants 
stated that HAART reminded them of their HIV status. By linking HAART with 
HIV, their lack of self-acceptance of HIV status exerted a negative influence 
on participants’ engagement with HAART taking.     
“I felt ashamed of myself and avoided the crowd, starting to lose the 
sense of myself…Cocktail treatment is equated with HIV. It is the same 
thing. Most people wouldn’t reveal what they are taking. I rarely saw 




wouldn’t reveal they were taking the treatment. They wanted to save 
face. It’s common in the Taiwanese society.”(P7, MSM, 30y) 
“They [medications] reminded me that I had problems in my body. This 
would affect my regular use of medications. I think that you may have 
heard other people viewed the treatment negatively and had many 
negative emotions. It just reminded me that I have HIV.” (P12, MSM, 
35y) 
In participants’ accounts presented above, they avoided or irregularly took 
HAART regimens in an attempt to ‘save face’ and keep painful or undesirable 
emotions towards HIV out of mind. P7’s mention of saving face means 
preserving one’s dignity. Being HIV-positive was perceived shamefully by 
many participants. Their perceived stigma related to living with HIV had 
decreased their willingness to take HAART medications openly so as to avoid 
stigmatisation and preserve their dignity in the Taiwanese society. This 
evidence resonates with the notion proposed by Scambler (2008) where “the 
discreditable” attempted to “pass as normal” to avoid stigmatisation. 
In addition, the visible or publicly known signs can also lead to the risk of 
stigmatisation, which is called “the discredited” by Scambler (2008). It was 
evident in the data below that the appearance of HAART medications and 
side effect of HAART on user’s body image were perceived as symbolic of 
HIV. In such conditions, Goffman (1963) called it as physical stigma where 
physical signs of stigmatised conditions are present and visible to others. 
When taking HAART regimens in public, some were concerned about the 
possibility of their HIV identity being discovered. Their perceived stigma 
related to HIV and non-integration of HIV identity into part of self-identity was 
revealed within the data to undermine their willingness to regularly take 
medications or refill medications. 
“When I was working in [xxx], I was afraid that people would see my 
pills. Thus, I didn’t take the medications most of the time. I felt 




Many people rather decided to not take the treatment.” (P5, Male 
heterosexual, 45y) 
“The medications looked distinct. I cannot do it. If taking them in public, it 
is hard to explain.” (P13, MSM, 31y)    
“I cannot take them outside. I just cannot do that. Really.These are not 
like other medications. They look really different from medications for 
other chronic diseases. Also, if we can refill the medications in 
pharmacies, I don’t think I have the courage to refill them there other than 
hospitals. I just feel weird. I will try to avoid [implicit meaning in Mandarin: 
avoid the possibility of being discovered.]” (P15, Male heterosexual, 53y) 
Participants’ statements presented below illustrated that by experiencing a 
change in appearance and losing weight due to side effects of HAART, it had 
made their HIV identity more visible, intensified their perceived stigma and 
vulnerability, hindered social interactions, contributing to intentionally 
skipping doses. Their experiences of side effects were reported to be more 
likely to occur at the beginning of taking a new regimen.  
“At the first or second month of taking the medications, I really wanted 
to stop taking the medications. I was experiencing some symptoms, 
inability to concentrate, dizziness, diarrhoea, and vomiting. These 
symptoms made me want to stop the treatment. At work, these caused 
me trouble. I had to stop my work and rushed to the toilet because of 
onset of diarrhoea. My colleagues thought I was weird. They thought I 
might take drugs so I looked abnormal. It’s impossible for me to tell 
them I am HIV positive. At that time, I had treatment interruption for 3 
months…Then the HIV specialist called me back. I started to continue 
the treatment. This is my second regimen. Again, when I just started, I 
experienced similar side effects as the first one. It lasted for a month, 
and then my body adapted to the regimen afterwards.” (P14, MSM, 36y)   
“It’s unnecessary to take these harmful medications. I was really against 




started the treatment, I lost a lot of weights. Before then I was 58kg. I 
thought I might add more fat to my body. Who knew that after taking it I 
would lose weight?! I really cared about losing weight, and this had 
influenced my medication taking.” (P4, MSM, 26y). 
By and large, it seems that perceived stigma related to HIV infection and 
feeling of shame carrying HIV status can decrease individuals’ sense of self 
and their readiness and willingness to accept treatment and take it publicly. 
Additionally, the distinctive appearance of HAART and its effects on 
participants’ body image is also a source of stigma. With visible body signs, it 
intensified some participants’ feeling of shame and self-stigma, and feeling of 
vulnerability when interacting with other people. Such collective disruptions 
had negatively influenced many participants’ medication taking, leading to 
treatment interruption.   
6.2.2.1.2. Non-disclosure of HIV status 
The previous sections have discussed the impact of social values on 
participants’ emotion and interpretation of HIV. With this in mind, it implies 
that participants’ emotion and perception could be viewed as interactional 
rather than just individual, which tied them into a social context (Yang et al., 
2007). Living in the Taiwanese society where the image of HIV is negatively 
portrayed, most participants felt afraid and insecure to disclose their HIV 
status. This imposed limitations on them and created a barrier between self 
and others. As a result, not disclosing HIV increased participants’ emotional 
burden and negatively affected their management of HIV and HAART taking.  
 “I don’t know. It’s just not good. It is a shameful disease. I don’t want to 
let my dad know. I just don’t want to let him know. ” (P16, Male 
heterosexual, 42y) 
“Once my HIV was confirmed, I was anxious and wouldn’t dare to tell 
my family. I secretly took it. Because I am an adult, I should take the 




As discussed in Chapter 3, ‘identity’ is developed through self-construction of 
meanings and that self-meanings are influenced by social values (Goffman, 
1963, Stryker and Burke, 2000). The link between one’s self-identity and 
behaviour is bridged through the shared meanings (Stryker and Burke, 
2000). The notions are coherent with participants’ stories in which their act of 
not disclosing their HIV status was linked to the meanings they constructed 
within the Taiwanese society. Two reasons emerged from the analysis, 
illustrating their concerns regarding non-disclosure of their HIV status — 
maintaining relationships and defending self from social threats.   
“I was afraid people would view me differently. I wouldn’t dare to tell my 
family. ” (P12, MSM, 35y) 
“Now it is a chronic illness, but you have the virus. You find it hard to 
confess. Actually, it is really hard. At the beginning of the relationship, I 
couldn’t disclose. Because after I decided to disclose, they [his previous 
partners] left. Most of them chose to leave. Usually, there was no happy 
ending.” (P9, MSM, 35y) 
The recurrent sub-category, non-disclosure, in the interviews conveyed a 
sense amongst participants that they wanted to maintain secrecy to avoid 
negative evaluation and hurt feelings. Aside from the fear of discrimination, 
the excerpt, “Most of them chose to leave. Usually, there was no happy 
ending.” from P9 indicated that his previous experience of being rejected 
seemed to intensify his negative perception of HIV and affected how he 
handled situations relating to HIV disclosure. Not only can other’s reaction 
towards the identity claims influence the affected individual’s acts, but also 
whether HIV positive identity is incorporated into sense of self can (Stryker 
and Burke, 2000). In ‘fear’ of people’s discovery of HIV status and/or 
negative reactions, many tended to avoid such potential risk by not taking 




“Not many people would take the medications openly. To me, I cannot 
do it. I will try to avoid the risk. I’ve never taken my medications 
outside.” (P1, MSM, 28y) 
“People don’t know my condition and I need to conceal. I just don’t want 
to explain what medications I am taking to others.” (P18, Female 
heterosexual, 32y) 
In short, by not disclosing HIV status to significant others, it seemed to have 
brought additional stress to participants and increase the challenge of 
building confidence to manage HIV and HAART.  
6.2.2.2. Integrated self-identity  
During the process of narrative re-construction, participants’ integration of 
HIV identity into their sense of self has assisted them in viewing their HIV 
status more positively and/or in being more resilient. It also appeared to 
enable them to be more motivated and willing to face and manage HIV and 
HAART. Three key aspects were identified to help participants to develop 
their integrated identity: Accepting HIV status, selective disclosure of HIV 
status, and feeling supported.   
6.2.2.2.1. Accepting HIV status 
In face of living with HIV and HAART, it seems understandable that 
participants could develop negative emotions and might not fully accept their 
new HIV positive status. It is evident from the data that self-acceptance is an 
active process that involves participants’ readiness and willingness to 
experience and face their HIV and emotions towards it, and incorporate it into 
their identity. Congruently, Pierce (2003) contends that psychological aspects 
of ownership can play a dominant role in owner’s identity. The growth of 
psychological ownership provides positive and uplifting effects and facilitates 
a close connection between the individual self and the object experienced 
(Pierce et al., 2003). In this study, many took time to adjust their emotions 
towards HIV and to accept the new HIV status. Data presented below show 




“I started to use drugs when I was the 20s. At that time, I wasn’t mature 
enough. I didn’t know how to protect myself. So now I had this 
irremovable label with me, HIV…Upon diagnosis of HIV, I had low self-
esteem. I had negative and self-destructive thoughts. I thought that why 
my life was so awful. I started to live my life in a self-destructive way. 
But it was the beginning. At that time, I was using MDMA. Then After I 
used amphetamine, I started to see through my life with HIV. Because 
amphetamine sensitised my sensations, it let me see myself and the 
surroundings clearly. Then I got to face HIV and accept it.” [Later in the 
interview, he stated] “In the past, when I used MDMA, I felt happy. 
That’s why I kept using it. Then when I used amphetamine, I only used 
a small amount of it with my friends. It gave me a pleasurable 
sensation, making me feel great being with sex partners. I couldn’t stay 
away from the drug dependence. To quit it, I decided to use a large 
amount of it, making myself feel unhappy. Then I developed 
hallucinations and behaved weirdly. Whenever I wanted to use it, I used 
a lot, making myself feel unhappy…It was hard and suffering. I had a 
fight with myself internally every day. In the end, I quit it by forcing 
myself to engage with external stimuli. Now I really cherish what is 
surrounding me. Getting on a train and listening to people’s chats and 
voices…It took me 7-8 months to quit drugs, get back to normal 
lifestyle, and let my viral load be undetectable.” (P7, MSM, 30y) 
“[When asking him about how he comes to terms with his HIV status, he 
said] I have gone through everything. It’s important to be positive. In this 
journey, my family was there. And partners. But I didn’t really value 
partners. I think it still depends on self. Even though they were there for 
me I could still fall apart. ” (P4, MSM, 26y) 
P7’s account presented above indicated that at the beginning of HIV 
trajectory he perceived the new HIV-positive status negatively, and such 
negative thoughts and emotions influenced how he managed his life with 




facilitated his development of values of living with HIV, and determine his 
subsequent acts of quitting drugs and optimising health outcomes. In light of 
P4’s account, his self-acceptance of being HIV positive also appeared to 
involve process and his experiential learning. Through self-reflecting on his 
own HIV journey and finding meanings attached to his life with HIV, he was 
able to move forward. These views give agency to the individuals where 
individuals’ acceptance of a new identity relies on the integration of their past, 
present and into future of the self that provides meanings and purposes 
(Williams, 1984). Individuals with coherent identity are more likely to perform 
a behaviour that can repair the discrepancy by altering the situation or 
creating a new situation (Stryker and Burke, 2000).  
While some needed time to adjust and adapt to new HIV identity, there were 
a few who accepted their HIV status upon the diagnosis.  
“I always used amphetamine while not wearing condoms. From the very 
beginning, I was already mentally prepared for it. Since I started to use 
it, I have known that I cannot quit using amphetamine. Moreover, I 
thought HIV is just a chronic illness. I didn’t have much reaction. I was 
prepared for it, and thus I felt fine. I think the sickness is not in people’s 
HIV itself but in their psychological part.” (P21, MSM, 35y) 
“Psychologically, HIV doesn’t affect me. I already knew that getting HIV 
was unavoidable if I kept engaging in drugs and sex. Of course, I didn’t 
want to get it. But when I lied on the bed, I have already accepted it.” 
(P3, MSM, 37y) 
“After I broke up with my boyfriend, I started to engage in promiscuity. I 
wasn’t surprised that I got HIV. I loved bareback [sex without the use of 
condoms]. I wasn’t surprised.” (P6, MSM, 52y)  
Participants’ self-acceptance conveyed a sense that they accepted the fact of 
being HIV positive rather than trying to deny or disown it. The narratives 
showed above, “I was mentally prepared for it” (P21, MSM, 35y), “I wasn’t 




knew that getting HIV was unavoidable” (P3, MSM, 37y), illustrated that they 
acknowledged the possibility of getting HIV through risky sexual practices. 
Their acknowledgement and emotional acceptance prepared them to accept 
their HIV status. Data also revealed that unprotected chemsex involved not 
only negative consequences (e.g. HIV transmission) but benefit outcomes 
(e.g. sensation stimulation). Participants’ sensation seeking increased their 
engagement with unprotected chemsex without regard to potential negative 
consequences.  
On the other hand, participants who were in denial of HIV status appeared to 
less expect their chance of getting HIV (Section 6.2.1.2.1.). P3’s statement 
—“ of course I didn’t want to get it, whereas I have accepted it” indicated that 
regardless of whether he found HIV pleasant or not his self-acceptance 
means accepting the true reality of being HIV positive. Whilst such reality 
cannot be changed, the data presented below show that P19 and P22 were 
able to accept HIV status which they might dislike, and to live with it with a 
positive attitude.  
“In the past, it was called a black disease, but now it is a chronic 
disease. Compared to cancer patients, who know they will die first or 
us. This is the fact which cannot be changed. Rather than being 
depressed, I would rather happily lead my life.” (P19, Male 
heterosexual, 43y) 
“It’s about our psychological part. In the past, people called it a black 
disease. Years later, it is now just a chronic disease. Living with it and 
letting it be part of me. (P22, Male heterosexual, 52y) 
The findings are congruent with Karnilowicz’s (2010) notion that the new 
identity is integrated into one’s sense of self when it is orchestrated in one’s 
own way rather than motivated by external forces. By accepting the emotions 
towards their HIV identity, some participants were able to put themselves in a 
position where they can balance their negative emotions with positive ones 




“Now I feel happy. I have changed my thought, thinking that if I wasn’t 
infected with HIV, I could not have quit drugs.” (P19, Male heterosexual, 
43y) 
“The scar will be there with you for the rest of your life. It depends on 
how you view it. If I think it is a scar on my face, I wouldn’t get along 
with it well. If I think it is part of my body, I would try to make it pretty or 
cover it up. It depends on yourself.” (P13, MSM, 31y) 
Participant 13 used ‘scar’ as an example to describe the perceived negative 
label of his HIV-positive identity. His self-acceptance did not mean he liked 
what was happening but once he gave up the resistance and denial, he took 
the energy he was struggling and used it to manage HIV illness more wisely. 
His positive thinking and emotion adjustment seems to have turned the 
discrediting HIV illness into his strength. Congruently, Kralik et al. (2004) in 
his article on self-management of chronic illness maintained the importance 
of intellectualising the condition in order to alleviate anxiety, reconfigure daily 
life, and reconstruct self-identity. P19’s and P13’s’ statements— “Now I feel 
happy” and “it is part of my body” indicate that by incorporating HIV identity 
into a sense of self they could recognise their value as a person and be 
happy being the persons they were, regardless of the HIV-related stigma. On 
one hand, data presented above provide an important insight into the impact 
of transition in cognitive thinking on emotion adjustment. On the other hand, 
by acknowledging and accepting emotions and realities, they also appeared 
to be more likely to accept the truth and think more rationally.  
As a result of the integrated identity, participants were less likely to always 
emotionally dwell on the past and be more willing to advance forward and 
regularly take HAART.  
“I already knew that HIV is a chronic illness a long time ago, which 
means that I should regularly take the medications. When I felt I was 




“I don’t know how I am feeling better. But I am just feeling better. It 
depends on whether a person wants health or not. Being healthy so that 
I am able to do many things.” (P22, Male heterosexual, 50y) 
“Now I am more proactive when it comes to dealing with things. In the 
past, when using heroin, I was very laid back. Now my life is changed. I 
think life shouldn’t be like that. I lead my life proactively. To regularly 
take the treatment, I need to face it and proactively deal with it. Not 
harm myself and avoid things.” (P20, Female heterosexual, 36y) 
In short, instead of avoiding, self-acceptance appeared to provide 
participants with a chance to learn from the experience of living with HIV and 
HAART. In turn, it also enabled them to grow in its management and to 
integrate it into life.  
6.2.2.2.2. Selective disclosure of HIV status 
Self-acceptance and emotional stability have potentially strong psychological 
and behavioural effects, as a result of self-control, self-enhancing, invested 
efforts and social approval (Pierce et al., 2003). With such feelings of 
ownership, it can assist individuals in defining or re-defining themselves and 
expressing their self-identity to others. Within the data, it showed that 
participants’ attempts to reveal HIV status could be the sign of seeking help 
and support. Such self-enhancing and seeking social approval could be 
viewed as self-identification.  
“I told my mum because I couldn’t take it anymore. Then my mum knew 
it.” (P13, MSM, 31y) 
“I was really down. I told my family that I was under arrest and had 
committed many crimes. I was also sick [HIV].” (P20, Female 
heterosexual, 36y) 
 “I was pregnant, and thus I needed to tell him. He accompanied me to 
the hospital and accepted my HIV status. He doesn’t have HIV.” (P10, 




The excerpts from P13, P10 and P20, “I couldn’t take it anymore”, and “I 
needed to tell him”, reflect that they were able to communicate the issue with 
their significant others in an attempt to share the burden and gain support. 
With the support from the significant others, it seems to enhance participants’ 
sense of self and self-acceptance. 
“I am glad that I didn’t have a fight with my family for too long. I thought 
why I previously made a lot of efforts to hide my HIV status. I feel 
thankful that my parents accept me. Although the situation wasn’t good 
by the time they just knew my HIV status, I am happy with the result 
now. I feel being in this family is good.” (P12, MSM, 35y) 
In line with P12’s experience, P7 had experienced family’s rejection at the 
beginning of HIV and HAART trajectory. Nonetheless, such negative reaction 
from significant others did not last; rather their families got to accept and 
support him afterwards.  
“I told my family about this [HIV]. They accepted it. They all knew my 
conditions. They also knew I used amphetamine and how much I used.  
They all knew. They were really angry at the beginning. But now they 
are fine and happy about my current conditions and forget about my 
past wrongdoings…At the beginning, me and my family were like 
enemies to each other. Now we are like friends. This is family.” (P7, 
MSM, 30y)  
The data presented so far provided an insight that participants’ disclosure of 
HIV could increase their chance of obtaining support and maximising their 
support resources, though they might experience stigmatisation at some 
points. By contrast, as discussed in the previous sections of this chapter, 
without disclosing their HIV status, some encountered the difficulty of 
handling HIV, HAART and illicit drug use, thereby they found it hard to 
manage overpowering emotions towards difficult situations, and experienced 




Being accepted and supported by significant others may not always be the 
case following disclosure. However, some participants strategically disclosed 
their HIV status to particular people who they trusted and were able to gain 
support from them. Based on the data, two discrete factors were taken into 
consideration by participants when disclosing their HIV status— the persons 
they disclosed it to, and how they disclosed HIV. The persons they chose to 
reveal their HIV status were often the ones they were close to and were less 
likely to discriminate them. 
“My aunt is open-minded. I feel thankful that I have my aunt. I was 
raised by my grandmother. When I just learned my HIV status, I didn’t 
have the courage to tell my grandmother. Instead, I told my aunt…She 
didn’t blame me. After telling her, I can openly be myself as an HIV-
positive gay man.” (P1, MSM, 28y) 
“You cannot be too open to your colleagues. Be nice to them, but I still 
keep my privacy. Maybe people will talk about my HIV and gossip.” 
(P09, MSM, 35y) 
The way participants strategically disclosed their HIV status optimised their 
chance of being accepted by significant others.  
“I would chat with him first and then educate him about the correct 
knowledge of HIV.  At the very beginning of hearing the word, HIV, his 
reactions were against it. Then I told him that not all of the HIV-positive 
people contracted HIV by promiscuity. The transmission route of HIV 
can be through blood.  I kept educating him. Then, in the end, I told him 
I am HIV positive. His reactions changed from feeling uncomfortable to 
feeling fine with this illness.” (P10, Female heterosexual, 33y) 
“I told them that I haven’t got a cold for two years, and they said oh yes. 
I used this method to let them accept. I educated them to view HAART 
as medications for treating a cold, not letting me get a cold. My parents 




Participants’ adaptation is, in part, a function of self-identity, in which 
individuals attempt to create and maintain their sense of self by altering the 
situation that helps infuse roles with personal meanings (Stryker and Burke, 
2000, Pierce et al., 2003). This is exemplified by P1’s narratives— “After 
telling her, I can openly be myself as HIV-positive gay man”— presented 
above. P1 was able to create positive change by disclosing his HIV status to 
his trusted aunt, contributing to enhancing his sense of self as an HIV-
positive gay man.  
According to participants’ statements, after disclosing HIV status to someone 
trusted and being supported, participants were more likely to feel at ease and 
secure when managing HAART use. 
“Now my partner and my friends already knew my HIV status. I don’t 
need to hide, and thus I am not afraid… I sometimes asked my partners 
and close friends to remind me of taking the medications.”  (P10, 
Female heterosexual, 33y) 
“When I told my sister about my condition, she was very considerate, 
gave me support. This medication can cause me to feel dizzy. With their 
support, I don't need to make excuses for why I am dizzy.” (P21, MSM, 
35y) 
In summary, participants’ strategic disclosure of HIV-positive identity to 
significant others appeared to open up an opportunity for gaining support and 
reduce the possibility of being rejected. In turn, such disclosure also 
decreased their levels of stress and anxiety that might overwhelm them, 
enhanced their internal strength to self-acceptance, and facilitated their ability 
to manage HIV and HAART. 
6.2.2.2.3. Feeling supported  
As discussed in the Section 6.2.1.4., “looking to outside people” should not 
be viewed as the only source of support. Participants also needed to become 
the source of support themselves. With the feelings of being loved, valued, 




develop a sense of self-esteem, self-respect, and self-identity. That is what it 
means feeling supported in this study.  
 “When I saw my mum’s full support. I knew that my mum loves me. My 
mum’s boyfriend also treats me like his son. It makes me feel like at 
home. Although I am not perfect and I used drugs, after quitting drugs, I 
want to enjoy living at home. For my family, I want to do well. I want to 
live. If I don’t regularly take medications and then get sick, they will be 
sad. I want to take care of myself. Let them see that I am good and 
happy.” (P13, MSM, 31y) 
“During this process, the HIV specialist always encourages me. I can 
feel the support. I feel thankful. I will bravely keep moving on. I need to 
take the responsibility of my life. Although it is painful to have HIV, this 
medical team is my only motivator to move forward.” (P2, MSM, 32y) 
The participants’ narratives presented above illustrated that their feeling of 
being loved and cared by family and health professionals enabled them to 
feel and think that they mattered, thus increasing their motivation to get well. 
In its fundamental sense, data revealed that feeling supported could also 
provide a sense of connectedness to others—to family, to friends, and to the 
community.  
“In this association, they accept me. It’s like there is no distance and 
gap between us. Here they all know I am HIV positive. I can reveal my 
HIV status in front of them.” (P8, Male heterosexual, 49y)  
“Our family is quite close. I initially only told my sister. Then later on my 
family started to discuss how to help me to go through it. They took me 
to a hospital for refilling the medications without showing their worries.” 
(P14, MSM, 36y) 
In light of the sense of connectedness, it is evident within data that 
participants who felt supported were more inclined to think that there was a 




respected, and where they were able to get help to work out any problems. 
Stryker and Burke (2000) proposed that the relationship and connectedness 
with others can enhance the incorporation of the salience of an identity into 
the self and provoked the behaviour choices in accordance with the 
expectation attached to that identity. The excerpts presented below— “You 
know how I know.that’s when feeling secure…” and “I can see…I feel 
thankful..” conveyed P12’s and P13’s sense of connectedness with others 
and such feelings facilitated incorporating HIV-positive identity into their 
sense of self and subsequent HAART taking. 
“You know how I know they started to accept me [family]?! That’s when 
they remind me to take medications. It was a big encouragement. They 
want me to live.” [Later he also stated] “Not only my family know my HIV 
status, but also my colleagues do. I want to stay in this company for the 
rest of my life. Do you know when people will settle down? That’s when 
feeling secure, and then they will settle down.” (P12, MSM, 35) 
 “The HIV specialist’s support has positively impacted my medication 
taking. Every time I came to the hospital, I would visit the HIV specialist. 
I would mindfully tell myself to visit her. Because I can see how hard 
she tries to assist us in taking medications. I feel thankful.” (P3, MSM, 
37y) 
With the feelings of being respected and cared for, it helped participants to 
enhance their self-esteem and sense of purpose in life. It is exemplified by 
participants’ stories: 
“I started to use drugs after I got HIV. Previously, I was controlled by 
amphetamine. My thoughts were very extreme. I was fighting with my 
boyfriend all the time. I even carried a knife to scare my boyfriend’s 
family. I ran away from my boyfriend’s place and called my dad that I 
wanted to die. My dad called police and tried to find where I was living. 
They found me in a hotel. I was naked at that time, and kept saying that 




screaming and destroying hospital’s stuff. I was put in a security room. I 
didn’t have that part of memory. My mum told me I was using diapers at 
that time. My dad even helped me to change my diapers. My mum said 
my dad cried a lot [sobbing].” [Later he added] “When only me dealt 
with the situation, I was very negative. Thinking that HIV is not curable 
and why I should take medications. I would rather just enjoy my life do 
whatever I wanted. That’s why I started to use drugs. After my family 
knew my situation, they made me not have negative thoughts and not 
have the thought that my life is meaningless.” (P11, MSM, 31y)  
 “This wife is the one I get married recently. She accepts me. My life 
has been changed and she can see it and was willing to marry me.” 
(P8, Male heterosexual, 49y) 
When it comes to enhancing ‘sense of self-esteem’ and ‘sense of self’, these 
seemed subtle when looking at the data, but it can be felt when deeply 
engaging with the data. P13 and P8’s statements, ‘they treat me well’ and 
‘they accept me’, and P11’s heartfelt experience of family’s support (when 
describing how his family helped him to go through the process, he was 
sobbing), were in a sense that they could feel they were being cared, 
accepted, and respected. With more strongly committed identity, an 
individual’s ability to perform well was greater (Stryker and Burke, 2000). This 
is evidenced in the excerpts from P8 and P13— “My life has been changed”, 
“I want to do well”, and “I want to live”, which conveyed their positive feelings 
of living in this world and their life aspiration.  
As with feeling supported by family and health professionals, a personal 
relationship with God was stated by some participants to provide a source of 
comfort in their troubled times, as well as a foundation for feeling 
unconditionally valued, loved and cared for.  
“In the past, I believed in Taoism. I couldn’t accept Jesus. After I went to 
rehab, I got a chance to read the Bible. A pastor also came to deliver 




spirit.].  I got to realise that why previous me always harmed myself. 
Love isn’t supposed to be like that. In Christianity, I got to realise that, 
especially as I feel accepted, wow, it is phenomenal. Without God’s 
mercy and grace, I don’t think I can move on. I feel thankful.” (P8, Male 
heterosexual, 49y)  
“I have lost so many things, and I got HIV. I didn’t know how long I 
could live. I felt resistant to accepting the realities. Then one time one 
pastor came visit me and delivered messages which were very 
touching. I started to take his class. This pastor was always there to be 
with me. We weren’t family but he didn’t charge me for the class fee, 
gave me food and a place to stay. It is faith, sense of belonging. I have 
done so many wrong things [Earlier in the interview, he stated he has 
done “cheating, robbery, killing and stealing”], and now it is the 
opportunity for me to change and live in a different kind of life and at a 
different stage of life. Faith gives me a sense of belonging.” (P19, Male 
heterosexual, 43y)   
Based on participants’ statements below, not only faith provided them with a 
sense of security and belonging, but it gave them peace and calm, and 
helped them to find hope, meaning and purpose in life and at difficult times. 
The positive impact of religious support on participants’ inner part seemed to 
have helped them to re-establish their value and belief system and 
strengthen their will to live meaningfully 
“Now I am calmer. In the past, I couldn’t be calm. I was very impulsive. I 
don’t know why I feel peace and calm after I was baptised. Then I 
started to take the cocktail treatment. [In the interview, he talked about 
his background] “Going back to my previous path would involve illicit 
drugs, gunshots, stealing, and killing. This kind of path…Our family is 
different and not like a normal family. Our family is a gangster family. 
When having a family gathering, there would be me and many of my 




“In prison, I wanted to kill myself and there was no hope. It was a really 
low moment for me. However, there I found God. It was like changing 
from feeling of desperation to feeling of hopefulness. I had 
hallucinations at that time, but after praying for 6 months they were all 
gone. It was like God’s love touched me. He forgave me and redeemed 
my sins. When I was released from jail, I forgot I have a husband 
because of my full enjoyment of being loved by God. My family told me 
if I wanted to see my husband. He was at the prison at that time. I said 
oh my. Then I started to write him letters and pray for him. One time I 
studied Bible and saw God’s Word—What God has joined together let 
no one separate. I felt God didn’t want me to give him up. Then after he 
was out of jail I told him I am HIV positive and asked if he still wanted to 
be with me? He chose to be with me. [Field note: Both of them are in 
sobriety now and remain in marriage]” (P20, Female heterosexual, 36y)   
“People need religious faith. I told one of my friends who I have known 
for 8 years while I was still using drugs. He took me to a church. We 
sang at the church. It made me realise the importance of not fearing 
stepping outside the drug circle and the importance of interacting with 
people. This faith has greatly influence my regular use of medications.” 
(P4, MSM, 26y) 
As a consequence, participants’ statements presented above— “If I don’t 
regularly take medications and then get sick, they will be sad. I want to take 
care of myself. Let them see that I am good and happy” (P13, MSM, 31y), 
“That’s when they remind me to take medications. It was a big 
encouragement. They want me to live” (P12, MSM, 35y), and “This faith has 
greatly influence my regular use of medications” (P4, MSM, 26y) illustrated 
that by feeling supported and finding meaning in life it seemed to motivate 
them and facilitate their willingness to face HIV and manage HAART.  
Taken together, the findings reflect that individuals’ feelings of being 




in the emergence of self-acceptance and management of illness 
(Karnilowicz, 2010).   
6.3. Discussion 
This study showed that during the HIV trajectory, social stigma related to HIV 
and its impact on support system in the society (external influences) 
undermined participants’ emotions and disrupted their self-identity 
reconstruction.  
Drawing on the literature review in Chapter 4, stigma was the predominant 
theme identified from the included studies conducted in Canada, USA, 
Ukraine, Russia and India  (Batchelder et al., 2013, Chakrapani et al., 2014, 
McNeil et al., 2017, Mimiaga et al., 2010, Rhodes and Sarang, 2012, Small et 
al., 2009, Ware et al., 2005). This implies that HIV-related stigma does not 
only occur in the developing countries but developed countries. In the same 
vein, in this study, participants lived in the Taiwanese society where HIV-
related stigma is prevalent, making it increasingly difficult to cope with HIV 
and HAART. Subsequently, many had developed negative emotions upon 
HIV diagnosis. Crawford’s meta-analysis (1996) indicated that the degree of 
stigma related to HIV is higher compared to the degree of stigma related to 
other health conditions, such as cancer, hepatitis, and leukaemia. Though 
other health conditions can be acute or lethal, yet those may not create the 
level of stigma as high as HIV does (Crawford, 1996). Drawing on the data, 
this can be explained by the association of HIV with other stigmatising 
attributes, such as drug use and homosexuality. Issues relating to its moral 
aspects seem to have made it more challenging to eliminate HIV-related 
stigma, gain support and integrate HIV positive identity into self-identity.  
The impact of HIV-related stigma on HIV-positive individuals’ psychological 
well-being and adherence to HAART has been documented in the systematic 
review by Katz et al. (2013). Comparing the general HIV population with HIV-
positive drug users, the difference lies in the fact that drug users not only 




drug users in this study tended to experience emotional difficulties, and avoid 
facing HIV as part of themselves by heavily using illicit drugs, especially 
when they found emotions were too difficult to handle. Their emotions 
towards HIV and perceived meanings attached to it led to biographical 
disruption and influence the process of self-identity re-construction (Bury, 
1982).  
Self-identity is an ongoing constructing process whereby the individual 
develops and forms a sense of self through personal experience and social 
interactions (Karnilowicz, 2010, Stryker and Burke, 2000). The participants’ 
negative self-perception towards HIV appeared to be deeply grounded in 
social values, which could disrupt the integration of HIV-positive identity into 
self-identity. By possessing HIV identity, some felt ashamed of living with it. 
Their feeling of shame had created a barrier to accepting HIV status and 
viewing it as part of the self. In turn, this led to an unwillingness to take 
HAART regimens publicly or disclose HIV status in fear of people’s discovery 
and rejection of them (Section 3.3: discreditable). In addition, participants’ 
concerns over the distinctive appearance of some HAART medications and 
their side effects on change in body image emerged within the analysis to 
also affect their HAART taking (Section 3.3: discredited). Data 
demonstrated that the visible signs that exposed HIV-affected participants to 
the risk of stigmatisation even intensified their fear and perceived stigma.  
On the other hand, accepting HIV status, selective disclosure, and feeling 
supported were revealed to facilitate keeping participants’ emotions in control 
and integrating HIV-positive identity into sense of self. Participants with a 
coherent sense of self appeared to think more rationally, and be more 
resilient. Participants’ selective disclosure of HIV status is in a similar manner 
to the concept of “mobilising resources” in Bury’s (1982) biographical 
disruption, which can be viewed as part of self-identity re-construction 
(Stryker and Burke, 2000). This study showed that self-disclosure increased 
the chance of gaining support. Having support at hand and feeling supported 




HAART, and to develop a sense of connectedness to people and the 
environment. With the sense of connectedness, they were inclined to feel 
valued and secure of living in this society and taking HAART regimens. In 
other words, participants’ feeling supported facilitated their adaptation of 
negative emotions, integrating new HIV identity into their sense of self, and 
developing positive thinking towards life with HIV and HAART.  
Participants’ self-identity re-construction involved the process of emotion 
adjustment and transition in thinking. This process required participants to 
integrate the past self into present self and towards the imagined future 
which provides them with a sense of unity and purpose in life (Williams, 
1984). It was evident in this study that the process was not linear but 
dynamic. Some participants accepted their HIV status without going through 
difficult emotions, but others experienced emotional difficulties and felt no 
motivation to live or accepted themselves as HIV positive afterwards. 
Resonate with the findings, it has been proposed by Kralik et al. (2004) that 
individuals’ narrative is in the form of self-management that relies on affected 









CHAPTER SEVEN: VALUES 
ATTACHED TO HAART  
7.1. Introduction 
Developing on the concept of HIV-positive identity as part of self-identity, the 
concept of values attached to HAART emerged as central to participants’ 
HAART-taking behaviour. In this study, the degree to which participants held 
their value of HAART greatly influenced their motivation and engagement 
with HAART taking. Throughout this chapter, the term value, here, refers to 
participants’ deep-seated belief in the importance of regularly taking HAART.  
Value development involves participants’ thoughts and feelings regarding 
HAART taking through the interaction of personal and social experience. 
Despite this concept emerged within the data, so far, there is a paucity of 
literature focusing on the theories relating to values (inner aspect). In 
addition, very little attention has been paid to the role of values in an 
individual’s health behaviour. Therefore, in this chapter, few existing 
theoretical literature is discussed when incorporating literature into findings.  
This chapter begins by laying out the proposed theoretical dimensions of 
participants’ value attached to HAART. Then, it proceeds to discuss how the 
values participants placed on HIV and HAART ignited/undermined their 
HAART-taking. The properties of the concept, values attached to HAART 








Table 8: A summary of values construction 
Concept Category Sub-category 
7.2. Values attached to 
HAART taking 
7.2.1. Lack of values 
attached to HAART taking 
7.2.1.1. Forming negative 
assumptions about HAART 
7.2.1.2. Not perceiving the 
importance/need of and 
disinterest  in regular HAART 
use  
7.2.1.3. Placing values on 
drugs more than HAART 
7.2.2. Developing the 
values of taking HAART 
7.2.2.1. Perceived benefits of 
HAART taking and perceived 
severity of erratic HAART 
use 
7.2.2.2. Having life 
aspirations 
7.2.2.3. Developing the 









7.2. Values attached to HAART  
 
Figure 9: Self-identity re-construction and values attached to HAART taking 
Figure 9 presents that participants’ integration of HIV-positive identity into 
sense of self can lay a foundation for the development of values attached to 
HAART taking. In this study, participants’ experiences of HAART-taking was 
centred around what they valued. The values participants placed on HAART 
was rooted internally and deeply in their belief system, wherein they attached 
meanings and purposes. To understand participants’ experiences of taking 
HAART, it is essential to gain further insight into their values with regards 
what they thought and believed to be important in their lives (cognitive 
thinking) and where their interest laid (tendency and preference). This 
facilitates understanding what drove and directed their HAART taking.      
7.2.1. Lack of values attached to HAART 
From the data, it appeared that developing values of HAART involved 
individuals’ perception of its importance, provoked motivation, cultivated their 
interest in investing time and efforts in it. However, some participants 
appeared to not hold a value of HAART and make it worthwhile doing. The 
key aspects of their lack of values attached to HAART are listed as below: 




importance/need of and disinterest in regular HAART use, and placing values 
on drugs more than HAART.  
7.2.1.1. Forming negative assumptions about HAART  
  
Figure 10: Interplay behind participants’ formation of negative assumptions 
At the initial stage of HIV diagnosis, some participants appeared to not fully 
understand HAART. In need of filling in informational gaps regarding HAART, 
the extracts from participants shows that there was unverified information 
(Figure 10: Unexamined information) circulating in their drug circles and 
few had believed it before starting HAART. In turn, it shaped their opinions 
about HAART.  
“At the first two weeks, I was struggling if I should go seek medical care. 
Because some people told me that there was no need to take the 
medications and without taking medications, HIV could still be 





Lack of knowledge 
and misinterpretation







“Most people are afraid of facing HIV and the treatment and are afraid 
of change. We have heard a lot in our circle that there are many side 
effects of cocktail treatment. Many rumours. The rumours spread 
around in our circle. It made them fear to change and receive treatment. 
Same as them, in the past, I didn’t want to take the treatment because 
of that. I couldn’t make a decision, and thus I kept staying in that circle. 
It wasn’t necessary to take the medications that could harm my body. It 
wasn’t necessary to take such harmful medications” (P4, MSM, 26y) 
“When I saw other people took cocktail treatment in jail, I would think 
they might die soon. I have heard a lot about its side effects in jail. This 
made me afraid of receiving treatment. After taking the treatment, I feel 
fine. Nothing happened.” (P20, Female heterosexual, 36y) 
P4 used the word ‘rumour’ to describe the information that was in circulation 
in their circle of drug friends. P12, P4 and P20’s narratives illustrated that as 
they took the information that they saw and heard into their cognitive 
process, the information was interpreted, and the unexamined information 
formed their negative assumptions about the need for taking HAART. In 
Oxford dictionaries, ‘assumption’ is defined as something that is taken for 
granted and is accepted as true without proof (Oxford dictionaries, 2017). By 
choosing to believe the negatives of HAART, it has heightened the levels of 
P12, P4, P20’s anxiety about receiving HAART (Figure 10: Negative 
emotion towards HAART), and influenced their decision of access to HIV 
care. Participants’ negative assumptions towards the side effects of HAART 
resonate with the concept of perceived barriers, proposed in the HBM, 
wherein an individual’s perception of barriers to health or health behaviour 
can hinder his/her performance (Becker, 1974, Janz and Becker, 1984, 
Rosenstock, 1974a and b). Furthering the notion of perceived barriers, 
Marshall and Biddle’s (2001) and Hall and Rossi’s (2008) meta-analyses of 
examining the effectiveness of the transtheoretical model on examining 
people’s health behaviour showed that at the pre-contemplation stage 




behaviour, consequently influencing their behaviour. Similarly, as shown in 
the data, participant’s negative assumptions of HAART and feelings of 
anxiety tended to occur at the beginning of their HIV trajectory, resulting in 
influencing their decision to take the treatment.   
According to P5 and P14’s narratives shown below, it pointed that the 
unexamined knowledge regarding HAART was widespread in their friend 
circles, which had influenced many of their peers’ decision to receive 
HAART.   
“I have heard many people said that. I don’t know if it is true. They said 
that there is no need to take cocktail treatment. It is fine to keep 
injecting drugs. Injecting drugs can increase CD4 cell count. A lot. Many 
people believed that.” (P5, Male heterosexual, 45y) 
“I have a friend who is HIV positive and a drug user. He doesn’t receive 
anti-HIV treatment. He has used drugs for 30 years. He is HIV positive, 
but he isn’t willing to receive the treatment. In this circle, some people’s 
thoughts are so advancing. I thought how come he can still live such 
long. He never receives treatment. Also, he uses a lot of drugs. 
According to his statements, he has been using a health product from 
his company and this product can give him energy. He said this is the 
key to maintaining health. We were almost influenced by him. It sounds 
magical. Once a day and 4 pills at a time. It might have influenced many 
people.” (P14, MSM, 36y)     
What participants chose to believe played an important part in their 
interpretation of HAART. For example, P4 and P14, at the beginning of HIV 
trajectory, were in denial, avoided their HIV specialist, and used drugs 
(Section 6.2.1.2.1.). Their lack of self-acceptance as being HIV positive, lack 
of knowledge and its emotional impact had influenced their decision-making 
tendency towards the rumours of unfathomable knowledge of HAART. This 




thinking and decision making (Figure 10: Misinterpretation and lack of 
knowledge). 
Participants’ negative assumptions towards HAART were also affected by the 
lack of effective communication with health professionals (Figure 10). Health 
professionals play an important role in educating patients and delivering 
correct information. Nonetheless, few participants brought up their 
unsatisfactory interactions with physicians in which information was not 
communicated as desired.  
“My physician didn’t force me to start the treatment but suggested me to 
take it. At that time I still felt resistant to starting it. Now my CD4 is 
increased to 600. If he told me to take it earlier so that my CD4 cell 
count could increase even more, I would have done so. While my CD4 
is fine, I still prefer to have it higher. Maybe it was because of ineffective 
communication.” [Later in the interview he added] “They didn’t tell me 
more. Maybe because they weren’t taking the medications, they 
wouldn’t think what situations or consequences we might encounter. In 
fact, what we encountered is much more complex and broad. This could 
affect our regular use of the medications. This is how I feel.” [In terms of 
his feeling of resistant, earlier in the interview, I asked him what he 
thought about HAART after the diagnosis of HIV and he said] “Firstly, I 
didn’t completely accept it, secondly, I didn’t completely understand it, 
and thirdly I didn’t want to know it.” (P13, MSM, 31y) 
“I told my physician that I have lost a lot of weight. I asked if it was 
because of the side effects of the medications. He said it was 
impossible and this type of medications didn’t have such a side effect. 
Then I thought why I kept losing weight. I told him and he said it was 
impossible. Then what should I do? I kept losing weight. So I thought if I 
skipped doses for three weeks I might gain weight. But I didn’t gain 
weight after three weeks.” [Field note: After the interview, he told me his 





The excerpt from P13 and P17— “I told him and he said it was impossible” 
and “they wouldn’t think what situations or consequences we might 
encounter” pointed that health professionals did not identify concerns of 
theirs and educate them accordingly. Without the knowledge of HAART, 
participants were less aware of the importance of taking it, in turn, this has 
formed participants’ own interpretation and assumption about the need for 
taking HAART (Figure 10: Negative assumptions). In addition to lack of 
informational support, P13’s extract showed that his emotion was not stable 
at the beginning of HIV trajectory, and he did not want to know HAART. His 
negative emotion and lack of readiness influenced the amount of information 
he could absorb.  
Taken together, it was evident that some participants tended to hold negative 
assumptions towards their HIV status and HAART, especially at the 
beginning of HIV trajectory. Such negative assumptions were revealed to be 
linked to their lack of knowledge and misinterpretation of HAART.  
Participants’ negative emotion and the lack of effective communication with 
health professionals were found to play a mediating role in their processing 
and interpretation of information relating to HAART. Congruently, drawing on 
the empirical evidence discussed in Chapter 4, the results also showed the 
strong linkage between drug users’ level of knowledge relating to HIV and 
HAART and their relationship with health professionals and engagement with 
healthcare (Chakrapani et al., 2014, Pach III et al., 2003, Ware et al., 2005). 
As a result, it was revealed in this study that participants’ negative 
assumptions about HAART negatively influenced their willingness and 
motivation to receive HAART.   
7.2.1.2. Not perceiving the importance/need of and disinterest in regular 
HAART use 
Participants’ lack of knowledge and negative assumptions towards HAART 
appeared to have an impact on their HAART-taking. Nonetheless, data 
suggest that acquisition of knowledge relating to HAART did not necessarily 




values participants placed on HAART appeared to have governed their state 
of motivation and HAART-taking behaviour. Such low levels of values of 
regular HAART use was shaped by the degree to which participants believed 
in the importance of regular HAART use. This notion is gradually unpacked 
throughout the section. 
 “Sometimes when I was sleepy, I would feel lazy to get up to take 
medications. I thought it was fine to take them next day. It doesn’t 
happen frequently, less than 3 times a month. I don’t care.” (P6, MSM, 
52y)  
“I had treatment interruption because I was laid back. Hence I didn’t go 
to hospital…Also, at that time my CD4 cell count was fine, at around 
500. I thought it was fine to stop the treatment.” (P16, Male 
heterosexual, 42y)  
P6 has taken antiretroviral medications for 15 years and is a relative adherer 
(Appendix 1), whereas data showed that he intentionally skipped doses 
sometimes. His statements— “it was fine to take them next day” and “I don’t 
care” indicates that skipping doses few times did not concern him. Congruent 
with P6, P16’s statements— “I was laid back”, “CD4 cell count was fine” and 
“it was fine to stop the treatment” showed that his CD4 cell count data, his 
own interpretation of the need for taking HAART, and his laid back led to low 
levels of value attached to HAART taking and treatment interruption for two 
years. In Rokeach’s book (1973), The nature of human values, he contended 
that a value is a belief that involves personal perception of what is true or 
false, good or bad, and desirable or undesirable. In other words, values have 
cognitive, affective, motivational, and behavioural components (Rokeach, 
1973) – A cognition that involves interpretation and develops a conceived 
value (e.g. “I thought it was fine”, P6, MSM, 52y), an affection that provides 
feeling about the object (e.g. “I don’t care”, P6, MSM, 52y), and a behaviour 
that is provoked when the value is activated (e.g. Skipped doses). These 




thinking and feeling the importance of taking HAART, participants were less 
likely to value it and to take HAART regularly.  
Drawing on participants’ narratives, their disinterest in regular HAART use 
conveyed the sense that there was no strong inclination towards taking 
HAART. By not perceiving regular HAART use as important and needed, 
participants were less inclined to invest time and energy in taking HAART. 
P13’s narratives below illustrated that what is in his mind could set the 
direction towards which his motives and interest go.  
“It all depends on personal “心態”. [My note: in Mandarin, its meaning is 
the combination of heart and attitude]. If his “心態” is like it is fine to take 
it later. Then he would miss the dose.” (P13, MSM, 31y) 
“I cannot take it too seriously. Now I have ruined the first line of 
antiretroviral drugs. Now I am using the second line of it. As a human 
being, we would sometimes seize opportunities to not take medications. 
I like to make excuses and take the opportunity of not doing things.  
This time I didn't take pills; then that's fine, I will take it next time. This is 
humanity... If I know this is the last chance, I wouldn't have missed 
doses.” [Earlier in the interview, he said] “There are many temptations. 
When I used drugs and had fun outside, I wouldn’t think of the time and 
my antiretroviral regimens.” (P1, MSM, 28y) 
The word “心態” (Hsin Dai) used by P13 is similar to the meaning of mindset. 
‘心’ means ‘heart’; ‘態’ means ‘attitude’. Taken together, it refers to the 
attitude towards HAART is shaped by ‘deeply valuing’ it. Without having the 
mindset that can facilitate engagement with HAART taking, participants 
appeared to manage HAART in a disinterested manner. The word, “心態”, 
was used by many participants throughout the interviews. Similar to the 
findings, Rokeach (1973) and Grube et al. (1994) described that as opposed 




cognitive system and personality makeup. An attitude is an organisation of 
several beliefs around a specific object, whereas a value is a single belief of 
a very specific kind (Rokeach, 1973).  
Many participants articulated that they quit drugs and regularly took HAART 
because of the value they placed on HAART and subsequent development of 
mindset (Section 7.2.2.3.). On the other hand, participants who did not 
develop the value of regular HAART use were less likely to consistently 
follow medication regimens. It was evident in P1’s narratives illustrating that 
by not perceiving the importance of regularly taking HAART he tended to be 
disinterested in it. Without valuing HAART, he appeared to make excuses for 
not taking it and rationalising his behaviour. As a result, the low level of a 
value he placed on HAART had directed his HAART-taking behaviour by not 
making much effort and time to engage with HAART taking. Instead, P1 
tended to place his value on chemsex more than the treatment (Section 
7.2.1.3.).  
P3 and P15’s narratives presented below showed that a low level of values 
and perceived necessity of regularly taking HAART could be born out of their 
personal experience in relation to their CD4 cell count and viral load. Without 
regularly taking antiretroviral medications, P3’s and P15’s CD4 cell count was 
stable and viral load remained undetectable, and therefore such results 
demotivated them to regularly take HAART. 
“Sometimes I think it is fine to make up for it next day. Because over the 
past few years, my CD4 cell count has been stable. Even though I didn’t 
take the medications for 10 days and then took them again for two days 
then not took them for 4-5 days then took them for 2-3 days again then 
not took them for another week, my viral load was still undetectable. I 
think it should be fine not taking the medications regularly. It becomes 
my excuse.” [Later in the interview he said] “Over these two weeks, I 
haven’t taken the medications regularly. I got laid back. I couldn’t find 




motivation. Now it’s like whenever I remember I would take them.” (P3, 
MSM, 37y) 
“It doesn’t matter. If I don’t take my medications, it is fine. Now my 
health is stable. I would think it’s fine to miss one dose, I can take it next 
day.” [Later in the interview I asked him the impact of not regularly 
taking HAART, and he said] “I don’t know what would happen if I don’t 
regularly take it. But every month I went checking my CD4 cell count 
and viral load. My viral load was undetectable. CD4 cell count was 300-
400. Since I started the treatment, my CD4 never went up to 500 but it 
could be up to 490. Since I started the treatment, it has been around 
300-400. But after I started using drugs again, it dropped to 200. Until 
now my CD 4 has never gone up much. I knew that if we initiated the 
treatment too late, it would be less likely to increase CD4 cell count.” 
(P15, Male heterosexual, 53y) 
To sum up, Rokeach (1973) maintained that values can undergo long-term 
changes, and the behavioural consequences are expected to follow from the 
change in value. In this study, participants’ values appeared to be implicit, 
whereas they could ignite/undermine participants’ motivation and HAART-
taking. Some participants were equipped with knowledge. However, it did not 
seem to matter, if not being interested in investing time and effort in HAART 
taking and not perceiving it as important and needed. In addition, 
participants’ experiences can also re-shape their perception of the need for 
regular HAART use.  
7.2.1.3. Placing values on drugs more than HAART 
The values participants placed on regular HAART use differed amongst 
participants. Illicit drug use was found to influence the values they placed on 
HAART in two ways— Hierarchy of values (personal preference) and the 
impact of drug effects on changing personal values. As discussed in the last 
section, P1 did not place much value on regular HAART use. Rather, his 
narrative shown below was in a sense that whenever he went out and 




“I often went out at midnight for having sex and using drugs. When 
having fun, I wouldn’t think of dosing times. I wouldn’t finish it within 3-5 
hours. In our circle, people who use drugs care about sex. I don’t like 
feeling time pressure. When having fun, we shouldn’t feel pressured. 
Most of the people in our circle spend lots of time involving in sex and 
drugs” (P1, MSM, 28y) 
“When I used drugs and engaged in sex [chemsex], I wouldn’t take the 
medications sometimes. Drugs could keep me alert. I used all my 
energy for the sex, and thus I didn’t regularly take the medications.” 
(P2, MSM, 32y) 
“Some would just crave for that euphoric effect, and constantly inject 
drugs to sustain that kind of feeling…Then would neither care what time 
it was nor notice dosing times” [Later in the interview, when talking 
about drug effects and its impact on access to care, I asked if 
methadone could help to alleviate drug effects and enable her to take 
medications] P18 said “It is very rare. I know that some experienced 
withdrawal symptoms, and then drank methadone to alleviate the 
symptoms. So they could have the energy to find drugs. I’ve even seen 
people who drank methadone and injected heroin at the same time. 
Then became very addicted to heroin and methadone. Then. it would 
be very difficult to quit both drugs.” (P18, female heterosexual, 32y)   
As with P1, P2 also appeared to prioritise chemsex over taking his HAART 
medications. In contrast to P1 and P2, some other MSM participants were 
able to regularly take HAART regimens while engaging in chemsex (Section 
7.2.2.1.). By comparing the two groups, it was revealed that values play a 
key part in guiding the way they looked at HAART and governing their 
HAART-taking behaviour. By valuing life with HIV and HAART, participants 
were more likely to develop their mindset and regain control over their 
HAART- and drug-taking behaviour (Chapter 8). However, in the cases of 
P1, P2 and P18, they tended to place more emphasis on drug use more than 




HAART use. In light of Rokeach’s (1973) notion of values, he proposed that a 
value represents one’s preference. A person could prefer a particular end-
state in comparison with others, leading to value hierarchy. Values can be in 
conflict, and thus when attaining one value, it can block another (Grube et al., 
1994). Such hierarchical order of individual values steered sequences of acts 
(Rokeach, 1973, Schwartz and Bardi, 2001).  
In addition to personal preference and choice, another concern was 
expressed by some participants regarding the effect of drugs on changing 
their perception of the importance of taking HAART. Such change in 
perception was stated by them to influence the values they placed on HAART 
and their engagement with HAART taking.  
“When using a lot of drugs and for a long period of time, we would not 
have self-awareness. We wouldn’t think of whether we needed to 
maintain health. I would feel why I should take the medications.” (P14, 
MSM, 36y) 
“Psychologically, I would feel it didn’t matter whether I had taken the 
medications or not. Using drugs already means not caring about your 
health.” [Later in the interview he added] “Because using drugs could 
distort my values and my worldviews. They were all changed and 
distorted. I wouldn’t care about my health.” (P15, Male heterosexual, 
53y) 
In the discussion of the change in personal values, issues related to shifted 
focus and thought while using drugs was prominent in interview data.  
“It is very rare that we could use drugs while taking cocktail treatment.” 
[Later he added] “Because drugs influenced the way I thought. It was 
like I couldn’t live without drugs. My focus was about money and how I 
could steal and rob to get money. To me, I didn’t even want my parents. 
I could play a game in an attempt to get money from my parents. I could 
also ask my closest girlfriend for money. It is impossible. If you don’t 




was completely controlled by drugs. To be honest, I wasn’t like that 
before I used drugs, and I knew how I should treat people.” (P19, Male 
heterosexual, 43y) 
“It’s really important to know what we are doing, but we don’t know what 
we are doing. It is really horrific. Most people are like that. 
Amphetamine can destroy your life, but the point is we don’t know. Most 
people think they are normal, including me. I thought I was normal, but 
actually, I wasn’t. By using amphetamine, I would think how wonderful it 
was to use it. Then I rationalised my behaviour.” [Later in the interview, 
he stated] “This thing had made me being abnormal. In the past, I could 
control very well and take the medications regularly. After heavily using 
it over the past three months, I was changed and became abnormal. My 
use of medications became erratic, either. As you can see, I haven’t 
refilled the medications for a month.” (P12, MSM, 35y)  
According to P19 and P12’s accounts, it was revealed that the psychoactive 
drugs they used could affect their cognitions, rationalise their drug-taking 
behaviour, and undermining their self-awareness. However, the degree to 
which illicit drugs impacted participants’ cognition and HAART taking 
appeared to depend on their self-control over their drug-using and HAART-
taking behaviours, which is discussed in Chapter 8: Conscious actions. 
Drawing on P19 and P12’s data, it shows that the low levels of values placed 
on HAART taking was influenced by the addictive effects of drugs on their 
cognition and emotion response to external difficulties. P12, for example, 
started to heavily use amphetamine after breaking up with his ex-partner. His 
heavy use of drugs helped him to focus on his work and avoid difficult 
emotions (Section 6.2.1.2.2.). His emotional state and heavy use of drugs 
undermined his cognitive functioning and ability to control his HAART- and 
drug-taking behaviour.  
To sum up, it seems that participants prioritised what was important to them 
based on their beliefs and preferences. When valuing illicit drugs more than 




times. On the other hand, the impact of illicit drug use on participants’ 
cognition and emotion also influenced their values placed on HAART and 
control over drug-taking bad HAART-taking behaviour. 
7.2.2. Developing the values of taking HAART 
Exerting conscious control to override drug-taking behaviour and embrace 
regular HAART use was difficult and challenging for some participants. It 
required their considerable cognitive resources and valuing HAART. The 
value participants placed on HAART was revealed to increase their 
motivation to initiate and/or maintain HAART-taking behaviour. To better 
understand the mechanism of developing the value of HAART taking, three 
subcategories emerged within analysis— perceived benefits of HAART and 
perceived severity of erratic HAART use, having life aspirations, and 
developing the values of taking HAART.    
7.2.2.1. Perceived benefits of HAART taking and perceived severity of 
erratic HAART use 
In Section 7.2.1.1., it has been discussed that some participants tended to 
hold negative assumptions of HAART, and this influenced their perception of 
HAART and subsequent HAART taking. On the other hand, within the data, it 
was revealed that some participants developed the values of HAART taking 
through their perceived benefits of HAART taking and the perceived severity 
of erratic HAART use. In addition, personal experiences emerged in the 
analysis to reinforce these perceptions. 
“HAART can increase my CD4, boost my immune system, and make 
my viral load undetectable. This is a big motivator for me.” (P2, MSM, 
32y) 
“Why I take the medications is that I want to live longer and protect 
others against HIV transmission. This makes me want to continue my 




“It is better to not stop the treatment because it could cause drug 
resistance. If it happened, there won’t be any treatment available for 
me. “ (P4, MSM, 26y) 
Participants’ perception of regular HAART use and its impact on personal 
and partner’s health resonates with “perceived benefits” and “perceived 
severity” in the HBM (Becker, 1974, Janz and Becker, 1984, Rosenstock, 
1974a and b), (Chapter 3). These concepts all convey how an individual’s 
acknowledgement of the benefits and risks of a health condition/treatment 
can influence his/her beliefs and motivation. The examples from P2, P12 and 
P4 illustrated that their acknowledgement of the benefits of taking HAART 
and the risks of erratic HAART use enabled them to see its importance. Of 
particular concern, it was evidenced that some participants were more aware 
of the importance of regular HAART use when perceiving the severity of 
erratic HAART use. With its risks in mind, participants were more inclined to 
be cautious about their HAART taking.  
  “During the time I engaged in a lot of risky sex, I knew I should 
regularly take the medications. I also cared about my diet and tried to 
eat healthily. In the meanwhile, I kept engaging in drugs and sex. I 
couldn’t stop. I knew I shouldn’t indulge in it. But I couldn’t stay away 
from it. I knew I wasn’t in a good condition at that time. Hence, I was 
particularly aware and thus took the antiretroviral medications 
regularly.” (P3, MSM, 37y) 
“As long as they are medications, they are always more harmful than 
beneficial. To me, the benefit of the treatment I can think of is only the 
decrease in viral load. [I probed further that it seemed that you consider 
it is more harmful than beneficial. What motivates you to regularly take 
the medications? And he answered] “I have taken the medications. I 
won’t stop because I am afraid that it might develop drug resistance. If 





“At the beginning of the treatment, I was particularly cautious, because I 
wanted to get better. Even when I was injecting drugs, I would remind 
myself to take the medications.” (P15, Male heterosexual, 53y) 
The examples presented above showed that P3, P4, P15’s heightened level 
of awareness regarding the importance of regular HAART use was due to 
their perceived severity of erratic HAART use, and its impact on their health. 
In the case of P4, although he perceived HAART as more harmful than 
beneficial, he still regularly took HAART due to his concern over drug 
resistance. His perception of the potential risk and loss appeared to 
particularly raise his awareness regarding the importance of regular HAART 
use. In line with P4, P1’s statements presented in Section 6.2.1.2.— “This is 
humanity... If I know this is the last chance, I wouldn't have missed doses”, 
also illustrated that he placed low levels of values on HAART due to his lack 
of awareness and concern about the importance of regular HAART use. The 
findings are in line with the PMT (Section 3.4.1.4.). In this theory, it is 
proposed that one’s perceived threats could increase the probability of 
selecting adaptive responses (Rogers, 1975, Weinstein, 1993). When 
perceiving the threats brought by an object, an individual is more inclined to 
raise the awareness. On the whole, an increase in awareness with regards 
the necessity of regular HAART use seemed to help enhance personal 
values placed on HAART and increase motivation in regularly taking HAART.  
From a temporal perspective, P3 and P15’s narratives showed that they 
tended to regularly take HAART at the early stage of HAART, whereas once 
their viral load was stabilised, their perceived need for regular HAART use 
was diminished (Section 7.2.1.2.). The findings indicated that the value 
participants placed on HAART and its long-term management may not 
always stay the same but tend to be dynamic. Congruently, values are 
viewed by Rokeach (1973) as not completely stable. Instead, value priorities 
can be rearranged as a result of personal experience, society or culture 
(Rokeach, 1973). P14 and P20’s narratives shown below pointed to the 




extended to personal experience and/or health professionals’ delivery of 
education.  
Examples of developing values through personal experience with HAART 
use: 
“I don’t know how come they can live that long without taking the 
treatment. To me, though I was almost influenced by them, I prefer to 
believe what doctors have told me as to the lab data. You can see that 
there is a big difference in viral load between the time I didn’t take the 
treatment and the time I take the treatment now. It means that my 
health is improving. This is the key motivator for me. To me, now I 
believe the treatment.” [At the end of the interview, he added that] 
“Firstly we need to be willing to take the medications, and then we will 
be more likely to regularly take HAART. The key is our internal part. We 
should be willing to take it first.” (P14, MSM, 36y) 
“At the beginning, I was afraid. I didn’t know if this treatment would 
affect me a lot. Then I asked my friend who is HIV positive. I asked this 
friend if I should take the treatment. He said I didn’t need to worry and it 
would be fine. Now I am receiving the treatment. I feel nothing.” [Later 
in the interview, she added] “Every three months we have to go for a 
check-up of viral load and CD4. Every time I could see how much they 
have been improved. My health is getting better. I could feel that this 
treatment is effective. Then I know I can take the treatment.”  (P20, 
female heterosexual, 36y) 
Examples of developing values through health professionals’ delivery of 
education on HAART: 
“The HIV specialist told me a very important concept of the treatment, 
which is why we need to take the medications and how it minimises the 
chance of transmitting the virus to others. Then, I realised how 




“I called the HIV specialist to discuss my experience of side effects of 
the treatment, and she said it is normal and the side effects should 
alleviate within few days. Then really, those side effects were gone after 
few days. And now I am quite used to this regimen.” (P19, Male 
heterosexual, 43y) 
The values that 14 and P20 placed on HAART changed as they learnt and 
experienced. Their positive experience of HAART use and optimal treatment 
outcomes strengthened their beliefs and values relating to HAART. In the 
cases of P12 and P19, at the early stage of HAART trajectory, they appeared 
to lack the knowledge of HAART. Nonetheless, with health professionals’ 
informational support, they developed a better understanding of their HAART 
regimens and came to value HAART and develop competence in tackling 
their regimens.  
Taken together, participants’ engagement with HAART taking were guided by 
how much they valued HAART. Such value creation mechanism appeared to 
involve individuals’ perceived benefits of taking HAART and perceived 
severity of erratic HAART use and through their reflection of personal 
experience. As a result, it assisted some participants in learning, heightening 
their awareness, and informing and guiding their HAART-taking behaviour.  
7.2.2.2. Having life aspirations  
In Chapter 6, it was discussed that some participants’ suicidality influenced 
their engagement with antiretroviral treatment. Their attempted suicide and 
suicidal thoughts were revealed to be due to their emotional distress and low 
levels of value placed on life with HIV. On the other hand, the data presented 
below showed that participants who valued life and had life aspirations 
enhanced their engagement with HAART taking.  These participants alluded 
to the notion that the value they placed on life was linked to their feelings of 
being supported and subsequent development of meanings and purposes in 
life. In that sense, it seemed that how they valued HAART and their life 
aspiration were formed through the interaction between participants and the 




“What keeps me to regularly take medications is my sister. She always 
takes care of me and financially supports me. My parents also care for 
me. They let me live my life without worries. I want to be good. I want to 
do something for them. I have so many things that I want to do but have 
not done yet. I want to live. I want to do something for them.” (P16, 
Male heterosexual, 42y)   
“I take the medications because my thought has been changed. 
Nowadays HIV is not that horrible and also I have a son. I want to live 
longer and see him grow up and have his own family.” (P15, Male 
heterosexual, 53y)  
“I want to live. I don’t want to let my family down.” (P11, MSM, 31y) 
“Basically, I can regularly take the medications because I want to live 
longer and I want to be with my family.” (P13, MSM, 31y) 
Drawing on their narratives, it showed that support from the family had given 
participants hope and aspiration to live, thereby they valued HAART and felt 
motivated to regularly take the medications. In addition to external support 
resources, such value development also needed participants’ internal 
validation, by which it means their deep-seated beliefs in the meaningfulness 
of regular HAART use brought to their life. By the same token, ‘self-
evaluation’ and ‘Forethought’, discussed in social cognitive theory (Section 
3.4.2.2.), provide similar notions of ‘life aspirations’ discussed here (Bandura, 
1991 and 2001). In the theory, self-evaluation of personal standards and 
environmental circumstances, and an individual’s thought about the present 
and foreseeable future were proposed to trigger motivation and change in 
behaviour. P6’s and P8’s extracts presented below illustrate their life 
experience was subjectively evaluated, and subsequently, meanings 
attached to HAART taking and motivation were developed.   
“Previously I volunteer in an association and I have seen people who 
are bed-ridden and cannot look after themselves. I am afraid. I don’t 




treatment I will die. I am afraid of death. I want to live. I want to live.” 
(P6, MSM, 52y) 
“If I want to live, I need to regularly take the medications. Although it is a 
chronic disease, if I don’t regularly take them I will get opportunistic 
infections. I have a friend who had treatment interruption for a while and 
also used drugs. He quickly developed opportunistic infections. I have 
another friend who can’t walk anymore.”  (P8, Male heterosexual, 49y)  
The values that P6 and P8 placed on life with HIV and the necessity of 
regular HAART use enhanced their commitment to regular HAART use so as 
to live longer. Congruently, P12 and P7’s narratives presented below 
illustrated that the values that they placed on HAART were aligned with their 
aspirations of what they wanted their life to be like. The excerpts— “The 
reason why I am taking the medications is to prolong my life… I want to 
pursue my dreams” and “Why I need to live… HIV and cocktail treatment are 
the gifts from God” conveyed not only their perceived importance of HAART 
taking but their aspirations in life.   
“The reason why I am taking the medications is to prolong my life and 
protect others. That’s why I continue my treatment. Nowadays, we can 
live until 70-80 years old. I want to pursue my dreams, like promotion 
and increase in salary. This year my life will be different. I want to help 
others.” (P12, MSM, 35y) 
“I have changed my thoughts and now stay in faith. I mean I modified 
my value. It is hard to modify my own value. I need my family’s support 
and I also need to step into a different environment to feel and 
experience different things and to establish my value. [I asked what the 
value is, and he answered]. “The value is how to define my life. Why I 
need to live. This is the value attached to my life…To me, now HIV and 
cocktail treatment are the gifts from God.  This treatment has pros and 





P12’s narratives showed that his life aspirations enhanced valuing HAART 
and strengthening his will to take it. This implies that values attached to living 
with HIV and HAART can orient an individual’s tendencies and actions. P7’s 
narratives pointed to the notion that changing or modifying his values of life 
with HIV and HAART goes beyond regarding it as important. Rather, P7 was 
able to appreciate its qualities and invest effort on transition in thoughts and 
behaviours.  
In short, with life aspirations, some participants appeared to be driven and 
more determined to create the life that they wanted to live. Their life 
aspirations were revealed to come from their connections with the social 
context and the values they placed on life. By valuing their life, participants 
were inclined to value HAART in an attempt to prolong life and pursue goals. 
In that sense, it seems that values are an expression of future orientation and 
life purpose. By having life aspirations and developing values of life with HIV 
and HAART, participants were more likely to feel motivated and to actively 
engage in taking HAART.          
7.2.2.3. Developing the mindset of valuing HAART taking  
In Section 7.2.1.2, P13’s mention of “心態” was an expression of setting his 
mind by deeply valuing HAART and from the bottom of the heart. Without 
such mindset, P13 articulated that a person would not take action to actively 
manage antiretroviral treatment. However, during the trajectory of HIV and 
HAART, a number of participants appeared to be able to develop a mindset 
that facilitated their HAART-taking. When placing the value on HAART 
taking, participants appeared to perceive its importance, develop the 
mindset, and make regular HAART use a reality.  
“Yes, I must take it. If my CD4 gets lower, I can develop some kinds of 
infectious diseases.” [Later in the interview he added]  “Not taking the 
medications makes me feel like it isn’t right. I feel like no I cannot miss 




“I thought I am still alive, so I cannot let my CD4 cell count being too 
low. It will make me get infections.” (P22, Male heterosexual, 50y) 
P5 and P22’s narratives— “Yes, I must take it”, “I feel like no I cannot miss 
doses”, “I cannot let my CD4 being too low” demonstrated that they tell 
themselves what they should do or what they cannot do in prevention of 
decreased CD4 cell count and opportunistic infections. It indicated that they 
perceived the importance of HAART. The words, ‘must’ and ‘cannot’ stated 
by P5 and P22 were in a strong sense that they set their mind on taking 
HAART. By setting their mind on taking HAART, it increased their motivation 
and their effort to take the actions. It is exemplified by P13 and P18’s 
narratives.   
“I regularly take the medications, because I want to be in a healthy 
condition. I want to live longer and be with my family.” (P13, MSM, 31y) 
“It depends on self. If you want to persist in regularly taking the 
medications, you will.” (P18, Female heterosexual, 32y) 
P13’s and P18’s mention of ‘I want to’, ‘persist’ and ‘will’ illustrates that 
driving force and strong mindset guided and influenced their HAART taking. 
In the example of P13, because he wanted to live longer, he made it happen 
by regularly taking HAART. Taking this into account, it seemed that valuing 
life with HIV and HAART plays a big role in conditioning participants’ mind to 
engage with HAART, as if it was values that governed their thoughts and 
motivated their behaviour. Congruent with this notion, P7’s narratives below 
showed that he developed a mindset in favour of regular HAART use by 
focusing on and valuing the good sides of HAART. With positive thoughts 
about HAART, his mind seemed to go towards that way, contributing to 
regularly taking HAART.  
“Finding its positive side and looking at its positive side. Also, it is 
needed to know its negative side, but we shouldn’t be overly concerned 




bits. As long as I have this kind of mindset, it is more than enough to 
help me regularly take the medications.” (P7, MSM, 30y) 
“My attitude is that I don’t feel like I like the medications, but I would 
view it as part of something that I have to do. Just regularly take it.” 
(P13, MSM, 31y) 
In the case of P13, he did not like HAART, whereas he perceived the 
importance of taking HAART so as to live longer and be with his family. His 
negative feelings towards HAART and perceived importance of taking 
HAART appeared to coexist. By focusing on what he wanted to do and had 
to do in mind, it seemed to have enabled him to let his rational mind prevail 
over his negative feelings towards HAART. As such, it indicates that the 
presence of negative emotion does not imply the absence of embedded 
rational thought. Rather, it was mainly his thinking which led towards 
developing values and a mindset that could facilitate regular HAART use. 
Meanwhile, he also accepted his feeling/emotion towards HIV and HAART.  
Findings presented so far showed that participants’ thoughts and emotion 
were inextricably bound together. In line with P13, P19 and P14’s narratives 
presented below also illustrated that developing the mindset of valuing life 
with HIV and HAART brought their intelligence and rational thinking to bear 
upon emotion.   
“By perceiving what kind of life you want to live, it would affect how you 
view everything. My mindset would affect how I see everything. Some 
people might give up themselves and stuff like that. Some might be 
more optimistic and not view HIV negatively. It’s the way you view 
things.” [Later in the interview, he stated ] “When I have the right 
mindset, I won’t be affected by other people.”  (P19, Male heterosexual, 
43y)) 
“Whether or not to regularly take HAART depends on our deep belief in 
HAART and our value of our own life.” [Later in the interview he added] 




to be affected by drugs. I should say that our internal part is the key.”  
(P14, MSM, 36y) 
In summary, having the mindset was revealed to play an important role in 
activating participants’ desire and motivation for regularly taking HAART. 
With such a mindset, it guided participants to perceive the world in a certain 
way and act upon. In reverse, the way participants perceived HIV and 
HAART through their experience also changed the priority of the values they 
placed on HAART and subsequent HAART-taking actions (Section 7.2.2.1.). 
Similar to the notion identified from the data, Rokeach (1973) views ‘value’ as 
relatively stable over time. It is stable enough to reflect the sameness and 
continuity of an individual’s personality within a given social context. Yet, it is 
also unstable enough to permit the re-organisation of value priority.  
7.3. Discussion 
The concept of health values can be applied in a similar manner as the 
concept of beliefs elucidated in the HBM. Both refer to the degree to which 
an individual has the trust or faith in health, treatment or behaviour (Becker, 
1974, Janz and Becker, 1984, Rokeach, 1973, Rosenstock, 1974b). In the 
HBM, it was felt that perceived benefits, perceived barriers, perceived 
susceptibility, and perceived severity were proposed to provide sufficient 
motivation to perform health behaviour. Nonetheless, it seems to somewhat 
confuse expectancy with motivation, and did not give sufficient explanation of 
the linkage between the two. Becker and his associates (1972) re-evaluated 
the model, and pointed out that an individual’s feelings and concerns are 
important components of his/her motives. Accordingly, they further suggested 
that the four dimensions of the HBM could predict health behaviour but only 
among those who highly value health (Becker et al., 1972). One of the 
limitations of their study is that the concept of values was not clearly defined. 
Compared with beliefs, the concept of values provides a deeper sense of an 
individual’s beliefs that can drive subsequent behaviour (Rokeach, 1973). 




proposed as an important concept of illustrating health behaviour; however, 
values have not been extensively explored and are difficult to be directly 
measured (Lau et al., 1986, Rokeach, 1973).  
‘Attitudes’ is another term that has been compared with ‘values’ in Rokeach’s 
(1973) book. In his book, he maintained that ‘values’ is a dynamic concept, 
having a more immediate link to motivation. Compared with ‘values’, 
‘attitudes’ is relatively peripheral in the belief system and is viewed as a 
casual belief about an object or situation. Fundamentally, ‘attitudes’ is the 
function of ‘value’ (Grube et al., 1994, Homer and Kahle, 1988). When 
choosing a term that can represent the data, ‘values’ was chosen because of 
its more central position.  
In this study, values appeared to play a central role in participants’ HAART-
taking behaviour, and could drive their underlying motives for HAART-taking 
behaviour. To understand HIV-positive drug users’ HAART-taking, it is 
important to gain insight into the values they place on HAART. At the 
beginning of HIV trajectory, some participants tended to possess negative 
emotions towards HIV and HAART and lack the knowledge of HAART. Their 
lack of knowledge was apparent mainly in relation to their unfamiliarity with 
HAART and preconceptions of HAART. Without effective communication with 
health professionals, they could even form a block in the channel of acquiring 
accurate information and clarification. In turn, what they believed to be true 
and good for them had further negatively influenced the value they placed on 
HAART and directed their disengagement with HAART taking. With adequate 
knowledge, it does not necessarily increase the levels of valuing HAART. To 
shape an individual’s values, it was evident in this study that personal 
preference and tendency can determine value priority. Some participants 
tended to value drugs more than HAART; others tended to not perceive the 
importance/need of taking HAART regularly. Together, these led to 
participants not perceiving regular HAART use as important or necessary.  
On the other hand, this study showed that individuals’ development of values 




risks and benefits of regularly taking HAART. The values they placed on 
HAART were arrived at through careful thoughts and reflection on the 
experience of taking HAART. By developing the values of regularly taking 
HAART, participants were more inclined to feel interested and motivated in 
investing time and efforts for it. In addition, the data demonstrate that to value 
HAART goes beyond regarding it as important; instead, it requires a person 
to develop the mindset of valuing HAART and keep it front and center, be 
oriented towards future, and be willing to make time and/or effort for it. Life 
aspirations was revealed to be aligned with the values attached to HAART. 
As participants had life aspirations for future events and connected with 
people and the environment, they were more likely to value HAART taking 
and strengthen their will to actively engage in it. In that sense, values can be 
an expression of future orientation and life purpose. However, it should be 
bear in mind that the values participants placed on regular HAART use were 
relatively stable but did not always stay the same. Rather, this study 
demonstrates that a value could change in its intensity and order over time 
as a result of the change in personal experience, social context, and culture.  
Taken together, ‘values’, therefore, refers to what an individual believes to be 
important at a deep level here. In other words, the values an individual holds 
seems to be a reflection of what she/he deeply and desirably believes and 
feels. It is the deep-seated belief that is targeted towards an individual’s 










CHAPTER EIGHT: CONSCIOUS 
ACTIONS  
8.1. Introduction 
In the last chapter, it was evident that values are an important driver of 
participants’ HAART-taking behaviour. In other words, by placing a value on 
HAART, it seemed to act as a driving force to direct participants’ HAART-
taking behaviour. However, to strictly follow a prescribed HAART regimen 
throughout the treatment process, data revealed that participants would need 
to make a conscious effort and be mindful of their HAART taking in the 
present moment and under the given situations. Therefore, this chapter 
focuses on participants’ conscious awareness and implementation of 
conscious actions, and how it impacted their regular HAART use. 
This chapter is divided into two main sections. The first section looks at 
participants’ experiences of taking HAART without conscious engagement at 
the correct time and in a given situation. The second section focuses on 
participants’ experiences of consciously managing regular HAART use 
through their self-control and self-adaptation. The elements of the two main 










Table 9: Constructs of conscious actions 
Concept Category Sub-category 
8.2. Conscious actions 8.2.1. Not taking conscious 
actions on HAART taking 
8.2.1.1. Lack of conscious 
awareness of HAART taking 
8.2.1.2. Not incorporating 
HAART into everyday life 
8.2.2. Taking conscious 
actions on HAART taking 





8.2.2.2.2. Use of external 
stimuli 
8.2 Conscious actions  
 
Figure 11: Identity-Values-Conscious Actions Model for sustaining HAART-taking behaviour 
Figure 11 shows that individuals’’ integration of HIV-positive identity into 
sense of self is fundamental to self-acceptance and emotional stability. The 
values individuals placed on HAART taking can drive their HAART-taking 




that could greatly influence participants’ ability to sustain their regular HAART 
use. “Conscious actions”, here, is referred to as an individual’s ability to be 
aware of and attend to HAART taking in the present moment and the 
demands of any given situations. The cocnept, conscious actions, is divided 
into two parts, 1) not taking conscious actions on HAART taking and 2) taking 
conscious actions on HAART taking, to explore its impact on participants’ 
ability to sustain regular HAART use.  
8.2.1. Not taking conscious actions on HAART taking 
Drawing on participants’ narratives, most of the participants had the 
experiences of forgetting to take HAART regimens during their treatment 
process. Participants’ forgetfulness was found to be linked to whether they 
consciously managed their HAART taking at dosing times and in a given 
situation. Under this category, there were two facets that emerged from the 
data to influence participants’ HAART-taking behaviour— lack of conscious 
awareness of HAART taking, and not incorporating HAART into everyday life.  
8.2.1.1. Lack of conscious awareness of HAART taking 
As discussed in Chapter 7, participants with a lack of value placed on 
HAART were less likely to invest time and efforts on HAART taking, which 
contributed to mindlessly managing their HAART taking. In this case, they 
tended to intentionally miss doses. On the other hand, even when 
participants tended to place values on HAART taking, many of them had 
unintentionally forgotten doses sometimes. It was evident in the data that 
their unintentional forgetfulness on medication taking was due to their lack of 
conscious awareness. 
 “When I watched movies, I didn’t notice my pill box, and the dosing 
time passed. When you looked at your pill box, you would know if you 
have taken your medications. If you didn’t notice it, you would forget. 
The next day, when I opened my pill box, I found out that I hasn’t taken 




“He wouldn’t remember whether he has taken doses or not. He skipped 
a dose because he didn’t know if he has taken doses. He took a double 
dose because he thought he hasn’t taken yet but actually he has.” (P13, 
MSM, 31y) 
P6 and P13’s narratives —‘if you didn’t notice it, you would forget’, ‘wouldn’t 
remember’ and ‘didn’t know if he has taken doses’ demonstrated their 
unawareness of the dosing times. Without consciously engaging in their 
HAART taking, participants were less able to attend to HAART taking, and to 
exercise control over HAART-taking behaviour, leading to intentionally 
missing doses. In the case of P6, his narratives, presented in the Section 
7.2.1.2., pointed that he rarely missed doses, less than 3 times a month. He 
still sometimes missed doses during the treatment process. Echoing the 
findings, Bandura (2001) in his social cognitive theory from an agency 
perspective illustrated that an individual’s consciousness is a very important 
element in his/her mental life, which can make life more manageable. This 
implies the central role consciousness plays in the cognitive regulation of 
action.  
Many participants’ lack of conscious awareness of HAART taking surfaced 
mainly in relation to their tiredness and busyness.  
“I did not take it mainly because I was busy. If I was busy, I would 
forget. Too many things to do.” (P3, MSM, 37y) 
“I was too busy at work. I forgot. I was too tired and I fell asleep. In that 
situation, I would forget to take doses.”  (P7, MSM, 30y) 
“When I got back in the evening, I was tired. In other words, after taking 
a shower, I would want to sleep right away and then I forgot your doses. 





“When I was tired after work, I would want to sleep. I wouldn’t 
remember taking medications. I would notice it the next day, thinking 
that OMG I forgot taking medications.” (P9, MSM, 35y) 
P3, P7, P9’s mention of ‘too many things’ and ‘busy at work’ illustrates that 
their involvement in other activities shifted their focus onto matters of concern 
other than HAART regimens. By taking participants’ attention away from their 
dosing times, it increased their likelihood of missing doses. In addition, 
drawing on P7, P8 and P9’s narratives, their busyness from work also 
increased their feeling of exhaustion. The narrative — ‘would want to sleep 
right away’ was in a sense that they could not process any more information 
but shut off their brain. With such feelings of exhaustion, participants 
appeared to decrease their awareness and attention on dosing schedules.    
In the case of participants who were on drugs, concern over the effect of 
drugs on impairing an individual’s ability to mindfully manage HAART taking 
has been brought up by many participants. Some examples are presented 
below. 
 “Using drugs would impair your hypothalamus. Sometimes, I thought I 
have taken medications. As I checked all of my medication afterwards, I 
found that I still had many medications.” (P4, MSM, 26y) 
 “Amphetamine can really impair my memory. To me, now I needed to 
take note so that I would be able to remember to take medications. 
After I took drugs, I would just stare at the screen of my computer. Even 
not blinked my eye. So I would forget and ignore something else. I 
completely ignored other external stimuli.” (P12, MSM, 35y) 
“When using amphetamine, I would be alert and fixated on my things. I 
wouldn’t take medications.” (P15, Male heterosexual, 53y)  
“Basically if you used drugs, your memory would get poorer. If you 
forgot, then you wouldn’t take it regularly. The regularity would be 




time, I have taken the medications, but I forgot I have taken and took 
them again.” (P13, MSM, 31y) 
Drawing on the data above, when on psychoactive drugs, it changed 
participants’ state of consciousness and/or impaired their memory. Without 
cognitively engaging in HAART taking, some had difficulty in remembering 
whether they had taken medications or not. As such, it indicates that external 
influences can undermine individuals’ consciousness and impede HAART-
taking behaviour. Nonetheless, in the existing theoretical literature, notions in 
relation to how and in what situation an individual’s consciousness cannot be 
well involved in health behaviour have not been deeply explored. Such 
unsatisfactory expositions of consciousness were found to be due to the 
emphasis scholars placed more on functional aspects of consciousness in 
health behaviour (Chapter 3) rather than its phenomenal aspects (Bandura, 
2001). 
In short, participants’ unawareness of HAART taking were more likely to 
occur when they were not in that state of mind of taking it during dosing times 
and in a given situation. Commenting on this, most participants who were not 
on drugs were unanimous in the view that their unintentional forgetfulness 
was commonly caused by external stressors, such as busyness and 
subsequent feelings of tiredness. Under the situation of using drugs, some 
alluded to the notion of the effects of drugs on altering their consciousness 
and impairing their memory. Considering these accounts, feeling busy or 
tired and under the influence of drugs seem to take participants’ attention and 
energy away from HAART taking. By not ‘being there’ to notice dosing times, 
it can increase the likelihood of missing doses, leading to inconsistency in 
following prescribed treatment regimens.   
8.2.1.2. Not incorporating HAART into everyday life 
Without establishing a lifestyle that incorporated HAART into routines, 
participants, on the whole, demonstrated that the level of their conscious 
engagement with HAART taking was lowered. Consequently, this contributed 




participants’ experiences where they could not or did not integrate dosing 
schedules into their daily routines — the complexity of HAART regimens and 
not developing habitual HAART-taking behaviour. 
“I feel thankful that the medication regimens are more simplified 
nowadays. In the past, I needed to take medications twice a day. And 
this caused me to forget doses sometimes. Because the regimen was 
more complicated. Two pills in the morning, three pills in the evening. I 
needed to organise pills by myself…Now I just need to take it once a 
day. At 8 am every morning. Taking it once a day is less likely to cause 
me to forget. Previously I forgot taking medications not because I didn’t 
take the medications but because I couldn’t remember I had taken 2 
pills or 3 pills.” (P20, Female heterosexual, 36y) 
“My previous regimen was taken twice a day. Different types of 
medications were taken at different times. When you didn’t want to let 
others know what you were taking, taking medications with you and on 
time was challenging...My current regimen is more simplified [In his 
socio-demographic information, it showed that he is currently taking one 
pill before sleep per day. The last time he missed doses was one year 
ago when he still used a more complex regimen]. In the past, I needed 
to take 4-5 pills at one time. It was suffering.” [Later in the interview, he 
added] “I changed to this regimen, because I often missed doses. Time 
issues.” (P9, MSM, 35y) 
“Firstly, the white pills needed to be put in the fridge. That was so 
inconvenient. Secondly, I needed to take so many cocktail medications 
in the early era. Now I don’t need to.” (P12, MSM, 35y) 
Based on P20, P12, P9’s narratives, it showed that HAART regimens in the 
past were more complex in comparison to current treatment regimens. The 
simplicity of HAART has decreased the amount of time and efforts that P20, 
P13, P9 needed to invest for regularly taking HAART. As a result, it helped 




the likelihood of forgetting or missing doses. In the case of P9, his self-stigma 
along with the complexity of his regimen collectively impeded his HAART-
taking behaviour. However, since he changed the regimen to a more 
simplified one, it helped him to manage his HAART more easily and 
mindfully. Congruently, the empirical evidence discussed in Chapter 4 also 
showed that the change in the HAART regimens over the period between 
early HAART era and recent HAART era has enhanced users’ adherence (de 
la Hera et al., 2011, McNeil et al., 2017, Mimiaga et al., 2010, Wittveen and 
Ameijden, 2002). 
There were participants who were able to incorporate HAART into routines 
and developed habitual HAART-taking behaviour. However, data revealed 
that such habitual and routinised acts did not necessarily involve 
consciousness. When taking HAART medications in a new or changing 
context, this requires the person to more consciously engage with HAART 
taking at the correct time. The data presented below showed that due to a 
lack of conscious engagement with HAART taking in the changing 
environment events, some were not able to manage to bring medications 
with them contingently, leading to missing doses.   
“If I am on a business trip for 1or 2 nights, I would sometimes forget to 
take the medications with me. If I remember I would bring them. If I 
forgot, I would take it next day.” [Earlier in the interview, he stated his 
habitual HAART use] “Taking medications has become a habit for me 
now.” (P19, Male heterosexual, 43y) 
“When I went out, I forgot to take medications with me. Sometimes, I 
visited my mum and stayed with her for one or two days, and then I 
forgot to bring my medications. Actually, I had prepared, but just forgot 
to bring my medication bag.” [Earlier in the interview, he mentioned 
about his habitual HAART use] “It seems like a habit of taking the 




“One time I went for a trip, I forgot to bring my medications. My wife was 
really upset that I forgot to bring medications.” [Earlier in the interview, 
he stated his habitual HAART use] “Taking the medications has been 
set into my biological clock now.” (P8, Male heterosexual, 49y) 
According to P19, P5, and P8’s socio-demographic information, it showed 
that they followed prescribed medications most of the time. Nonetheless, 
they seemed to be trapped in a rigid perspective of their usual way of taking 
HAART. Without being conscious of their HAART-taking act and linking the 
act with different environment events, it led to forgetfulness.  
This notion resonates with “self-reactiveness” in social cognitive theory by 
Bandura (1991 and 2001). Self-reactiveness places an emphasis on an 
individual’s deliberative ability to give shape to appropriate courses of action 
and regulate the execution (Bandura, 1991 and 2001). In this study, without 
consciously engaging with HAART taking at dosing times and in a given 
situation, participants tended to perform the behaviour devoid of subjectivity 
and conscious control. 
In summary, to sustain consistency of regular HAART use required 
participants’ conscious engagement with such acts at the correct time and in 
a given situation. However, it seems challenging to maintain a high level of 
consciousness throughout the HAART trajectory, both at the beginning 
(those who have not incorporated HAART into everyday life) and at the 
maintenance phase (those who have established habitual HAART-taking 
behaviour). In that sense, it implies that the operation of conscious 
engagement with HAART taking does not exist in isolation from the external 
environment; rather it required participants to be aware of external 
influences, and proactively and consciously manage their HAART-taking in 
the demands of given contexts.       
8.2.2. Taking conscious actions on HAART taking  
In this study, consciousness is construed as a controlled and intentional 




and self-adaptation so as to fit HAART use into external environment and 
different situations. In that sense, with consciousness, this allowed 
participants to manage the long-term treatment more intentionally and 
strategically. In the following, taking conscious actions on HAART taking 
involves self-control over the behaviour and self-adaptation. 
8.2.2.1. Self-control over HAART-taking and drug-taking behaviours 
Section 8.2.1. discussed that a lack of conscious engagement can 
undermine an individual’s management of HAART taking. On the other hand, 
exerting self-control was revealed to increase the likelihood of maintaining 
participants’ regular HAART use in this study. When participants had the 
control over their behaviour, external influences and use of drugs were less 
likely to impede their regular use of HAART. It is exemplified by P1’s and 
P9’s experiences. 
“My viral load was undetectable once before. My viral load went 
undetectable during the period between June and December 2014. At 
that time, I had a stable job, working from morning to evening. After 
work, I felt tired. I was very healthy at that time. Basically, there were 
many temptations, but I wouldn’t want to go out and have chemsex. The 
reason I didn’t engage in it was my controllability. When I wanted to 
have fun, I would go for it. When I wanted to stop, I would stop.” (P1, 
MSM, 28y) 
“Using drugs wouldn’t affect my regular use of medications, as long as I 
didn’t overly engage in chemsex. As I mentioned earlier, you should 
know how to engage in chemsex and how to control self to not be 
influenced by drugs. So I think it doesn’t matter.” (P9, MSM, 35y) 
Although P1 did not regularly follow prescribed HAART regimen at the time of 
interviewing, he had regularly taken a HAART regimen before. His regular 
HAART use was established when he had a healthy lifestyle and did not 
engage in chemsex. By his definition, a healthy lifestyle seemed to mean 




wanted to…, I would..” and “It was my controllability”, illustrated the notion 
that his decision on whether or not to take HAART and to engage in chemsex 
depended on what he wanted and valued and his self-control. The words 
‘wanted’ and ‘would’ used by P1 were in a sense that he placed values on 
HAART taking (Section 7.2.2.), which subsequently drove his HAART-taking 
behaviour and strengthened his willpower to control his behaviour.  P9’s 
account —“you should know how to…and how to control” — implicitly 
indicates that through the process of his cognitive evaluation, he was able to 
control his own behaviour. In that sense, it seems that an individual’s values 
and self-control are inextricably linked. In the same vein, self-efficacy in the 
HBM, self-reflectiveness in social-cognitive theory, and perceived behaviour 
control in the theory of planned behaviour all convey the belief in an 
individual’s ability to perform and control behaviour (Ajzen, 1985, 1991 and 
2002, Bandura, 1991 and 2001, Rosenstock et al., 1988). Accordingly, 
participants’ deep belief in the importance of regular HAART use had 
enhanced their perceived and actual behaviour control through self-
evaluation and self-reflectiveness.  
P9’s mention of not overly engaging in chemsex so as to regularly take 
HAART indicated his ability to inhibit and resist interference from overuse of 
drugs. In Section 7.2.1.3. and 8.2.1.1., participants’ narratives revealed that 
drugs could exert a significant and negative impact on their medication 
taking. One of the main challenges faced by drug-using participants to 
regularly take HAART regimen was their craving for the euphoric effects of 
drugs and withdrawal symptoms. Such feelings were discussed in Section 
7.2.1.3. to draw some participants’ attention away from receiving HAART and 
to decrease the value they placed on HAART. Nevertheless, by taking control 
from overly indulging in drugs, it helped current drug-using participants to 
consciously manage their HAART taking. The examples are presented 
below. 
“There were some who used drugs and at the same time regularly took 




injecting heroin heavily to fall asleep. It would be enough to just use 
heroin for avoiding withdrawal and not let myself feel too discomfort.” 
(P18, Female heterosexual, 32y) 
“Now drugs don’t affect my use of medications. I have my own rules. I 
used amphetamine only when I was in a good mood. Because if you 
use it when you feel down, it will make your emotion even worse.” (P21, 
MSM, 35y) 
P18 and P21’s narratives presented above showed that they were able to 
temper what they wanted and to ensure that they were not over indulging. By 
developing the mindset of valuing HAART, it helped them to be more 
conscious of and exert control over their behaviour. In addition, an 
individual’s self-control involves not only the values he/she places on HAART 
but also perseverance.  , 
 “I told myself. I have to take the pills. It becomes like a habit. Also, I 
usually take medications with me. I know I must take the medications. I 
always tell myself I must take medications and I cannot miss doses. I 
have to think that if this regimen is not effective I will need to change to 
another regimen.” (P10, Female heterosexual, 33y) 
“I am a careful person. Regardless of whether I use drugs or not, I 
would be careful about my medication taking. Since I started the 
medications, I forgot taking pills only less than 10 times. Maybe even 
less than 5 times. Because I always remember that there are limited 
regimens available. If I run out of the regimens, I can only wait for 
death.” (P11, MSM, 31y) 
In the examples of P10 and P11, the sociodemographic information 
(Appendix 1) showed that P10 never missed doses, and the last time P11 
missed doses was more than 3 months ago. The words — ‘must’, ‘regardless 
of (situations)’, and ‘always remember’ conveyed P10 and P11’s 
determination and perseverance of regularly taking HAART in the demands 




the consequences of erratic HAART use played an important role in the 
development of their strong sense of perseverance and self-control. 
By and large, participants in this study needed to manage not only HAART 
but also addiction. Chapter 6 discusses drug use as a common coping 
strategy to avoid realities and difficult emotion among participants; Chapter 7 
discusses how heavy use of drugs could influence participants’ cognitive 
thinking and decrease the values they placed on HAART; Section 8.2.1.1. 
looks at how drug use negatively impacted participants’ consciousness and 
memory. These point to the notion that drugs posed a negative and 
significant impact on participants’ medication taking. In an attempt to 
minimise the impact of drugs on HAART taking, some participants were able 
to control their drug intake, and this helped them to manage their regular use 
of HAART more easily and effectively. However, the key to self-control 
among participants was to value HAART first, and then they were more likely 
to be aware and persist on following prescribed HAART regimens. 
8.2.2.2. Self-adaptation 
Data revealed that the ways participants consciously managed HAART 
taking are closely linked with self-adaptation. Self-adaptation here is referred 
to as one’s ability to apply cognition and reason to develop skills and adjust 
behaviour to meet goals. In this study, many participants demonstrated that 
they could adapt to changes in any given situations in an attempt to regularly 
take HAART.  
As noted in Section 8.2.1.2., a new and altering context increased the 
likelihood of participants’ unintentional forgetfulness, negatively influencing 
their engagement with HAART taking. Such forgetfulness was particularly 
found to be due to their lack of attention and conscious awareness. While 
participants in this study differ in capabilities of allocating attentional 
resources to respond to contingencies in the environment, it was evident that 
some participants who placed values on HAART taking and persevered with 





“Thinking that if drug resistance occurs I will need to change my 
regimen and re-adapt to a new regimen. I want to avoid it, so I am quite 
careful about it. No matter how the medications could affect me, I would 
still take them.” (P13, MSM, 31y) 
“I always follow the prescribed regimen. The nurse told me that if I don’t 
regularly take the pills, those will be ineffective. Then I will feel awful. 
Thus, even if I used drugs, I rarely forgot to take the pills.” (P11, MSM, 
31y) 
P13’s account showed that his intention and purpose of regularly taking 
HAART provided direction for such acts. In line with P13, P11’s account — 
“Even if I used drugs, I rarely forgot to take the pills” —offers an important 
insight into how the values he placed on HAART functioned as a point of 
reference for exerting conscious control over HAART taking, and self-
adapting for accommodating his treatment schedule. As discussed earlier in 
Section 7.2.2.2., the values P13 and P11 placed on HAART appeared to be 
established through their positive interactions with family. With the feeling of 
being supported by family and development of value of HAART, it fostered 
their directedness and enhanced their adaptability for managing HAART 
taking, regardless of the challenges they faced while taking HAART. 
Congruent with the findings, Bandura (1991 and 2001) in his social cognitive 
theory maintained that people do not have direct control over social 
conditions. However, the outcomes that individuals values can drive their 
motivation and mobilise their efforts to reach the attainment (Bandura, 1991 
and 2001). When having shared values and beliefs with others, it can even 
lead to collective power to produce desired outcomes (Bandura, 1991 and 
2001). To maintain proficiency under ever-changing conditions of life, 
Bandura (2001) suggested a continued investment of time, efforts, and 
resources.  
In line with Bandura’s notions, participants in this study appeared to develop 
skills and strategies, and mobilise resources in an attempt to maintain their 




they developed to change or fit different tasks and environment features. Two 
aspects of participants’ management of HAART taking are listed as follows: 
1) self-protection to avoid stigmatisation and side effects of HAART and 2) 
the use of external stimuli to reinforcing HAART-taking behaviour. 
8.2.2.2.1. Self-protection 
In prevention of public stigmatisation, P10, P16 and P19’s accounts showed 
that they were able to adopt an alternative explanation of HAART 
medications. 
“In the past, I would say it was vitamins. Now my friend gave me an 
empty bottle. I would lie that I was taking supplements.” (P10, Female 
heterosexual, 33y) 
“I would just tell them it was for my gout.” (P16, Male heterosexual, 42y) 
“Last time I went abroad, my friend asked me what I was taking. I told 
them that it was vitamins. They believed it. We just wanted to protect 
ourselves. It was my privacy.” (P19, Male heterosexual, 43y) 
In Chapter 6, HIV-related stigma was identified to be one of the major 
concerns amongst participants. The examples from P10, P16, and P19 
demonstrated that by giving an alternative explanation of the medications 
taken, they were able to regularly take HAART while avoiding stigmatisation. 
In P19’s passage, it showed that his strategy was used to protect himself 
from harm meanwhile maintaining health. In the face of HIV-related stigma in 
the Taiwanese society, P10, P16, and P19 were able to hone their attentional 
and self-adapting skills so that they could enhance their engagement with 
HAART taking.  
To avoid side effects of HAART, P4 and P12 took pills with meals or before 
sleep. If side effects were unbearable, P8’s account below shows his ability 
to actively communicate with health professionals about his concern, and 




“At night, our body is repairing. I would take medications before sleep, 
so the damage caused by the medications can be repaired.” (P4, MSM, 
26y)  
“The first time I used a medication, it caused me night sweat. When 
taking it before sleep, my bed was completely wet in the next morning. I 
didn’t take the medication for long. I asked my doctor to change my 
regimen.” (P8, Male heterosexual, 49y) 
“After I had my meal and medications, I could taste the medications. It 
made me feel uncomfortable. Then, later on, I found that when I had the 
medications after my first bite of the meal, I would feel fine. I found this 
strategy.” (P12, MSM, 35y) 
While some participants had treatment interruption or did not initiate HAART 
due to its side effects (Section 6.2.2.1.1. and Section 7.2.1.1.), P4, P8, and 
P12’s accounts show that their experiences of the side effects of HAART did 
not impede their HAART taking. Rather, they were able to find ways to 
manage side effects or ask a physician or a nurse specialist to change their 
regimens.  
8.2.2.2.2. Use of external stimuli 
In addition to strategies used to protect self from harm and to regularly take 
HAART, many participants used external stimuli as a means of reinforcing 
their regular HAART use. For example, the following passages show that 
participants were able to incorporate HAART into their life by linking dosing 
times with daily schedules, placing medications at a visible place, using a pill 
box, setting phone alarms, or significant others’ reminding. 
Linking dosing times with daily routines: 
  “I set my dosing time at night. It helps my bowel movement next 
morning. I adjust it based on my biological clock. This treatment is not 
really harmful, as long as you use it appropriately. It can make you even 




“Every morning, I would take medications. It becomes part of my life. It 
is normal. I have to do this. I usually take the two medications and also 
vitamins.” (P20, Female heterosexual, 36y) 
“When dosing times came, I would take it. At the very beginning, my 
dosing time was a bit bizarre. I needed to adjust one or two hours 
forward or backwards all the time. I set my dosing time at 10 pm or 2 
am, but I couldn’t take my medications on time. Now I have changed it 
to 12 am. When 12 am arrived, I would remember to take the 
medications.” (P21, MSM, 35y) 
Placing medications at a visible place: 
“Before sleep, I placed my medications near my phone. I would 
remember to take medications.”(P19, Male heterosexual, 43y) 
“I rarely forget. I usually put my medications in a visible place so that I 
would be able to notice and take the medications. When dosing times 
came, I would take it.” (P22, Male heterosexual, 50y) 
Using a pill box: 
“When you see your pill box, you would notice if you have taken 
medications or not. When I opened the pillbox and found I missed one 
dose, I would take it immediately to make up for it.” (P6, MSM, 52y) 
“At the beginning, I was quite careful. When dosing times come, I would 
take the medications. I put the pillbox in the room and then I would be 
able to know if I have taken the medications or not.” (P15, Male 
heterosexual, 53y) 
Setting phone alarms: 




“I usually use phone alarms to remind myself of taking medications. 
When it rang, I would take the medications.” (P17, Male heterosexual, 
37y) 
Significant others as reminders 
“He [her husband] always reminds me of taking medications.” (P10, 
Female heterosexual, 33y) 
“My wife is my supervisor. Supervising me whether I have taken my 
medications.” (P8, Male heterosexual, 49y) 
The aforementioned environmental cues were used by participants to 
strategically remind them of taking doses. As discussed in Section 8.2.1.2., 
not every participant was able to consciously manage regular HAART use. 
However, by setting up an environmental cue or stimulus, participants were 
able to respond to the cue or stimulus promptly every time it was given. This 
finding is congruent with “cues to action” emphasised in the HBM for 
triggering health behaviour (Rosenstock et al., 1988).  Likewise, the data in 
this study revealed that cues or stimuli that could trigger conscious actions 
played an important role in preventing participants from forgetting doses and 
in maintaining their HAART taking.  
8.3. Discussion   
There is considerable theoretical literature that attempts to explain and 
predict individual health behaviour. However, evidence for the maintenance 
of health behaviour remains unclear, which is, in part, due to the lack of 
theoretical elaboration on the behaviour maintenance process following initial 
behavioural change (Kwasnicka et al., 2016).  According to Rotter’s social 
learning theory (1960), the potential for a behaviour (so-called behaviour 
potential) is directly predicated on the strength of one’s drive and need, on 
the basis of past experience, that the given behaviour can lead to satisfying 
outcomes. In the same vein, values were found in this study (Chapter 7) to 




changes. These theoretical expositions all provide a sense that subsequent 
behaviour changes are triggered and enacted based on one’s beliefs and 
needs at a given time and in the demands of given contexts. To manage 
long-term HIV treatment, it is crucial to gain insight into an individual’s 
behaviour change and maintenance, and develop strategies to maintaining 
such behaviour over time and across contexts. However, the existing 
accounts fail to explain what conditions are required to maintain health 
behaviour, prevent relapse, and re-establish health behaviour after relapse. 
The theory of planned behaviour (Ajzen, 1991 and 2002) and Bandura’s 
social cognitive theory (1991 and 2001) stress that behaviour is a function of 
human cognition with regards intentionality, controllability, and self-
regulation. While these theories explain behaviour within the same theoretical 
constructs as behaviour change, the contents of the constructs may change 
substantially from behaviour initiation to behaviour maintenance.     
In Chapter 6, it was discussed that the value participants placed on regular 
HAART use can drive initial behaviour change. However, to maintain 
individuals’ regular HAART use, this study found that it requires participants’ 
implementation of conscious actions over the course of their HIV trajectory. 
Participants’ lack of conscious awareness and not incorporating HAART into 
daily routines were revealed to influence their conscious engagement with 
HAART taking. Without being consciously aware of HAART taking, 
participants were inclined to forget doses. This was predominantly common 
in the situations where they were tired/busy or under the influence of drug 
psychoactive effects. On the other hand, not incorporating HAART regimens 
into daily routines also decreased participants’ conscious awareness of their 
dosing times in the demands of given situations. As a consequence, this led 
to occasionally and unintentionally missing doses among participants who 
valued HAART taking. 
For those who were able to sustain regular HAART use, they tended to have 
a heightened sense of situational awareness while performing HAART taking, 




behaviour needs to be constantly evaluated in an attempt to attain desired 
outcomes. After initial adoption of HAART-taking, participants evaluated the 
results of their behaviour. If the results meet their desired outcomes, their 
behaviour was reinforced (Chapter 7). On the other hand, when not meeting 
participants’ needs (e.g. emotion, immediate need of getting fixed), some 
participants had treatment interruptions. In prevention of this, participants’ 
ability to self-control and self-adapt emerged in the analysis to be an 
important determinant of enhancing and sustaining their HAART-taking 
behaviour.  The ability to self-control and self-adapt is a continuous process, 
which needs participants’ investment of time and efforts to develop cognitive 
skills and to mobilise resources.  
Participants’ HAART taking could vary over time as a result of individual or 
contextual factors. Thus, for those who could maintain their regular HAART 
use most of the time, they tended to possess the characteristics of 
perseverance and determination. With such characteristics, they were more 
likely to actively control behaviour by being aware of external influences and 
strategising about what they desired and valued (e.g. giving alternative 
explanation of HIV medications and use of alarms). In the existing theoretical 
literature, development of habitual responses has been supported to 
enhance the maintenance of health behaviour and decrease execution of 
conscious effort (Hofmann et al., 2008, Verplanken et al., 1999). In this study, 
it was found that such automatic responses did not sustain the consistency of 
participants’ regular HAART use, particularly when they were not in the state 
of mind that could keep them attentive to the changing or different 
environment (e.g. feeling of exhaustion). Instead, participants’ ability to 
develop self-adapting strategies and skills assisted them in managing regular 
HAART more effectively. As a result, consciously and strategically managing 
HAART taking enabled participants to fit regular HAART use with the external 
environment and to achieve sustained performance of regular HAART use 










To answer the research questions (Table 10), in this conclusion chapter, I 
firstly recapitulate the three major concepts, and discuss how they were 
linked to influence HIV-positive drug users’ long-term management of 
HAART taking. Due to the impact of participants’ illicit drug use on their 
HAART taking, a comprehensive account of how their illicit drug use 
interactively influenced their HAART taking is provided. Following the 
recapitulation of the findings, I will move on to discuss the implications for 
future research, nursing practice and policy, contribution to knowledge, and 
limitations of this research.  
Table 10: Research questions 
Main research question: 
What are the experiences of taking HAART among HIV-positive drug 
users? 
Four underpinning sub-questions: 
1. What meanings do HIV-positive drug users attribute to their experiences 
of taking HAART? 
2. What is the process of their HAART-taking behaviour?  
3. How are meanings of HIV-positive drug users’ experiences relating to 
HAART taking constructed through its process? 
4. What contributes to the stability and change of HIV-positive drug users’ 





 9.2. Identity-Values-Conscious Actions Model 
 
 
Figure 11: Identity-Values-Conscious Actions Model for sustaining HAART-taking behaviour 
This section aims to recapitulate the study findings— HIV-positive identity as 
part of self-identity, values attached to HAART, and conscious actions, and 
how these were linked to influence participants’ HAART-taking behaviour. As 
a result, the Identity-Values-Conscious Actions Model was further developed 
(Figure 11). 
9.2.1. HIV-positive identity as part of self-identity 
The impact of HIV-related stigma on HIV-positive drug users’ lives appeared 
to be profound in this study, emotionally, physically and socially. It has been 
documented that such impact did not only occur in Taiwan but globally 
(Batchelder et al., 2013, Chakrapani et al., 2014, McNeil et al., 2017, 
Mimiaga et al., 2010, Rhodes and Sarang, 2012, Small et al., 2009, Ware et 
al., 2005). HIV-related stigma is not a singular entity but intersects with other 
stigmas, such as homosexuality, risky sexual behaviour, illegal drug use, and 
criminality. These discrediting attributes portrayed by Taiwanese and global 
societies could pose a negative and significant impact on how HIV-positive 
drug users perceived themselves as HIV positive, built relationships with 




al., 2017, Mimiaga et al., 2010, Rhodes and Sarang, 2012, Small et al., 2009, 
Ware et al., 2005).  
Identity is defined by Sharma and Sharma (2010) as “an individual’s 
comprehension of him or herself as a discrete, separate entity (p.119).”  Self-
identity is an ongoing process of construction whereby one develops and 
forms a sense of self through personal experience and social interactions 
(Karnilowicz, 2010, Stryker and Burke, 2000). In this study, participants’ 
negative perception of HIV infection was deeply grounded in social values, 
wherein HIV is negatively portrayed by the Taiwanese society. Concerned 
about living with lifelong and stigmatising HIV condition, the sub-categories 
pertaining to emotional distress, avoidance coping, heavy drug use and 
suicidality reoccurred throughout the dataset, particularly in the beginning of 
HIV trajectory. Reluctance to face and accept HIV positive identity as part of 
self resulted in the erratic use of HAART and treatment interruption. Taken 
together, by possessing the new HIV positive identity, it contributed to the 
disruption of participants’ self-identity.   
On the other hand, the findings in this study suggested that participants’ 
integration of HIV positive identity into the sense of self laid a solid 
‘foundation’ for facing HIV and managing HAART. With a coherent sense of 
self-identity, participants were more inclined to be in control of their emotion, 
think rationally, and be resilient. This notion echoes Pierce and his 
associates’ notion of emotion ownership (2003), which refers to having 
control over one’s emotion. They maintained that having emotion ownership 
can assist in re-defining the sense of self and expressing it to others (Pierce 
et al., 2003). In this study, participants’ psychological distress was alleviated 
by their feelings of being supported by, and connectedness, to others and 
society. Being cared for, accepted, and respected by others enabled them to 
regain a sense of personal control which is integral to self-concept and self-
esteem. These findings resonate with Baumeister’s (1999) self-congruence. 
Self-congruence is defined as self-perception that is in accordance with 




perceived acceptance from others can decrease internal conflicts, and thus 
enhance psychological well-being necessary to fulfil self-integration into 
society, and provide a blueprint for the least conflicted plan of actions 
(Baumeister, 1999). From these perspectives, this indicates that social 
connection can facilitate adapting to difficult emotions.  
The impact of an illness on individuals’ sense of self and lives has been well 
documented in the theoretical literature (Bury, 1982, Goffman, 1963, 
Karnilowicz, 2010, Stryker and Burke, 2000). However, far too little attention 
has been paid to the role of self-identity in influencing an individual’s health 
behaviour. Building on the existing theoretical literature, integration of HIV-
positive identity to self-identity emerged in this study as a powerful foundation 
for HIV-positive participants to connect with others, adapt to negative 
emotions, and develop positive thinking towards life with HIV and HAART.  
9.2.2. Values attached to HAART 
Based on the findings, it was revealed that participants’ identity formation 
involved their development of values relating to HAART. As participants 
viewed HIV as part of their self-identity, they were more likely to value regular 
HAART use. Integrated identity, therefore, laid a foundation for developing 
values of regularly taking HAART among participants. However, integrated 
identity did not necessarily lead to values development in respect to regular 
HAART use. Some participants accepted themselves as HIV positive but did 
not value HAART, resulting in erratic HAART use. Values attached to HAART 
emerged in the analysis to play a core role of driving participants’ HAART-
taking behaviour. Values are defined, in this study, as a reflection of what an 
individual deeply believes to be important and necessary. Participants’ 
decision to regularly take HAART is centred around what mattered to them 
and what they wanted. This is the deep-seated belief that was targeted 
towards participants’ needs and motives for behaviour. The concept of values 
attached to health is similar to the concept of beliefs elucidated in the HBM 
(Becker, 1974, Janz and Becker, 1984, Rokeach, 1973, Rosenstock, 1974b). 




“beliefs”, the concept of values provides a deeper sense of beliefs that can 
drive individuals’ acts (Rokeach, 1973).  
In this study, developing the values of taking HAART involved participants’ 
perception of its importance and preference to carry out the action, which is 
formed and reformed through the ongoing process of personal and social 
experience. At the beginning of HIV trajectory, a lack of knowledge and 
negative assumptions relating to HAART were surfaced in the analysis to 
undermine the values participants placed on HAART. By contrast, the 
acknowledgement of pros and cons of regular HAART could increase the 
levels of participants’ awareness and subsequently develop the values of 
taking HAART. In particular, participants’ perception of the 
risks/consequences of not regularly taking HAART appeared to enhance their 
awareness. This finding follows closely on from the PMT by Rogers (1975) 
and Weinstein (1993), with their notion that perceived threats are more likely 
to increase the probability of selecting adaptive responses compared to 
perceived rewards. 
Preference is another important component, identified in the study, to shape 
the values participants placed on regular HAART use. Preference conveys 
the sense of an individual’s tendency to choice, leading to value hierarchy. 
The hierarchical order of individual values is proposed by Rokeach (1973) to 
steer sequences of an individual’s acts. In this study, participants tended to 
prioritise what was important to them. The more an object has value to the 
participants, the more they preferred it over another. When the values they 
placed on drug use and regular HAART use were in conflict, some were in 
favour of pursuing chemsex or injecting drugs but ignored HAART regimens.  
An individual’s value can change in its intensity and order over time as a 
result of the change in personal and social experience. Many participants in 
this study were able to develop the values they placed on HAART. Having 
gone through difficult emotions towards living with HIV and HAART, “life 
aspirations” was found to be inextricably linked with the development of 




social context, thereby giving hopes, meaningfulness, and values in life. The 
findings are consistent with the results from empirical studies, which showed 
that acquisition of support from others could enhance their willingness to live 
longer and motivation to take HAART (Batchelder et al., 2013, de la Hera et 
al., 2011, Mimiaga et al., 2010, Ware et al., 2005). In that sense, values 
attached to HAART seemed to be an expression of future orientation and life 
purposes. By developing the mindset of valuing HAART, it activated 
participants’ desire and motivation of regularly taking HAART. 
The role of values in an individual’s health behaviour has not been 
extensively investigated in empirical studies and theoretical literature. Most 
literature focused on the impact of an individual’s beliefs on health behaviour, 
but did not deeply get into ‘values’ underpinned in the beliefs. Therefore, this 
study provides an important opportunity to advance the understanding of this 
concept and how it can influence individuals’ HAART-taking behaviour. 
9.2.3. Conscious actions 
Placing values on HAART emerged in the analysis to act as a driving force to 
direct participants’ HAART-taking behaviour, whereas to manage and sustain 
long-term and regular HAART use requires an individual’s involvement of 
consciousness. Consciousness is construed here as a controlled and 
intentional process where an individual reflects upon mental activity and 
foster self-control and self-adaptation so as to fit HAART use into external 
environment and different situations. In other words, participants would need 
to manage their long-term HIV treatment intentionally and strategically. 
Bandura’s (2001) emphasis of the importance of consciousness in cognitive 
regulation of action rings true in the analysis of conscious actions in this 
study.  
The findings of this study suggest that without taking conscious awareness to 
the fore at the dosing times, participants tended to unintentionally forget and 
miss doses. This was especially common when participants were in the state 
of tiredness or busyness. In addition, under the circumstances of heavily 




impairing their memory and levels of consciousness. Together, these 
circumstances seemed to take participants’ attention and energy away, 
subsequently undermining their ability to consciously manage HAART taking. 
These findings were in line with the results from the existing empirical studies 
that HIV-positive drug users were more likely to miss doses (de la Hera et al., 
2011, Harzke et al., 2004, Mimiaga et al., 2010, Wittveen and Ameijden, 
2002). Aside from this, how participants reacted to and dealt with external 
influences also posed an impact on their HAART taking. Similar to the results 
from the empirical qualitative literature by Harzke et al. (2004), Mimiaga et al. 
(2010), and Wittveen and Ameijden (2002), findings from this study revealed 
that not incorporating HAART regimens into an everyday routine can 
increase the likelihood of forgetting dosing times. It occurred either due to the 
complexity of HAART regimens or when not consciously aware of the 
changing environment and linking HAART taking with the environment. 
These findings imply that the operation of conscious engagement with 
HAART taking does not exist in isolation from the external environment. 
Rather, it required participants to be aware of external influences, and 
proactively and consciously manage their HAART-taking in the demands of 
given contexts.  
Taking conscious actions to manage regular HAART use involved 
participants’ self-control and self-adaptation to the given situations, and it 
needed to go through the process of their self-evaluation and self-
reflectiveness. By placing high levels of values on regular HAART use, some 
participants appeared to be determined and persevere. Such deep beliefs 
and strong willpowers were found to facilitate building the bridge between 
perceived and actual behaviour control, further developing skills to 
strategically manage regular HAART use. By consciously and strategically 
engaging with HAART taking, it enables participants to fit HAART taking with 
the external environment and sustain their performance of regular HAART 
use. The empirical literature discussed in Chapter 4 also indicates that some 
HIV-positive drug users were able to develop strategies to managing HAART 




2002). However, these empirical studies did not explore the mechanism 
underlying their coping behaviour. Thus, the findings in this study can add 
knowledge to fill the gap in the current evidence base and provide a more 
comprehensive understanding of HIV-positive drug users’ experiences of 
taking HAART. 
9.2.4. Summary  
Drawing on the findings, the integration of HIV identity into the sense of self 
was revealed as fundamental for HIV-positive drug users’ self-acceptance. 
By accepting self as HIV positive, individuals are more likely to face and 
manage their HIV condition and HAART. However, regular HAART use 
cannot be explained and predicted solely by an individual’s integrated 
identity. Some participants with an integrated identity did not value HAART 
and not take it regularly. Instead, the values participants placed on regular 
HAART use appeared to play a central role in directing and driving their 
HAART-taking behaviour. Valuing HAART involves that an individual 
perceived its importance and has the tendency to take it regularly. Once 
participants placed the values on regular HAART use, they were inclined to 
feel motivated in taking HAART, leading to behaviour changes. However, this 
study found that to maintain regular HAART use required participants’ 
conscious engagement with HAART taking. HAART is a long-term treatment 
which requires individuals to strictly follow treatment regimens. To sustain the 
performance of regular HAART use, participants’ self-control and self-
adaptation were particularly found to help manage their HAART taking 
consciously and strategically.   
9.3. Participants’ experiences of taking drugs and 
HAART 
A number of empirical studies reported that active drug use could greatly and 
negatively influence HIV-positive drug users’ HAART taking (Arsten et al., 
2002, Azar et al., 2015, Bouhnik et al., 2002, Carrieri et al., 2003, French et 




et al., 2014, Joseph et al., 2015, Kalichman et al., 2015, Magidson et l., 2015, 
Mellins et al., 2009, Moore et al., 2012, Palepu et al., 2006, Roux et al., 2008, 
Sharma et al., 2007, Wood et al., 2004). However, the interplay between 
drug use and HAART use among this group of the population remains 
unclear in the current evidence base. In this study, participants’ drug use was 
revealed to be linked to their emotion, values, and self-control. These have 
been discussed under each concept, and thus the focus of this section is to 
recapitulate the findings and provide a comprehensive understanding of the 
collective and interactive effects of drug use on HIV-positive drug users’ 
HAART-taking behaviour. 
Participants’ drug use appeared to be closely linked to their emotion. During 
the HIV trajectory, many participants had experienced difficult emotions due 
to HIV-related stigma and family crisis. In the same vein, to date, several 
lines of evidence have revealed HIV-positive drug users’ experiences of 
emotional distress due to stigmatisation and a lack of support (Batchelder et 
al., 2013, Chakrapani et al., 2014, McNeil et al., 2017, Mimiaga et al., 2010, 
Witteveen and van Ameijden, 2002). Building on the results of the previous 
studies, some in this study were inclined to adopt avoidance coping, such as 
denial and drug use, instead of facing the difficulties. Illicit drugs were 
reported by participants to provide pleasure and healing effects. In response 
to stress, some used drugs to fill a void of emptiness and to obtain happiness 
and avoid stress. This is congruent with Anderson’s (2003) notion that when 
situations do not meet one’s choice, the person could avoid the situations in 
hopes of mitigating difficult emotions. Aside from drug use as a coping 
strategy, it was evident in this study that participants’ physical and 
psychological dependence on drugs can also influence their drug-taking 
behaivour. With the experience of drug dependence, it interfered with 
participants’ judgement and increase the likelihood of engaging in risky 
behaviours, such as chemsex and injecting drug use, in an attempt to get 
fixed and soothe anxiety. These risky behaviours were found to greatly 
disrupt participants’ lifestyle and dosing schedules. As a result, it impeded 




interference were found to widen the accessibility gap of HIV care among 
drug users. Such a structural barrier has also been documented in Mimiaga’s 
study (2010). 
Drug use affected the values participants placed on HAART. In particular, 
when participants’ lifestyle and HAART-taking were in conflict, some placed 
an emphasis on drugs more than HAART in pursuit of euphoric effects. 
Values represent individuals’ preference, and the hierarchical order of values 
can influence individuals’ sequence of acts (Rokeach, 1973). In addition, 
drugs were revealed by participants to have the effects of changing and 
distorting their thinking and perception, leading to the rationalisation of drug-
taking and decreased self-awareness of HAART taking. Drugs, therefore, 
became some participants’ main focus and immediate need, and thus they 
were less likely to care about their health and HAART. Given the addictive 
effects of drugs, current literature suggests the effectiveness of methadone 
on decreasing frequency of drug use and promoting drug users’ HAART-
taking (Azar et al., 2015, Hicks et al., 2007, Joseph et al., 2015, Lambers et 
al., 2011, Lappalainen et al., 2015, Lee et al., 2016, Nolan et al., 
2011, .Palepu et al., 2006, Roux et al., 2008, Turner et al., 2003). 
Nonetheless, the findings of this study pointed out that whether methadone 
could effectively treat drug users’ addiction and enhance HAART taking 
depends on where individuals’ values lie. This implies that individuals’ deep 
beliefs are key to managing HAART taking. 
While drug use might affect one’s HAART taking, the findings suggest that it 
is possible to regularly take HAART while still engaging in drug use as long 
as individuals can control themselves over their behaviour. Psychoactive 
drugs impaired an individual’s memory and conscious awareness of 
behaviour and lead to forgetfulness, especially when heavily using drugs. 
However, by taking control from overly indulging in drugs, participants 
appeared to be able to consciously manage their HAART-taking. In the 
existing theoretical literature, most of the focus has been on perceived 




Rosenstock et al., 1988). However, the literature has not clearly explained 
how perceived behaviour control is translated into actual behaviour control. In 
this study, it was found that putting thought into action with regards regular 
HAART use requires individuals to place values on HAART and the 
implementation of conscious actions. As a consequence, individuals are 
more likely to have the ability to manage their drug use and long-term HIV 
treatment.      
9.4. Implications 
9.4.1. Implications for nursing practice 
Nurses play a crucial role in supporting HIV-positive drug users during their 
treatment process, and often have a close connection to them. Thus, it is 
important to use this communication line to address common barriers to 
taking HAART. At the beginning of HIV trajectory, many participants 
experienced emotional distress. This finding suggests that upon diagnosis of 
HIV, nurses need to pay a particular close attention to HIV-positive drug 
users’ psychological well-being by eliciting HIV-positive drug users’ concerns, 
feelings, and self-perception of being HIV positive and taking HIV 
medications. This study offers evidence that patients’ sense of self can be 
also affected by the social context where feelings and thoughts arise. Thus, 
assessing HIV-positive drug users’ support system, including family, friends, 
partners and community resources, can facilitate understanding their support 
sources and identifying the underlying issues that can potentially influence 
their emotion and HAART taking.  
HIV disclosure was found to help increase the chance of obtaining support. 
However, this is one of the major challenges that HIV-positive drug users 
encountered when attempting to gain support. The findings in this study 
suggest that nurses should 1) encourage patients to reflect on and 
understand their emotions, 2) understand patients’ support system, 3) 
educate patients about the importance of self-disclosure, 4) support patients 




educator for and a mediator between patients and their family if patients 
agree, 6) provide referrals and community support resources to meet 
patients’ individualised needs. Together, by providing individualised care and 
integrated services, this can assist HIV-positive drug users in connecting with 
people and society, and enhance their feelings of self-worth, connectedness, 
and hopefulness and meaningfulness of living with HIV and HAART. It is 
recommended to help patients face and deal with their emotions first, and 
then to assist them in making rational decisions and developing strategies to 
emotion regulation in replacement of avoidance coping.  
The findings brought important implications that values attached to HAART 
are the driver of HIV-positive drug users’ HAART-taking behaviour. 
Nevertheless, helping HIV-positive drug users to develop values of HAART 
might take time. The reasons behind it are that it takes time for HIV-positive 
drug users to perceive the importance of regular HAART use, and to develop 
the mindset of valuing it. Thus, this study recommends nurses to regularly 
assess HIV-positive drug users’ needs, and provide education and emotional 
support throughout the treatment process. Peer support and educator groups 
should also be facilitated by nurses to provide support and advice on 
practical issues HIV-positive drug users commonly encountered, and develop 
a sense of community. In doing so, it allows HIV-positive drug users to gain 
insight into the pros and cons of regular HAART use, and increase their 
awareness of its importance. Before and at the beginning of receiving new 
HAART regimen, side effects emerged in the analysis to be one of the major 
concerns among HIV-positive drug users. It is suggested to provide sufficient 
information before initiation of HAART. This can enhance their readiness of 
taking HAART and minimise their misinterpretation of it.  
The meaning of regular HAART use is constructed through HIV-positive drug 
users’ interaction with others and how they perceive themselves and the 
world. Part of the treatment journey involves HIV-positive drug users’ gradual 
discovery and development of values attached to HAART. In that sense, it 




population with patience, non-judgemental attitude, and compassion. 
Commenting on this, the findings of this study provide support for the 
premise that nurses should educate and guide drug users by using 
motivational interviewing techniques (Miller and Rollnick, 2012). Motivational 
interviewing is defined as “a collaborative conversation style for 
strengthening a person’s own motivation and commitment to change (Miller 
and Rollnick, 2012, p.12).” In addition to the use of these communication 
techniques, provision of support from spirituality and religion can also play a 
powerful role in helping HIV-positive drug users to develop the values of 
regular HAART use, and strengthen their will to make behaviour changes.       
Concerning the need for long-term management of HAART taking, forgetting 
to take doses was common among HIV-positive drug users in this study. This 
was mainly due to their tiredness/busyness, non-incorporation of HAART into 
everyday life, changes of environment, or drug effects. To minimise external 
influences, the findings in this study suggest that nurses should regularly 
evaluate the values HIV-positive drug users placed on regular HAART use, 
and assess their ability to self-control and adapt in response to 
contingencies. 
9.4.2. Implications for policy 
To resonate with Sustainable Development Goals (SDGs) plan of action (UN, 
2015, UNODC, 2016), the findings in this study suggest building a strong link 
between police authority, health services, and social services. Criminalisation 
of drug use and fear of police interference can greatly influence HIV-positive 
drug users’ decision to access HIV and addiction services. This study 
suggests to add the role of police officers as a gatekeeper, providing referrals 
to health and social services. By integrating police support services into 
health and social services, it can help to engage this hidden population in the 
integrated health and social care, and optimise their health outcomes  
A number of HIV-positive drug users in this study experienced psychological 
issues and stigmatisation. It is suggested that mental health services for this 




as part of HIV care. While policy pertaining to anti-HIV stigmatisation is 
enacted, HIV-related stigma remains prevalent in Taiwan. It is important to 
extensively promote HIV education in communities, including schools, prison 
settings, and other public areas, with the aim to decrease public 
assumption/prejudice towards HIV-positive drug users.   
Although the number of female HIV-positive drug users is small among the 
HIV population in Taiwan, a lack of addiction service provision that is tailored 
to meet female HIV-positive drug users’ needs could leave them more 
vulnerable to the impact of gender inequality. Drug use can pose an impact 
on access to HIV care and HAART taking among HIV-positive drug users. To 
enhance female drug users’ access to HIV care, issues relating to their 
problem drug use should be tackled. In that regard, this study offers 
suggestive evidence for the provision of addiction services that are gender 
responsive in Taiwan. 
Furthermore, this study suggests that the Identity-Values-Conscious actions 
model can serve as a guide for the national government to understand 
elements of the model of behaviour change and maintenance in HIV-positive 
drug users.   
In short, national government plays a key role in creating an inclusive and 
non-discriminatory society for people with all backgrounds, including HIV-
positive drug users. By integrating them into society, it can enhance their 
sense of community, decrease the likelihood of engaging in risky behaviour 
and crimes, and optimise health at the individual and public health levels.    
9.4.3. Implications for future research 
During the course of this research, a few questions emerged which would be 
valuable to be examined further in future research. 
The expositions of HIV-positive drug users’ HAART-taking are unsatisfactory 
in the current evidence base. It is recommended to study HIV-positive drug 
users’ HAART-taking in different social contexts and understand their 




this study could serve as a point of reference for understanding HIV-positive 
drug users’ experiences of taking HAART in future research projects. In 
addition, it is worth suggesting research to test this model. 
In this research, no difference in HAART taking among males, MSM, and 
females was identified. However, there were only a few female HIV-positive 
drug users recruited in this study. Thus, an implication of this study limitation 
for future research is to focus on female HIV-positive drug users and to see if 
there are any gender differences in HAART taking among HIV-positive drug 
users. In addition, this research did not involve the families of HIV-positive 
drug users. Family is often one of the important aspects in HIV and addiction 
care. It is suggested to understand drug users’ drug use and HAART taking 
from their families’ perspectives. This can provide a fuller picture of drug 
users’ and their families’ concerns about HIV, HAART, and drug use, and 
further develop a more comprehensive and tailored adherence interventions 
that meet affected individuals’ and their families’ needs. 
Values emerged in the analysis to be the core category, whereas the concept 
of values is under-researched in the field of health behavioural research. The 
findings in this study have significant implications for understanding this 
concept in future behavioural research. The constructs of values developed 
in this study and the exposition of values in Rokeach’s (1973) work could be 
taken into account.      
9.5. Contribution to knowledge  
In addition to the provision of some direction for future research, this study 
has made three major contributions to the current literature. 
Firstly, this is the first qualitative study exploring HIV-positive drug users’ 
experiences of taking HAART in the developed country in Asia. Concerned 
with the difference in culture between Eastern and Western countries, the 
way people perceive HIV, HAART and drug use in Asian contexts might differ 




can extend our knowledge of the mechanism underlying HIV-positive drug 
users’ risk and health behaviour within Asian social contexts.  
Secondly, this study, for the first time, developed a conceptual model used to 
understand HIV-positive drug users’ experiences of HAART-taking, including 
behaviour changes and behaviour maintenance. The model of this study can 
be further examined in other social context and refined to fit in different 
contexts. This model can also be used in the future to develop an adherence 
assessment tool and associated adherence interventions.   
Finally, this is the first conceptual model developed and used to understand 
drug users’ experiences of drug use as well as HAART use in Taiwan and 
internationally. When delivering interventions, nurses should assess HIV-
positive drug users’ drug use problems as well as adherence to medications. 
Having said that, this model can offer valuable insight into the interplay 
between HIV-positive drug users’ risky behaviour and health behaviour.  
9.6. The impact of findings 
The research findings and further development of associated interventions 
will be written in reports and articles, and be disseminated to hospitals and 
NGOs involving in HIV and addiction care in Taiwan. As such, it may assist 
service providers in developing the competence to deliver adherence 
interventions to meet HIV-positive drug users’ needs. Aside from the 
workshops, findings will also be disseminated to peer-reviewed journals and 
conferences. Policy makers will be invited to join a roundtable discussion to 
explore the impact of current policies on drug users’ adherence to HAART, 
and how to move forward to enhance drug users’ health behaviour as well as 
potential for impact on their families/significant others.       
With regards the implications of the findings discussed in Section 9.4., 
workshops and training in relation to adherence to antiretroviral treatment 
could be delivered to service users, providers and families/significant others. 




HIV-positive drug users to develop lay summaries of the findings, and to 
obtain their ideas and thoughts about how to shape associated adherence 
interventions, strategies and services. Appropriately targeted panel 
discussions and events could also be undertaken to relevant stakeholders in 
the fields of HIV and addiction, aiming to present and discuss the lay 
summaries of the research findings and further develop future research 
priorities related to adherence interventions/strategies based on the findings.    
9.7. Limitations      
While this study can make contributions to knowledge within the field of HIV, 
addiction, and behavioural research, there are limitations.  
Firstly, the aim of this study is to develop a conceptual model that can 
enhance understanding HIV-positive drug users’ experiences of HAART-
taking. However, during data collection, there were challenges of finding 
female HIV-positive drug users due to a small number of this subgroup in 
Taiwan (N=913) (CDC, 2017), and the possible influence of social 
expectation towards the female gender. Only three female participants were 
recruited in this study. Thus, the findings in this study may not be able to fully 
convey female HIV-positive drug users’ experiences of taking HAART.     
Secondly, findings of this study indicated the impact of social support and 
social stigma on participants’ sense of self and value development. However, 
structural factors, particularly infrastructural factors (e.g. accessibility of 
HAART), were not identified within the findings, and were not found to be the 
main concern for the majority of participants. It is acknowledged however that 
structural factors have been found to be relevant to individuals’ health 
behaviour (Chapter 2: Literature review) as supported by the Behavioural 
Change Wheel proposed by Susan Michie (2011). Future research building 
on the findings of this study, in the Taiwanese culture, could look to take 
account of this element and explore its impact on individuals’ adherence to 
HAART. Despite this being a possible limitation of the study, the conceptual 




potential of being transferred to other social contexts, offering opportunities to 
explore and examine the structural element that was less focused and 
evident in this thesis.  
Thirdly, in the literature review, ‘substance’ misuse was not included in the 
search terms due to my concerns over its broad definition (as opposed to the 
specific focus of this review on drugs) and a large number of relevant 
quantitative studies identified in the databases. Nonetheless, not including 
‘substance’ in the search could lead to omitting articles that are relevant to 
drug users’ adherence to HAART. Therefore, it would be worth including 
‘substance’ in the search in future research to maximise the chance of finding 
relevant studies.  
Fourthly, this research drew on grounded theory approaches to explore drug 
user’s experiences of taking HAART, and to further develop a conceptual 
model that facilitates understanding their behaviours. Whilst recognising that 
other approaches could have been used such as phenomenology to explore 
drug users’ experiences considering that its aim is to understand the 
meanings of participants’ stories (Breakwell, 2004), the rationale for using 
grounded theory was related to the focus on theory development through 
understanding individuals’ experiences. Therefore, in order to move beyond 
understanding, drawing on grounded theory approaches was considered the 
most appropriate.    
Fifthly, this study relies on participants’ self-report, social desirability bias and 
recall bias may become issues (Van de Mortel, 2008). To minimise the taken-
for-granted assumptions, reflexivity was employed throughout the study 
process, where I wrote research memos to document the research decisions 
I made and my reflection on the research process.  
Sixthly, in this study, data were analysed by only one researcher, SS, which 
could potentially bring researchers’ assumptions into analysis and 




Aisha Holloway and Dr Rosie Stenhouse’s supervision of this study 
enhanced the transparency of the study process (Charmaz, 2014).      
Last but not least, concerned about small sample size, the use of convenient 
and purposive sampling in this qualitative study, the findings cannot be 
representative of HIV-positive drug users in Taiwan (which is often the 
limitation of qualitative research) (Gerrish and Lacey, 2010). However, the 
provision of a thick and rich description of participants’ experiences of taking 
HAART in this study allows other researchers to evaluate the applicability of 
the data to other contexts, which can enhance transferability (Polit and Beck, 
2008).     
9.8. Conclusion 
To conclude, this study aims to deeply explore HIV-positive drug users’ 
experiences of taking HAART and subsequently develop a conceptual model 
that can help to understand their experiences of HAART-taking in the 
Taiwanese context. Though it has been documented that HIV-positive drug 
users were less likely to adhere to HAART compared to the general HIV 
population, the mechanism underlying such behaviour remained unclear. 
This study should prove to be particularly valuable to advance understanding 
HIV-positive drug users’ HAART-taking. The key strengths of this study are 
1) the in-depth understanding of HIV-positive drug users’ experiences of 
HAART taking and illicit drug use in Taiwan, 2) the further acknowledgement 
of how HIV-positive drug users’ illicit drug use interactively influenced their 
HAAR-taking behaviour, and 3) the development of Identity-Values-
Conscious actions Model that can be applied to understand HIV-positive drug 
users’ behaviour changes and maintenance. Taken together, these findings 
can provide implications 1) for nursing adherence assessment and 
associated interventions targeting this group of HIV population, 2) for the 
enactment of health and social policies that can create peaceful, just and 




develop a more robust health behaviour model and evidence-based 
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Appendix 2: Summary of theories/models in relation to health behaviour 
Theory/model Core constructs 
Health Belief Model (HBM) 
(Becker, 1974, Janz and Becker, 
1984, Rosenstock, 1974a and b) 
The HBM was spelt out in terms of four constructs 
 Perceived susceptibility  
 Perceived severity 
 Perceived benefits 
 Perceived barriers 
Added concept: Cues to actions, self-efficacy 
Information-motivation-
behavioural skills model (IMB 
Model) (Fisher and Fisher, 1992 
and 2002) 
Health outcomes <- Health behaviour <- Adherence behavioural skills <- Information + 
Motivation 
Moderating factors: social factors 
Protection motivation theory 
(Rogers, 1975, Weinstein, 1993) 
Three components determining the intensity of protection motivation (Rogers, 1975): 
 The magnitude of harm of a depicted event 
 The probability of that event’s occurrence 
 The efficacy of the protective response 
 Self-efficacy 
A Revised version of protective motivation (Weinstein, 1993): 
 Threat appraisal  
− Severity and vulnerability 
− Intrinsic rewards 
 Coping appraisal 
− Response efficacy  
− Response costs 
 
Use costs and benefits of the existing or recommended behaviour to predict the 




Theory of planned behaviour 
(Ajzen, 1985, 1991 and 2002) 
Behaviour: 
 Behavioural intention 
− Attitude towards actions 
 Beliefs about the outcomes of the behaviour 
 Evaluation of expected outcomes 
− Subjective norms 
 Normative beliefs 
 Motivation to comply 
 Perceived behavioural control – Control beliefs 
Health Locus of Control (HLC) 
(Rotter, 1966) 
 Internal locus of control:  A belief that life can be controlled 
 External locus of control: A belief that life is controlled by external factors that cannot 
be controlled by the individual or chance/fate controls an individual’s life 
Social cognitive theory: from Self-
regulation perspective (Bandura, 
2001) 
Structure of self-regulation system: 
 Self-monitoring: it refers to how an individual’s performance is self-
monitored and cognitively processed  
 Judgement: An individual’s standards for guiding behaviour 
 Self-reactiveness:  An individual’s affective reaction that can lead to 
motivating behaviour 
 Self-efficacy 






(Prochaska and Velicer, 1997) 
Involves six stages of change – Precontemplation, contemplation, preparation, action, 
maintenance, and termination.  
 At the pre-contemplation stage, individuals are not intending to change 
their behaviour, typically it occurs in the first 6 months. Their lack of 
intention tends to be due to a lack of awareness.  
 Contemplation is the next stage, where individuals are more aware of 
pros and cons of changing behaviour, and are intending to take action 
















 At the preparation stage, individuals are intending to change behaviour 
in the immediate future. Typically, individuals already have taken some 
significant actions in order to change behaviour, such as gathering 
information of concerns. 
 At the action stage, individuals are actively engaging in making a 
change in their behaviour.  
 At the maintenance stage, individuals are attempting to maintain their 
behaviour change, which starts 6 months after change (action). 
 The termination stage is the stage where individuals have zero 
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Transition out of 
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work and injecting 











and had a 
protective effect 
against being non-
adherent.   

















The proportion of 
achieving at least 
95% adherence 
increased over 
time from 19.3% 
in 1996 to 65.9% 
in 2009.  
Initiation year was 
associated with ≥ 
95% adherence.  
Nolan et al. (2011) 
/(1996-2008) 
Title: Adherence 
and plasma HIV 
















30% of the 267 
participants had ≥ 
95% of adherence 
during the first 
year of ART. 
≥95% adherence, 
participation in 
MMT, and older 


















drug users: The 
role of methadone 
maintenance 
therapy 







129 out of 278 
had ≥ 95% 
adherence 






use and improved 
adherence  
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85.9% of 650 
participants 
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cell count, while 
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was defined as 





359 were IDUs 
(25.3%).  
History of injection 





At 12 months of 
after ART 
initiation, 30.3% of 
non-IDU versus 
42.5% of IDU had 
discontinued 


















users living with 
HIV/AIDS 











refers to the 
sustained use of 
ART, and is the 
opposite of 
discontinuation, 
which refers to 




They had not 
picked up any 
components of 
their HAART 
regimen for one 
month. 
In total, 71 (44%) 
participants 
discontinued 






































study in New 
York 
French et al. 
(2011) 
 





with Changes in 








(use of cocaine, 
crack, heroin in 




number of pills 
prescribed per 
day and the 
number of doses 
they missed in 
the 3 days  
71.7% of 2089 
had ≤ 95% 
adherence 
Clients who 
changed from no 
substance use at 
one interview to 










being not sure to 
very sure about 
the effectiveness 
of ART were 
significantly more 







changed from low 
stress to high 
stress were three 
times more likely 





study in 9 
states of the 
USA 
Chitsaz et al. 
(2013) 
Title: Contribution 
of substance use 














number of pills 
prescribed per 
day and the 
number of doses 
they missed in 
the 7 days  
 
Among all 
subjects, 72% had 
used drugs in the 
30 days. 
Drug use severity 
was negatively 
correlated with 1) 
having an HIV 
care provider, 2) 
being prescribed 




and paid for work 
was associated 















multiple sites of 
USA 
Sharpe et al. 
(2004) 
Title: Crack 













measured with a 
single question, 
“How often are 
you able to take 
the HIV/AIDS 
drugs exactly the 
way your doctor 








always and not 
always. 
Crack users and 
users of other 
drugs were less 
likely than non-





study in South 
Florida  







abusers: the role 









Total ARV doses 
prescribed and 
total doses 
missed in the 
past 7 days 






















of doses taken 
One in five was 












injection drug use 
















are stabilised on 
methadone 
remain at high risk 






























percent of doses 
taken during the 
previous 7 days. 
4-week interval for 
follow-up, over 6 
month period 
Compared to the 
first month, there 
was a significant 
drop in adherence 
at Months 2, 3, 4, 
and 6 for 
percentage dose 
adherent. 
There was a 
reduction from 
76.7 at Month 1 to 




66.4 at M1 to 57.3 













with adherence to 
antiretroviral 















doses to never 
missing doses) 
Perceived efficacy 










Hicks et al. (2007) 
Title: The impact 
of illicit drug use 
and substance 
abuse treatment 










doses missed in 
the past 2 weeks. 
Adherence was 
defined as taking 
greater than or 




drugs in the 
HAART regimen 





likely to be 
adherent than 
former (68%) or 
never users (77%) 
Former users in 
substance abuse 
treatment were as 
adherent to 
HAART as never 
users 
Former users who 










































































of doses taken 
during the 





The majority of 
participants were 
MSM (94%). 
Among the MSM, 
84% identified as 
predominantly or 
exclusively gay. 
Positive affect was 
independently 




injection drug use 











adherence to ART 
A multisite 
cohort study 














missed doses in 
the past three 
days 
Complete 
adherence in the 
past 3 days: 55% 




medical care in 
HIV-infected 
adults diagnosed 
with mental and 
substance abuse 
disorders 
45% of those on 
ARVs reported 
skipping 
medications in the 








































number of doses 
missed versus 
doses prescribed 
over the past 4 
days for all daily 
medications 
Mean adherence 
rates ranged from 
94.46 to 97.72 % 
in the past 4 days 





















There was only an 
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and Mental Health 
Problems 
N=1889  HIV-positive 
individuals (23% 








46% of the 
participants were 
adherent 
Those in the drug 
use only group 
were not 
significantly more 
likely to be 
nonadherent than 
those with no 




group was more 
likely than those 
with no problems 
to have poor 
access. 
Drug use group 
was more likely to 
report poorer fit of 
the medication 













With HIV Infection: 


























the past 7 days at 
three-time points, 
baseline, Week 
12, and Week 24. 
Adherence was 
dichotomized as 
either 100% (no 
missed doses or 
pills any time in 








drug use on the 










report of more 
than two missed 
doses over the 2 
weeks 
Active drug users 




of active drug 






22% of former 
drug users and 




Hinkin et al. 
(2007) 












dose events by 
prescribed doses 
during 1 month 
period 
Adherence: 




rate was 79% as 





for the entire 
sample dropped 
from 74.4% for the 
first 2 months, to 
68.5% for months 
3–4, down to 
62.6% for months 






than both the 
other-drug positive 
group (P = .001) 













than did the 
cocaine only 
group. The mean 
adherence rate for 
the cocaine only 
group was 68.1% 




Drug use was 
associated with 
4.1 times greater 
risk of being a 





10% points, from 
77.4% to 68.4%, 
the drug abuse 
group experienced 
a more precipitous 
decline with their 
mean adherence 
rate dropping over 
18% points (from 




































Arnsten et al. 
(2002) 
Title: Impact of 





in HIV infected 
drug users 
N=85 HIV-positive 







the number of 
cap opening  by 








use, female, not 
receiving social 
security benefits, 
not being married, 
positive for 
depression, the 
tendency to use 
alcohol or drugs to 





predictor of poor 
adherence was 
active drug use. 
Adherence among 
active cocaine 
users was 20%, 
compared to 66% 

















Active Drug Users 










indicated that they 
intentionally miss 
their ART when 




of mixing HIV 
medications with 








































22% of the study 
population were 





















for those with 















Carrieri et al. 
(2003) 
Title: Failure to 
Maintain 
Adherence to 
HAART in a 






N=96 HIV-positive IDUs Convenient 
sampling 
Adherence 




behaviour at any 
visit before the 








during the week 
prior to the visit.  
Non-adherence 
means taking 








adherent at all 
follow-up visits. 
Lack of a stable 
relationship, active 









Moatti et al. 
(2000) 
Title: Adherence 
to HAART in 
French HIV-
infected injecting 










less than <80% 
of prescribed 
doses in the past 
7 days 
34.8% took less 












events during the 
prior 6 months 
and active drug 
use 






drug users: The 
impact of social 
instability  
N=210 HIV-positive 


























Roux et al. (2008) 
Title: The impact 








evidence from the 
MANIF2000 
cohort study 






was used to 
reclassify as non-
adherent those 




HAART in the 4 
days and in the 4 










injection, on OST 









































number of days 
that medication 
was not taken in 
the last 6 
months. 
The rate of non-
adherence (95%)  
ranged from a 
minimum rate of 
6.2% (in 2002) to 
a maximum rate of 
18.9% (in 2005) of 
the visits per year. 
Of the 76 
participants who 
were adherent on 
their first included 
visit and who had 
a follow-up visit, 
26 became non-
adherent at least 














at home) and 


















Jordan et al. 
(2014) 
Title: Correlates of 
non-adherence to 
antiretroviral 





therapy in Hanoi, 
Vietnam 
N=100 HIV-positive 
individuals with a 










reported drug use 
within the previous 
6 months, with 
22% reporting 
current drug use.  
 
Overall levels of 
self-reported ART 
adherence in this 
cohort were high 
(83% reporting 
perfect/very good 
adherence at the 
time of study 
enrollment) 
 
Active drug use 
and duration of 

















and impact of 
ARV provision to 
current and ex-
injecting drug 
users in Manipur 
(India): An initial 
assessment 















Experience of side 
effects, whether 


















Summary of the included qualitative studies (N=11) 















maintained drug users  
15 HIV-positive 










Negative themes are related 
to continued drug use 
1. Denial and resistance 
2. Shame 
3. Perceived isolation 
Positive themes are related 
to decreased drug use 
1. Acceptance of HIV and 
motivation to adhere 
2. Empowerment  
3. Perceived connectedness 















- Group 1 (N=8): Never on 
ART 
1. Involving in active drug use 
2.Lacking information from 
health professionals about 
HAART 
3. Having ambivalent or 
negative attitudes about the 
safety of the medication and 
the intentions of health care 
providers 
Group2 (N=7): Stopped AZT 
and never sought other 
treatment. 
 1. Active drug use 
2. Lack of contact with HIV 
services 
3. Negative experience with 
side effects from AZT  
4. Exposure to negative 









members of this group from 
continuing their use of ART or 
later considering the use of 
ART 
Group 3 (N=9): Stopped 
undergoing HAART 
1. Perceptions of HAART that 
altered in significance as their 
circumstances and 
experiences with the 
medication changed (e.g. level 
of drug use, lack of available 
drug treatment, severity of 
side effects, prior experience 
with clinicians) 
Group 4 (N=10): Undergoing 
HAART 
Working, living with relatives, 
receiving disability payments, 
improved health, trusted 
medical doctors, taking 
HAART in their own ways   
Ware et al. 
(2005) 
Adherence, stereotyping 
and unequal HIV 
treatment for active 
users of illegal drugs 
52 HIV-positive 











1. Daily lives of participants 
2. How drug use impedes 
adherence 
 *Acquiring drugs 
 * Consuming drugs 
 *Recovering from drug use 
3. Not carrying medication 
4.Competing priorities 
5. Redefining regimens 
6. Efforts to adhere to HAART 










  *Prioritising adherence  
  * Sticking with a set of rules: 
the significance of routines 
for adherence 
Canada Small et al. 
(2009) 
The impact of 
incarceration upon 
adherence to HIV 
treatment among HIV 
positive injection drug 












1. Entry into the correctional 
system and interruption of 
treatment 
2. Difficulties accessing HIV 
medications within the 
correctional system 
3. Challenges related to 
institutional health care 
services and HIV care 
4. The importance of 
advocacy and communication 
5. HIV discrimination amongst 
prisoners 
6. Problems upon release to 
the community 
McNeil et al. 
(2017) 
Antiretroviral therapy 
interruption among HIV 
positive people who use 





drug users who 
had not filled an 
ART prescription 
for a period of at 













1.Individual and contextual 
influences on treatment 
fatigue 
2. Negotiating prior adverse 
ART experiences 
3. Social isolation and 
treatment motivation 
Socio-structural  
1. Structural vulnerability and 
discontinuities in the continuity 
of HIV care 
Russian Rhodes and 
Sarang 
(2012) 
Drug treatment and the 
conditionality of HIV 


























2. The problem of drugs in HIV 
treatment access 
3. The problem of inadequate 




“It is easier for me to 
shoot up”: stigma, 
abandonment, and why 
HIV-positive drug users 










1.Stigma and poor patient-
provider relationships 
2. Fragmentation of health 
care 
Ukraine Mimiaga et 
al. (2010) 
“We fear the police, and 
the police fear us”: 
structural and individual 
barriers and facilitators 
to HIV medication 
adherence among 
injection drug users in 
Kiev, Ukraine 










1. Harassment and 
discrimination by police 
2. Opioid dependence  
3. Complexity of drug regimen 
4. Side effects 
5. forgetting 
6. Co-occurring mental health 
problems 
7. HIV stigma 
Facilitators 
1. Cues for pill taking  
2. Support and reminders from 
family, significant other, and 
friends 
3. Opioid substitution therapy 
4. Wanting improved health 
5. Knowledge about HAART 
6. Storage of medications 











et al. (2014) 
Barriers to antiretroviral 
treatment access for 
injecting drug users 
living with HIV in 
Chennai, South India 
19 HIV-positive 
IDUs 










Family and social barriers 
1.Lack family support and fear 
of societal discrimination 
2.Unmet basic needs -  food 
and shelter 
Health care system barriers 
1.Actual or perceived 
unfriendly hospital 
environment and procedures 
2. Provider-perceived 
nonadherence 
3. Actual or perceived 
inadequate counselling 
services and lack of 
confidentiality 
4. Lack of effective linkages 
between ART centres, 
needle/syringe programs, and 
drug dependence treatment 
centres 
Individual-level barriers 
1. Active drug use 




Spain De la Hera et 
al. (2011) 
The opinions of injecting 
drug user HIV patients 
and health professionals 
on access to 
antiretroviral treatment 





















1.Lack of coordination among 
hospital services 
2. Difficulties in accessing 
non-specialised services  
3. Their perceptions of a 











1. A good doctor-patient 
relationship 
2. Family responsibility 
(Female participants) 
3. Complexity and side effects 
of the treatment 
4. lack of social support 
5. active use of recreational 
drugs 
6. Accessibility of services 









Drug users and HIV 
combination therapy 
(HAART): Factors which 
impede or facilitate 
adherence 
27 HIV-positive 









Determinants in relation to 
the medication 
1. Side effects 
2. Treatment regimen 
3. Form and flavour 
Determinants in relation to 
the individual 
1. Acceptance of the condition 
2. Cognitive aspects 
3. Mental health 
4. Knowledge 
5. Physical health 
6. Material circumstances 
Determinants in relation to 
the environment 
1. Relationship with health 
practitioners 




Appendix 4: Information sheet and Consent form 
 
Exploring the experiences with antiretroviral therapy among HIV-positive 
drug users: Constructivist grounded theory 
 
Information sheet for participants 
 
I would like to invite you to participate in this research project.  You should only 
participate if you want to; choosing to not take part will not disadvantage you 
in any way. Before you decide whether you want to take part, it is important for 
you to understand why the research is being done and what your participation 
will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Please contact me if there is anything that is 
not clear or if you would like more information. Thank you for taking time to 
read this information sheet. 
Purpose of this research 
To understand your experiences with HIV treatment.  
Why have you been chosen? 
You are being invited to take part in this study, as you have received HIV 
medications and have had the experiences of illicit drug use. Your 
participation can help us understand HIV-positive drug users’ experiences 




help us to recognise unforeseen issues and design services which are able 
to support the needs of people who are HIV positive and drug users. 
Do I have to take part? 
No, taking part is voluntary.  If you don’t want to take part, you do not have to 
give a reason and no pressure will be out on you to try and change your 
mind.  You can pull out of the discussion at any time without penalty. If you 
decide to take part, you will be asked to sign the informed consent, and a 
copy of it will be given to you. 
What is involved in participating? 
You will be invited to take part in an interview about your experience with HIV 
treatment. The interview will take place in a private conference room at the 
National Taiwan University Hospital, Taiwan Lourdes Association, or 
Operation Dawn, and at the time most convenient for you. The interview will 
take approximately 30-60 minutes. It is intended as an opportunity for you to 
express your views and experiences of HIV treatment.  
 
What will happen to the data after my interview? 
The interview will be digitally-recorded, so that I don’t forget important things 
that you say. All names will be removed during transcription and replaced 
with a code number. I will also remove names of places or organizations 
during transcription so that you cannot be identified.  
All personal information will be kept separate from the interview transcripts to 
protect your anonymity. The digital files will be password protected at Szu-
Szu Ho’s computer, and all documents will be kept in Szu-Szu Ho’s locked 
cabinet at the School of Health in Social Science at the University of 
Edinburgh. All of the research data will be confidential, and only Szu-Szu Ho, 
Dr Aisha Howlloway, Dr Rosie Stenhouse and the clinical supervisor Wang-




the end of the study, if you would like to know the findings of this study, I will 
give you a summary of anonymised findings. 
It is also intended that research findings will be disseminated through 
journals and conferences. All results will be anonymised so that it is not 
identifiable to outsiders. 
What are the benefits of participating? 
There will be no direct benefit to you, although people often find it feels good 
to have some listen to their experiences. Your participation will benefit people 
who are drug users living with HIV through increased understanding of your 
experiences of HIV treatment. This understanding will help improve the 
support available to HIV-positive drug users.  
What are the risks of participating? 
There is no apparent risk of participation. If you feel uncomfortable talking 
about your experiences, you do not have to answer any question if you don’t 
wish to do so. You do not have to give us any reason for not responding to 
any question, or for refusing to take part in the interview.  
If you have any concerns or issues that you would like to discuss with 
someone in a therapeutic environment, a list of support or treatment services 
and contact information will be given to you following the participation of this 
study.  
All of the interview data will be anonymised and kept confidential. However, 
there are limits to promises of confidentiality. You may not need to inform us 
of instances of harm to other people or illegal activity for which you have not 
already been convicted. The use of in-depth interviews in this study will allow 
you to have control of agenda and prevent over-disclosure. 
Reimbursements 
 
You will not be provided with any incentive to take part in the research. 
However, I will give you an NT$200 Seven-Eleven voucher (equivalent to 4 





Who is the researcher? 
My name is Szu-Szu Ho, studying PhD in Nursing Studies at the University of 
Edinburgh. I am a registered nurse who had previously worked at an infection 
unit of a medical centre. My research interest is to understand patients’ 
health behaviour, particularly among people who are HIV-positive and/or 
drug misusers.  
Contact information 
If you are interested in taking part in this research and have any questions 
about this research, you may contact:  
Szu-Szu Ho, 
A PhD student at the University of Edinburgh 
Email: s1225521@sms.ed.ac.uk; sisi863@hotmail.com 
Tel: +886 0978356081; +44 07477463891 
Line ID: sisi863 
This proposal has been reviewed and approved by the Research Ethics 
Committees (RECs) at the National Taiwan University Hospital and the 
School of Health in Social Science at the University of Edinburgh, which are 
committees whose task is to make sure that research participants are 
protected from harm. If you wish to find more about the RECs, please 
contact:  
School of Health in Social Science, University of Edinburgh 
Email: Jo-Anne.Robertson@ed.ac.uk 
Address: Medical School, Teviot Place, Edinburgh EH8  
National Taiwan University Hospital 
Tel: (02) 23123456 # 63160                                                                                              
Address: No.1, Changde St., Zhongzheng Dist., Taipei City 100, Taiwan 









Exploring the experiences with antiretroviral therapy among HIV-positive 




By signing  below,  Participant 
initials 
I confirm that I have been informed of this study’s 
information, and I have read the participant information 
sheet. 
 
I have been given the opportunity to ask questions before I 
sign, and any questions I asked have been answered to my 
satisfaction. 
 
I understand that participation is voluntary and that I can 
withdraw at any time without penalty.  
 
I agree that interviews will be digitally recorded.  
I understand that data will be anonymised and confidential, 
and will be stored and secured in accordance with data 
management policy at the University of Edinburgh. 
 
I understand that data will be confidential and kept secure 
at Szu-Szu Ho’s computer and locked cabinet at the School 
of Health in Social Science. Only Szu-Szu Ho, Dr Aisha 
Howlloway, Dr Rosie Stenhouse and Dr Wang-Huei Sheng 





I agree that anonymised research findings will be 
disseminated through publication and conferences. 
 
I consent to participate in this study  
 
Signature of Participant ___________________ 
Date ___________________________ Day/month/year  
Researcher: 
By signing  below,  Researcher 
initials 
I have accurately read out the information sheet to the 
potential participant, and to the best of my ability made sure 
that the participant understands the purpose, the procedure, 




I confirm that the participant was given an opportunity to 
ask questions about the study, and all the questions asked 
by the participant have been answered correctly and to the 
best of my ability. 
 
I confirm that the individual has not been coerced into 
giving consent, and the consent has been given freely and 
voluntarily. 
 
A copy of this form has been provided to the participant.  
 
 
Signature of the principle investigator________________________ 
  
Signature of the researcher taking 
consent__________________________ 






Appendix 5: Form of collecting socio-demographics 
Socio-demographic characteristics  (Code number:_____) 
Age: ______  
Gender 




o Less than high school          
o High school or equivalent  
o College graduate                  
o Postgraduate                         
Main support source 
o Spouse 
o Other family members 
o Friends 
o No one 
o Others______  
Source of income 
o Paid employment  
o Spouse /family  
o Welfare/unemployment 
o Others ______    
History of illegal drug use 
Oral drug users_____/ Intravenous drug users____ 
Current drug users_____/Past drug users____ 
Substance use 
o Heroin ( HIstoric   Current) 
o Cocaine  ( HIstoric   Current) 
o Amphetamines ( HIstoric   Current)   




o Others _________   
Length of drug use 
o Less than one year  
o 1-3 years   
o 3-5 years   
o > 5 years   
Frequency of drug use if current use 
o < 1 time/ week   
o 2-3 times/ week   
o 4-6 times/ week   
o > 7 times/ week   
Ever in drug withdrawal 
o Yes   
o No    
Ever had methadone maintenance treatment/needle exchange 
programme/addiction therapy  
o Yes    
  Methadone treatment   ( current;  historic) 
  Needle exchange programme ( current;  historic) 
  Addition therapy ( current;  historic) 
o No    
HAART medications  
How long have you been diagnosed with HIV positive 




                                
______________________________________________ 





                                
______________________________________________ 
                                
______________________________________________ 
                                
______________________________________________ 
 
How long have you been on HAART medications? _________ 
How often did you follow HAART regimens? 
  All of the time  
  Most of the time  
  About half of the time  
  Some of the time 
  Never 
When was the last time you missed taking any of your medications? 
  Within the past week ____ 
  1-4 weeks ago ____ 
  1-3 months ago ____ 
  More than 3 months ____ 











Appendix 6: A guideline for semi-structured 
interviews 
Guideline for the semi-structured interviews  
 Self-introducing the interviewer 
 Creating a comfortable and welcoming interview environment 
 
Questions guideline (interview questions may change based on 
participants’ answers)  
Initial questions: 
 Tell me about your experience with being HIV positive. 
Probe: (5Ws) What HIV illness means to you? What contributed to 
this feeling?  
 Tell me about your experience with drug misuse. 
Probe: How you feel about this? Why? How you managed? 
 How does being HIV-positive and a drug misuse impact on your life?  
Probe: What happened? Under what conditions? Why? How you 
managed?  
 Please describe how you feel over the course of HIV illness and 
drug misuse? 
Probe: Tell me why your views have changed or remain the same? 
What have you learned? 
 Tell me about your experiences with HIV treatment?  
Probe: (5Ws)  
 What does HIV treatment mean to you? 
Probe: What contributed to this feeling? 
 How do you feel before and after taking this regimen (At beginning 
versus years later)?  
Probe: Tell me why your views and/or actions may have changed (if 
any)?  What have you learned? 
 Could you describe the lessons you learned through receiving this 
treatment? 
 Has there ever been a specific time when you haven’t taken your 
medication?  
Probe: 1) Why?  
            2) Please describe the situation.  
            3) What contributed to this change or continuity?  
            4) What helps you to manage? 
 Who and what has been the most helpful to you over the course of 





 After having these experiences, what advice would you give to 
someone who has just started the treatment? 
 Is there anything else you think I should know to understand better? 





















Appendix 7: Criteria for assessing studies with 






Has your research achieved intimate familiarity 
with the setting or topic? 
√ 
Are the data sufficient to merit your claims?  √ 
Have you made a systematic comparison? √ 
Do the categories cover a wide range of empirical 
observations? 
√ 
Are there strong logical links between the gathered 
data and your argument and analysis? 
√ 
Has your research provided enough evidence for 






Are your categories fresh? Do they offer new 
insights?  
√ 
Does your analysis provide a new conceptual 
rendering of the data? 
√ 
What is the social and theoretical significance of 
this work? 
√ 
How does your grounded theory challenge, extend, 





Do the categories portray the fullness of the 
studied experience? 
√ 
Have you revealed both liminal and unstable taken-
for-granted meanings? 
√ 
Have you drawn links between larger collectivises 






Does your grounded theory make sense to your 
participants or people who share their 
circumstances? Does your analysis offer them 








Does your analysis offer interpretation that people 
can use in their everyday worlds? 
√ 
Do your analytic categories suggest any generic 
processes? 
√ 
If so, have you examined these generic processes 
for tacit implications? 
√ 
Can the analysis spark further research in other 
substantive area? 
√ 
How does your work contribute o knowledge? How 
does it contribute to making a better world? 
√ 
 
 
